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For most pathogenic bacteria, the adherence to host cells is a crucial step for infection. 
Therefore, targeting bacterial attachment could be a potential way for treating bacterial 
infections. This thesis focuses on the interactions between the adhesin Multivalent 
Adhesion Molecule (MAM7) from the commensal Escherichia coli strain HS with host 
receptors, aiming to understand the molecular basis of these interactions. Targeting the 
interactions between MAM7 and host cells was one of this study’s aims towards 
developing anti-bacterial agents. In this study, HSMAM7 based adhesion inhibitors- beads 
coupled to HSMAM7 and an engineered bacterium expressing HSMAM7- were designed 
and their role as anti–adhesion agents against pathogenic bacteria was investigated. This 
study demonstrates that HSMAM7 based inhibitors have the ability to displace pathogenic 
bacteria from the host cells.  
Dissecting the binding of HSMAM7 to host receptors was the second part of this study. 
The findings revealed that HSMAM7 binds to sulfatide, several components of the 
extracellular matrix (ECM) and mucin. Further investigation of the interaction between 
HSMAM and host receptors revealed that HSMAM7 binds to mucin and the host lipid 
sulfatides via specific recognition of a shared 3-O-sulfo-galactosyl moiety in a sulfation 
dependent manner.  
Sulfatase-producing Bacteroides thetaiotaomicron affect the binding of HSMAM7 to 
mucin. HSMAM7 binding to mucin was inhibited in the presence of B. thetaiotaomicron 
and that means the commensal E. coli would be free and able to attach to the host 
epithelial cells, a finding of potential relevance for inflammatory bowel diseases (IBDs). 
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Chapter 1.  Introduction  
1.1 Bacterial attachment to host cells: principles and prevention 
1.1.1 Bacterial attachment to host cells 
Bacterial attachment to host cells is an important step towards bacterial colonization and 
infections (Ribet and Cossart, 2015). Pathogenic bacteria express a wide range of 
bacterial adhesion factors that enable them to achieve tight interactions with host cells. 
Initial tight attachment of bacterial cells to the host cell surface is prerequisite for 
translocation of effector proteins, disruption of host actin cytoskeleton or induction of host 
cellular signalling that aids bacterial transmigration (Stones and Krachler, 2016). The 
adherence is important for bacterial pathogenicity due to several factors. First, the 
bacterial cell is able to attach to the target cells in the host. In addition, the attachment 
aids the bacterium to not be removed by the host secretions or killed by host defences 
(Lewis et. al., 2016). Thus, successful binding to host cells enhances bacterial ability to 
survive within the host and cause infections (Ribet and Cossart, 2015). Varieties of 
infectious diseases can be caused due to bacterial adherence such as oral, respiratory, 
urinary, gastrointestinal tracts and wound infections (Bosch et. al., 2013; Kim et. al., 2015; 









1.1.2 Molecular basis of host-bacterial interactions 
Bacterial attachment to host cells involves the interactions between specialized structures 
on both host cells and bacterial cells.  Based on the nature of these structures, three types 
of adhesin-receptor interactions have been described. Hydrophobin-protein interactions, 
lectin-carbohydrate interactions and protein-protein interactions (Ofek et. al., 2003a). 
To achieve tight adherence between bacteria and host cells, bacteria need to overcome 
the repulsive forces that result from the similar charges found on both host cells and 
bacterial cell surface. Brownian motion, electrostatic forces, Van der Waals forces, 
hydrophobic interactions (Gottenbos et. al., 2002) and complementary interactions result 
in bacterial attachment that involves two steps. First, non-specific weak reversible 
interactions between hydrophobin on bacterial surface and hydrophobic moieties on the 
host cell surface (Krasowska and Sigler, 2014). These interactions take place during early 
stages of bacterial host contact. Subsequently, specific irreversible interactions occur 
between bacterial adhesins and host cell receptors (Bank et. al., 2011; Seneviratne et. al., 
2011; Umeda et. al., 2012). These interactions include lectin-carbohydrate interactions or 
protein-protein interactions. Lectin-carbohydrate interactions occur when lectins on the 
bacterial cell surface interact with the sugar groups on the host cell membrane such as 
those found in glycoproteins, glycolipids or proteoglycans (Esko and Sharon, 2009; Ofek 
et. al., 2003a). An example includes the binding of FimH adhesin from uropathogenic E. 
coli to mannose-containing host glycoprotein receptors (Lewis et. al., 2016). In addition, 
these interactions involve the binding of the host cell surface lectins such as mannose 
receptors on macrophages, to the surface with bacterial lipopolysaccharides, capsular 




Protein–protein interactions occur between proteins on both bacterial cells and host cells.  
These interactions usually involve the binding of bacterial proteinaceous adhesins to 
extracellular matrix (ECM) proteins, integrins and cadherins. Examples include S. aureus 
fibronectin binding protein A (FnBPA) which bind to the extracellular matrix fibronectin. 
This interaction facilitates bacterial binding to host cell surface by exploiting fibronectins 
binding to the host cell integrin α5β1. The binding of S. aureus FnBPA to integrin α5β1 via 
fibronectin has been shown to aid bacterial uptake into host cells (Sinha, et. al.1999). 
Adhesin of collagen from E. faecalis (Ace) that binds to collagen Type IV, collagen Type I 
and laminin (Nallapareddy et. al., 2006). In addition, invasin, a surface adhesin on 
Yersinia pseudotuberculosis that binds to β integrins to invade mammalian cells (Isberg 
and Leong, 1990), and internalin, a surface protein on Listeria monocytogenes, binds to 
host cells E- cadherin to get into host epithelial cells (Bonazzi,et. al., 2009).   
 
 
1.1.3 Mechanisms of bacterial attachment  
Studying and understanding the mechanisms used for attachment by pathogenic 
bacteria is important for development of novel antibacterial therapies. Bacterial aderence 
to host is critical for the infection and mainly mediated by specialized structures 
expressed on bacterial cell surface commonly known as adhesins (Bank et. al., 2011; 
Seneviratne et. al., 2011; Umeda et. al., 2012).  Adhesins can be made up from proteins 
or polysaccharides. Proteinaceous adhesins are organized either as appendages 




protein present directly on bacterial cell surface and serve as adhesion factors (Craig et. 
al., 2004; Chagnot et. al., 2012). The interaction between fimbria or pili with host 
receptors occur via fimbrial tips. Polysaccharide adhesins are commonly constituents of 
bacterial cell membrane, cell wall or capsule (Wilson et. al., 2002). These adhesins are 
able to recognize and bind to host receptors (Heilmann, 2011). Due to the role of 
adhesins in bacterial binding that provide bacterium the resistance to the clearance by 
mucosal secretions (Kline, et.al., 2009). In addition, the formation of bacterial biofilm that 
depend on bacterial adherence to host cell increase bacterial resistance to the 
antibiotics. Furthermore, bacterial binding result in changes in host signalling that aids 
bacterial spread and avoid the host defence (Stones and Krachler, 2015a). Thus, 
bacterial adhesins are considered as a critical virulence mechanisms for variety of 
pathogenic bacteria (Bosch et. al., 2013).  
 
                                                                             
1.1.3.1 Adhesion mechanisms of Staphylococcus aureus    
Staphylococcus aureus is an important pathogenic bacterium due to the ability to cause 
serious infections and the resistance to antibiotics (Schito, 2006). S. aureus can cause 
different infections to the host such as pneumonia, meningitis, bacteraemia, toxic shock 
syndrome and wound infections. The interaction with the host ECM components is the first 
stage towards biofilm formation (Otto, 2008). S. aureus possess different proteins to 
interact with the host ECM. These proteins are known as microbial surface components 
recognizing adhesive matrix molecules (MSCRAMMs), (Clarke and Foster, 2006; Chagnot 




enzyme that recognizes LPXTG motif at C- terminal of protein and cleaves between the 
threonine and the glycine. Deletion of the srtA gene in S. aureus leads to failure to anchor 
surface proteins and thus inhibition of bacterial infections (Weidenmaier et. al., 2008). 
Fibronectin binding proteins (FnBPs) are a major family of MSCRAMMs that mediates the 
interaction of most clinical isolates of S. aureus with fibronectin (Peacock et. al., 2000). It 
has been shown that biofilm formation in methicillin resistant S. aureus (MRSA) is 
promoted by FnBPA and FnBPB (O'Neill et. al., 2008). Clumping factors (CIfs) ClfA and 
ClfB are another group of MSCRAMMs. ClfA binds to fibrinogen protein (Scully, et. al., 
2015) and ClfB, in addition to fibrinogen, binds to type I cytokeratin 10 on squamous 
epithelial cells, that results in bacterial colonization of the nasopharynx (O'Brien et. al., 
2002). Collagen binding proteins (Cna) (Patti et.al., 1992), elastin binding protein(Ebps) 
(Downer et.al., 2002) and Staphylococcal protein A (spa) are further MSCRAMMs that 
allow the bacteria to avoid the host immune response (Votintseva et. al.,2014).  
Another group of proteinaceous adhesins is the secretable expanded repertoire adhesive 
molecules (SERAMs) (Chavakis et. al., 2005). These proteins include extracellular 
adherence protein (Eap), extracellular fibrinogen binding protein (Efb) (Lee et. al, 2004) 
and Coagulase (Coa) which binds to collagen, fibronectin, laminin and fibrinogen 
(Watanabe, et. al., 2005). In addition, the family of autolysin/adhesinscontains proteins 
that have both enzymatic and adhesive properties, such as autolysin AtI which binds to 
fibronectin (Hirschhausen, 2010) and autolysin/adhesin from S. aureus  Aaa  that 
mediates the adherence to fibronectin, fibrinogen and vitronectin (Heilmann et. al., 2005). 




intercellular adhesin (PIA), teichoic and lipoteichoic acids (Heilmann, 2011; Lin et. al., 
2015).                                                                                                                          
 
1.1.3.2 Adhesion mechanisms of Enterococcus faecalis 
Enterococcus faecalis is an opportunistic Gram positive pathogenic bacterium that has 
been shown to be a causative agent of nosocomial infections with resistance to antibiotics 
(Vilela et. al., 2006). E. faecalis can cause a wide array of diseases such as urinary tract 
infections, bacteraemia, endocarditis and wound infections (Fowler et. al., 2005; Olawale 
et. al., 2011). E. faecalis possess surface proteins associated with bacterial adherence to 
host ECM proteins (Nallapareddy and Murray, 2006). It has been shown that E. faecalis 
has a family of putative MSCRAMMs (Sillanpaa et. al., 2004) and pilus subunits (Sillanpaa 
et. al., 2013). Fibronectin-binding protein (EfbA) mediates the binding to fibronectin, 
collagen I, and collagen V (Singh et. al., 2015). In addition, the adhesin of collagen from 
E. faecalis (Ace) mediates the binding to collagen Type IV, collagen Type I and laminin 
(Nallapareddy et. al., 2006a).  Ace plays an important role in the E. faecialis infections 
including endocarditis. It has been shown that deletion of genes encoding Ace attenuates 
bacterial colonization of the heart valve (Singh et. al., 2011). In addition, E. faecalis 
express the endocarditis and biofilm-associated pilus (Ebp) that shows a significant role in 
bacterial pathogenicity (Montealegre et. al., 2015). Ebp is an extracellular hair-like 
structure consisting of three subunits EbpA, EbpB and EbpC, and adhesion to host ECM 
proteins occurs via the subunit EbpA (Schembri et. al., 2015). Ebp interacts with ECM 




receptors or indirectly via ECM proteins (Nallapareddy et. al., 2011a). The Ebp pilus 
contributes to bacterial infections including urinary tract infections and endocarditis 
(Nallapareddy et. al., 2006b; Nallapareddy et. al., 2011b; Singh et. al., 2007). Disruption of 
genes encoding Ebp attenuates bacterial infections (Nallapareddy et. al., 2006b).  
 
1.1.3.3 Adhesion mechanisms of Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a Gram negative opportunistic pathogen which can cause a 
wide range of infections especially in immunocompromised patients (Sadikot et. al., 2005). 
It causes bacteraemia, respiratory system infections, urinary tract infections and wound 
infections (Alharbi and Zayed, 2014; Kim et. al., 2015; Li et. al., 2005). P. aeruginosa 
expresses different structures that mediate the binding to the host cells such as flagella, 
type IV pili, lipopolysaccharide (LPS), surface polysaccharide (alginate) and lectins 
(Sadikot et.al., 2005; Chemani et.al., 2009).  
The major adhesins in P. aeruginosa are flagella and type IV pili (Jyot et. al., 2007; Lillehoj 
et. al., 2002). The single polar flagellum is involved in motility, adhesion of the bacteria to 
host cells and biofilm formation (Bucior et. al., 2012). The major flagellar protein is flagellin 
that interacts with Muc1 mucin (Lillehoj et. al., 2002). In addition, flagellin is detected via 
Toll-like receptor (TLR5) at the cell surface (Raoust et. al., 2009). It has been found that 
deleting flagellum genes such as flagellar cap fliD leads to disruption of motility and 
adherence (Arora et.al., 1998).  
Type IV pili are composed of pilin subunit PilA, which is produced in the cytoplasm and 




2015; Lee and Schneewind, 2001). Many studies have shown that pili play a significant 
role in the bacterial binding and colonization of mucosal epithelial cells. Type IV pili bind to 
glycolipids on the epithelial surfaces (Craig et. al., 2004). 
The glycolipid LPS is anchored in the bacterial outer membrane and comprises of lipid A, 
core oligosaccharide and O antigen (Pier, 2007), recognized by TLRs such as TLR2 and 
TLR4 which effectively defend against P. aeruginosa infections (Mc Isaac et. al., 2012; 
Raoust et. al., 2009). In addition LPS mediates binding to the glycolipid Asialo GM1 
(Gupta et.al., 1994). Exopolysaccharide (alginate) mediates the binding to mucin on 
tracheal cells (Ramphal et. al., 1987; Lovewell et.al., 2014).  
The adhesion of P. aeruginosa is also mediated by carbohydrate binding lectins, such as 
LecA and LecB. Lectins are present on the outer membrane and recognize 
glycoconjugates on the epithelial cells (Chemani et. al., 2009; Tielker et. al., 2005). 
Blocking lectins may prevent P. aeruginosa infections (Sharon, 2006; Thomas and 
Brooks, 2004; Grishin et. al., 2015). It has been revealed that using lectin inhibiting 
carbohydrates (methyl derivatives of galactose and fucose) on P. aeruginosa lung 
infection, both in vitro using lung epithelial cell line and in vivo using a murine model, 







1.1.3.4   Multivalent adhesion molecules (MAMs) 
Recently, it has been reported that many Gram negative bacteria have outer membrane 
proteins known as Multivalent Adhesion Molecules (MAMs) which facilitate bacterial 
attachment to host cells throughout the initial steps of host infection (Krachler et.al., 2011).  
MAMs consist of six or seven mammalian cell entry (Mce) domains headed by an N-
terminal hydrophobic region (Krachler and Orth, 2011), (Figure 1.1). However, proteins 
comprising of a single mce domain are found in Mycobacterium tuberculosis (Arruda et. 
al., 1993), pathogenic Leptospira strains (Zhang et. al., 2012), and higher plants (Lu and 
Benning, 2009).  
The first description of mammalian cell entry domains was in M. tuberculosis. M. 
tuberculosis contains four mce operons, known as mce 1, mce 2, mce 3 and mce 4. The 
mce loci consists of two yrbE (yrbEA and yrbEB) genes encoding two integral membrane 
proteins, homology to ATP binding cassette (ABC) transporter permeases which 
responsible  for translocation of substrates through membranes, and six mce genes 
(mceA, mceB, mceC, mceD, mceE, and mceF) as substrate binding proteins (Arruda 
et.al., 1993; Casali and Riley, 2007). The physiological function of these is thought to be in 
lipid metabolism (Santangelo et. al., 2009; Casali and Riley, 2007), in addition to the role 
in M. tuberculosis virulence (Chitale, 2001). It has been found that expressing M. 
tubercolusis mce1A in non-pathogenic E. coli allows this bacterium to enter and persist 
inside epithelial cells (Arruda et.al., 1993).  
Pathogenic strains of Leptospira species possess an Mce protein, a surface-exposed 
outer membrane protein, which use α5β1 and αvβ3 integrins as host receptors (Zhang et. 




disruption of mce gene attenuates the ability of the bacterium to enter to host cells (Zhang 
et.al., 2012; Cole et.al., 1998). 
Plants such as Arabidopsis contain a TGD2 gene that encodes for TGD2, a chloroplast 
protein which consists of a predicted transit peptide, a transmembrane domain and an 
mce domain similar to the mce domains of mycobacteria, and it binds to phosphatidic acid 
(Lu and Benning, 2009).  
Ekiert et. al., reported that E. coli contain three mammalian cell entry (Mce) proteins; 
MlaD, PqiB and YebT. MlaD is a peripasmic hexameric ring, PqiB comprises of three 
MCE domains, whereas YebT (known as MAM7) contains seven MCE domains. The Mce 
proteins involved in the carrying of lipids between bacterial inner and outer membranes 
(Ekiert et. al., 2017). 
 The well characterized V. parahaemolyticus MAM7 is an outer membrane protein and 
consists of an N- terminal region of 44 amino acids for MAM localization on the bacterial 
outer membrane and seven mce domains that are exposed extracellularly and responsible 
for bacterial binding to host cells. Removal of the N-terminal region of MAM7 results in 
cytoplasmic retention of the protein (Krachler et. al., 2011). The attachment of MAM7 to 
host cells occurs via recognition of the host receptors, fibronectin and phosphatidic acid 
(Krachler and Orth, 2011). V. parahaemolyticus MAM7 uses fibronectin as a co–receptor 
to facilitate the initial binding with host cells. Biochemical analysis of this interaction 
revealed that MAM7 binds to the 30-kDa N-terminal fragment of fibronectin and at least 
five mce domains of MAM7 are required to achieve stable binding between MAM7 and 
fibronectin. The interaction between V. parahaemolyticus MAM7 and phoshatidic acids on 




RhoA and actin rearrangements in host cells leading to disruption of the epithelial barrier 
and finally help bacteria to arrive at the underlying tissue (Lim et.al., 2014; Stones and 
Krachler, 2015b). MAM7 contributes to bacterial virulence due to its function in bacterial 
attachment, a key step towards infection. It is known that many bacterial virulence factors 
are regulated and their expression is induced in response to a change in invironmemtal 
conditions during infection (Pizarro-Cerda and Cossart, 2006). However, MAM7 adhesin is 
constitutively expressed and thus is able to mediate initial attachment to host cells early 
during infection (Krachler and Orth, 2011), therefore facilitates the translocation of 
effectors into host cells via secretion systems (Filloux et. al., 2008; Zhang and Orth, 2013; 
Cambronne and Roy, 2006). 
 Using a nematode infection model, it was demonstrated that lethal effects mediated by 
T3SSs resulted from feeding Caenorhabditis elegans worms with V. parahaemolyticus 
RIMD 2210633 or V. parahaemolyticus POR1. However, the ingestion of mutant strains 
lacking MAM7 leads to reduced mortality (Krachler et. al., 2011). Similar results of a 
MAM7 dependent reduction in mortality were obtained when Galleria mellonella larvae 
were injected with Shigella sonnei wild type or MAM7 deletion strains (Mahmoud et. al., 
2016). Moreover, in a guinea pig model, keratoconjunctivitis was caused due to the 
infection with Shigella sonnei   wild type compared to a MAM7 deletion strain which did 
not cause infection (Mahmoud et. al., 2016). In addition, using mammalian cell models, it 
has been shown that disruption of MAM7 gene in pathogenic bacteria such as V. 
parahaemolyticus, Y. pseudotuberculosis, V. cholerae, enteropathogenic E. coli or 
Shigella sonnei results in decreased bacterial attachment and cytotoxicity (Krachler et. al., 




adherent bacteria. It has been revealed that expressing MAM7 in the non-adherent E. coli 
BL21 enables them for attachment and competition with pathogens for binding sites 
(Krachler et. al., 2011). The competition between BL21 expressing MAM7 with pathogenic 
bacteria results in inhibited bacterial adherence and cytotoxicity towards host cells. 
Targeting MAM7 or using MAM7 based tools is a promising way towards developing 
antibacterial therapies. In tissue culture models, V. parahaemolyticus MAM7 based 
inhibitors were used to inhibit the infections caused by multi-drug resistant pathogens 
such as P. aeruginosa, E. coli, Acinetobacter baumannii-calcoaceticus complex and 
Klebsiella pneumoniae (Krachler et. al., 2012). In addition, a MAM7 based inhibitor 
blocked S. aureus (MRSA) infection without interfering with host cell functions (Hawley et. 
al., 2013). Recently, MAM7 based inhibitor, recombinant GST-MAM7 coupled to beads, 
has been used in vivo to heal burn wound infections caused by multi -drug resistant P. 


















Figure 1.1 Diagram of MAM7 protein architecture. The N-terminal transmembrane region 











1.1.4 Ways to prevent bacterial attachment   
Considering that bacterial attachment is a key step towards infections, targeting bacterial 
attachment is a promising approach to inhibit bacterial colonization and infection at an 
early stage. Antibiotics prevent bacterial infections by killing or inhibiting bacterial growth, 
by interfering with essential bacterial functions, and hence, bacteria have developed 
mechanisms to resist antibiotics and survive. In contrast, anti–adhesion therapy prevents 
bacterial infections by targeting a virulence-specific function, which in theory gives less 
selection pressure and therefore would result in less resistance. It works by blocking 
bacterial adherence to host cells without killing them (Cozens, 2012; Krachler and Orth, 
2013). A variety of ways can be used to inhibit bacterial adherence and thus prevent 
infections, such as disruption of adhesin biosynthesis (Larsson et. al., 2005; Jahanshahi 
et. al., 2010), receptor analogs (Ofek et. al., 2003b; Kouki et. al., 2013), anti-adhesive 
vaccines (Langermann and Ballou, 2003; Kisiela et. al., 2015), probiotics and engineered 
probiotics (Asahara et. al., 2011;Paton et. al., 2006) and adhesin analogs (Krachler et. al., 
2012; Daep et. al., 2011), (Figure 1.2). These strategies will be covered in detail in the 














Figure 1.2 Different strategies to prevent bacterial adhesion. A: disruption of adhesin 
biosynthesis. B: receptors analogs. C: anti-adhesive vaccines. D: probiotics and 












1.1.4.1 Disrupting adhesin biosynthesis 
The ability of bacterial cells to attach to host cells could be inhibited by the exposure to 
sub inhibitory concentrations of antibiotics. Morphological changes could cause bacteria to 
lose the ability to adhere (Wagner and Hensel, 2011). It was found that using sub 
inhibitory concentrations of ciprofloxacin induce morphological changes such as formation 
of filaments in Escherichia coli, Klebsiella oxytoca, Enterobacter cloacae and 
Acinetobacter calcoaceticus biotype anitratus (Wojnicz et. al., 2007). P. aeruginosa 
adherence was inhibited when sub inhibitory concentrations of piperacillin and tazobactam 
were used due to the changes that occurred in the bacterial morphology and 
hydrophobicity (Fonseca et. al., 2004). Using sub inhibitory concentrations of 
trimethoprim, sulphiazine and sulphamethaxazole resulted in prevention of the binding of 
E. coli to host cells. In general, these antibiotics at sub inhibitory concentrations inhibit 
protein synthesis and bacterial fimbriae display (Jahanshahi et. al., 2010).  
In addition, disruption of pili could be accomplished via the interference with fimbriae 
assembly by the chaperone–usher pathway. This pathway involves the delivery of the 
pilus subunits by chaperone FimC, which are translocated by Sec apparatus in the inner 
membrane, to the outer membrane where the subunits are separated from chaperone 
FimC and assembled via the usher FimD (Pizarro-Cerda and Cossart, 2006).  It has been 
reported that using pilicides, bicyclic 2-pyridones inhibited the attachment of E. coli as a 
result of the binding of pilicides to the surface fragment of the chaperone that contributes 
to the interaction with the usher protein (Larsson et. al., 2005; Pinkner et. al., 2006; Aberg 




biosynthesis using curlicides, a group of bicyclic2-pyridone derivatives (Cegelski et. al., 
2009). 
 
1.1.4.2 Inhibition using receptor analogs  
Characterization of host receptors helps in designing and developing adhesion inhibitors. 
Receptor analogs are polysaccharides that are similar to those on host receptors and 
competitively block bacterial adherence to the host cells surface (Ofek et. al., 2003b).  
Usually, bacterial adhesion factors target the host receptors containing sugar groups such 
as glycoproteins, glycolipids or proteoglycans. Thus, using soluble oligosaccharides as 
adhesion inhibitors may inhibit pathogens that bind to host cells by lectins (carbohydrate 
binding adhesins) (Ofek et. al., 2003b; Kouki et. al., 2013). Receptor analogs can be 
obtained from a range of natural and synthetic sources. The naturally sourced analogs 
involve milk and plant extracts. Oligosaccharides, glycoproteins and glycolipids in human 
milk contain sugar groups similar to the host glycans. Therefore, milk glycans 
competitively bind to pathogens and inhibit infections (Peterson et. al., 2013). Milk glycans 
have protective effects against infant diarrhoea (Morrow et. al, 2004), in addition to 
preventing the binding of a variety of enteropathogenic bacteria to Caco2 cells (Salcedo 
et. al., 2013). Plants such as Cranberry, Ginger, Cayenne and green tea are attractive 
sources of adhesion inhibitors (Stapleton et. al., 2012; Kontiokari et. al., 2001; Bonetta et. 
al., 2012; Bensch et. al., 2011). Cranberry extract prevents Helicobacter pylori binding to 
human red blood cells and mucus (Burger et. al., 2000), and inhibits the binding of E. coli 




attachment of Propionibacterium acnes, H. pylori and S. aureus due to it containing acidic 
polysaccharides (Lee et. al., 2006).  
Studying the interactions between bacterial adhesins and host receptors provides 
information which helps to design synthetic receptor anologs to inhibit bacterial 
attachment (Almant et. al., 2011; Salminen et. al., 2007). For example, the mannosylated 
uroplakin Ia (UPIa) on the urothelial cells serve as a binding site for FimH present at the 
tip of type 1 pili on the uropathogenic E. coli cell surface (Zhou et.al., 2001; Min et.al., 
2002).  It was found that the adherence of E. coli mediated by type 1 pili was reduced 
using multimeric heptyl-mannosides in a murine model (Gouin et. al., 2009). 
Uropathogenic P-fimbriated E. coli recognize Galα1, 4Gal motif in the host glycolipids. 
Thus, the trisaccharide globotriose (Galα1, 4Galα1, 4Glc) inhibited bacterial colonization 
of mouse bladder (Leach et. al., 2005). Furthermore, various strains of Streptococcus suis 
bind to host glycolipids via Galα1-4Gal-containing oligosaccharides. Therefore, using a 
multivalent adhesion inhibitor containing Galα1-4Gal- may result in the inhibition of 
bacterial adherence (Kouki et. al., 2013).  
 
 
1.1.4.3   Anti adhesin vaccine 
Immunization of the host to produce adhesin -specific antibodies is an attractive way to 
protect the host from infections (Kisiela et. al., 2015). Protection can be achieved by active 
or passive immunization. Active protection involves the application of adhesin directly to 




treating the host with antibodies prepared in another host. For example, the infection of 
enterotoxigenic Escherichia coli (ETEC) in pigs is mediated by K88 fimbria. The binding of 
K88 with glycosphingolipids on enterocytes aids bacterial colonization and release of 
enterotoxins that cause diarrhoeal disease (Dubreuil et. al., 2016). It has been shown that 
the immunization of piglets with vaccines based on K88 fimbriae prevent diarrhoeal 
disease (Melkebeek et. al., 2013).  
The FimH adhesin mediates Escherichia coli adherence to bladder cells.  It has been 
shown that anti FimH antibodies inhibit the adherence of E. coli to bladder cells in vitro 
(Palaszynski et.al., 1998). In addition, the immunization with FimH adhesin protects 
against uropathogenic E. coli infections in mice and monkeys (Palaszynski et. al., 1998; 
Langermann and Ballou 2003; Langermann et. al., 2000; Kisiela et. al., 2015). An anti-
adhesin vaccine was used to inhibit P. aeruginosa infection. It was reported that a small 
peptide in P. aeruginosa strain K (PAK) pili can bind to epithelial cells. The immunization 
of a murine model with a vaccine based on this peptide leads to inhibition of P. aeruginosa 
infections (Cachia and Hodges, 2003). Streptococcus mutans cause tooth decay and its 
binding is mediated by the surface protein known as streptococcal antigen I/II (SA I/II). It 
has been revealed that S. mutans colonization was delayed when SA I, II adhesin 







1.1.4.4   Probiotics and an engineered probiotics 
Probiotics are live microorganisms, which when administered in adequate amounts, 
confer beneficial effects to the host. The most used probiotics are Lactobacillus and 
Bifidobacterium, in addition to Bacillus, Pediococcus and yeasts (Soccol et. al., 2010).  
Many studies showed the antagonistic role of probiotics against enteropathogenic bacteria 
via the production of antimicrobial agents, competition for nutrients and competition for the 
binding sites on mucosal epithelial cells (Soccol et. al., 2010; Abedi et. al., 2013). The 
anti-adherence properties of probiotics have been investigated and revealed their 
effıciency in blocking pathogenic bacterial adhesion (Banerjee et. al., 2009). Using a 
murine model, it has been reported that colonization by Bifidobacterium breve strain 
Yakult and Bifidobacterium pseudocatenulatum DSM 20439 prevents the production of 
shiga toxin and protects mice from Shiga toxin-producing Escherichia coli (STEC) 
infections (Asahara et. al., 2004). The competition of Lactobacillus delbrueckii subsp 
bulgaricus with Escherichia coli reduced E. coli attachment to Caco-2 cells (Abedi et. al., 
2013). Another study revealed that the attachment of V. parahaemolyticus to HT-29 cells 
was reduced using L. plantarum AS1 (Satish Kumar et. al., 2011). Furthermore, 
Lactobacillus salivarius was able to inhibit Salmonella enteritidis colonization in chickens 
(Pascual et.al., 1999).  Another in vivo study using a murine model showed that the 
infection of Salmonella enterica serovar Typhimurium DT104 (DT104) was inhibited using 
the Lactobacillus casei Shirota strain (Asahara et. al., 2011).  
Although probiotics effectively prevent enteropathogenic infections, they are non- specific 
in action and their activity may differ from host to host. In addition, many factors affect 




the formulation as a probiotic product (Morrow et. al., 2008). Therefore, engineered 
probiotics have been generated. The designer microbes can be engineered to express 
lipopolysaccharides mimicking host receptors. It has been shown that the probiotic 
Escherichia coli was engineered to express lipopolysaccharide similar to host receptor 
(ganglioside) for enterotoxogenic E. coli or cholera toxin therefore prevent diarrheal 
infections (Paton et. al., 2006). In addition, probiotics could be designed to express 
specific bacterial adhesin which bind to host mucosal surface and compete with 
pathogens for the binding sites. It was found that the pre incubation of Caco-2 cell with the 
recombinant  Lactobacillus paracasei  expressing Listeria adhesion protein (LAP) results 
in inhibition of L. monocytogenes infection (Koo et.al., 2012). In addition, the colonization 
of pig intestine by ETEC was inhibited using engineered L. acidophilus expressing ETEC 
K99 fimbriae (Chu et. al., 2005). 
 
 
1.1.4.5 Inhibition using adhesin analogs  
This strategy relies on isolated bacterial adhesins or synthetic or recombinant adhesin 
fragments binding to host receptors and thus competing with bacterial adhesins and 
preventing their binding to host cells (Shoaf and Hutkins, 2009). Several investigates have 
shown the potential role of adhesin analogs in inhibiting pathogens adherence. Daep et. 
al., showed that the initial colonization of the oral cavity by the anaerobic bacterium 
Porphyromonas gingivalis occurs via the interaction with Streptococcus gordonii by a 
specific region of the streptococcal SspB polypeptide (BAR) on the S. gordonii surface. 




prevents the binding of P. gingivalis to S. gordonii and thus inhibits P. gingivalis to form 
biofilms (Daep et. al., 2006; Daep et. al., 2011). Another study revealed that a synthetic 
peptide mimicking the S. mutans adhesin AgI/II (p1025) sequence reduced Streptococci 
adherence to the immobilized salivary receptor (Kelly et. al., 1999). Furthermore, 
Streptococcus colonization was reduced when lipoteichoic acid was used as inhibitor to 
block bacterial adherence to the host receptor (Cox, 1982). Moreover, in a tissue culture 
model, the recombinant MAM7 from V. parahaemolyticus was used to prevent the 
adherence of a range of multidrug-resistant pathogens (Krachler et. al., 2012). In addition, 
MAM7 coupled to beads competed with S. aureus (MRSA) for the binding site without 
interfering with host cell functions (Hawley et. al., 2013). In experiments using a rat model, 
a MAM7 based inhibitor has been used to treat burn wound infections caused by P. 
aeruginosa (Huebinger et. al., 2016).  
 
 
1.2 Host receptors 
1.2.1 The extracellular matrix 
 Extracellular matrix (ECM) is a collection of macromolecules secreted by cells and fills 
the intercellular space. The extracellular matrix is made up of two main classes of 
components: proteoglycans or glycosaminoglycans (GAG), and fibrous proteins such as 
collagen, laminin, elastin, vitronectin, fibrinogen and fibronectin (Jarvelainen et.al, 2009; 
Schaefer and Schaefer, 2010). The glycosaminoglycans provide a gel-like structure and 




provided by the fibrous proteins. ECM provides cells with structural support, in addition to 
other functions such as mediating cell proliferation, adhesion, migration and differentiation 
(Westerlund and Korhoner, 1993; Hynes, 2009). 
The ECM constituents are exploited by pathogenic bacteria for adherence and stimulation 
of inflammatory responses, which result in colonization and invasion of the host. In 
addition, they are targeted by pathogen proteases that degrade them and increase tissue 
damage (Singh et. al., 2012). This review will cover several extracellular components and 
examples of bacterial attachment to ECM components.  
 
 
1.2.1.1 Proteoglycans and glycosaminoglycans 
Proteoglycans are macromolecules found on the cell-surface and as part of the 
extracellular matrix. They consist of a core protein coupled to glycosaminoglycan (GAG) 
chains (Kjellen and Lindahl, 1991; Schaefer and Schaefer, 2010). Glycosaminoglycans 
are linear polysaccharides containing repeats of disaccharide units. Based on core 
disaccharides structures, glycosaminoglycans are divided into several categories: 
Heparan sulfate (HS)/heparin, Keratan sulfate (KS), Chondroitin sulfate (CS)/dermatan 
sulfate (DS), and Hyaluronan (Schaefer and Schaefer, 2010). 
Heparan sulfate proteoglycans (HSPGs) consist of heparan sulfate (HS) chains covalently 
bound to a variable core protein. HS chains are linear polysaccharide chains with 
repeating sulphated disaccharide units. Based on their location, HSPGs can be 




syndecans, the ECM HSPGs such as perlecan, agrin and type XVII collagen, and HSPGs 
inside intracellular vesicles such as serglycin (Sarrazin et. al., 2011). HSPGs contribute to 
the organization of the ECM by the interactions with ECM constituents such as vitronectin, 
laminin and fibronectin (Bernfield et. al., 1999; Sarrazin et. al., 2011). 
HSPGs bind to several ligands such as chemokines, cytokines and growth factors, and 
this binding confers protection against proteolysis (Sarrazin et. al., 2011).  
HSPGs are attractive targets for bacterial adherence, colonization and invasion (Garcia et. 
al., 2016). It has been shown that N. meningitidis binds to HSPGs via the adhesin OpaC 
to invade epithelial cells (de Vries et. al., 1998; Bos et. al., 2002). Heparan sulfate (HS) 
proteoglycans mediate the binding and invasion of L. monocytogenes to host cells via the 
surface protein ActA (Alvarez-Dominguez et. al., 1997). In addition, HPSGs mediate P. 
aeruginosa (Plotkowski et. al., 2001; Bucior, et. al., 2012), S. aureus (Garcia et. al., 2014) 




Fibronectin is a high molecular weight glycoprotein that is important in several cellular 
functions such as cell adhesion, migration, differentiation (Yamada and Clark, 1996; 
Hocking et.al., 2000), and wound healing (Cho et. al., 2006). 
Generally, fibronectin comprises of two similar subunits of approximately 250 kDa, linked 
by two disulfide bonds. Each subunit encompasses three types of repeating units: type I, 




variable region (Pankov and Yamada, 2002). Two types of fibronectin exist; soluble 
plasma fibronectin and insoluble cellular fibronectin (To and Midwood, 2011). Plasma 
fibronectin is synthesized by hepatocytes and secreted into the blood in a soluble form 
and incorporated into fibrin clots during wound healing (Cho et. al., 2006). It does not 
contain the extra domains A and B (EDA and EDB). Insoluble cellular fibronectin is 
synthesized by fibroblasts and other cells and deposited locally and organized as a 
network of fibrils on the cell surface via the binding with cell surface receptors (integrins) 
(Singh et. al., 2010). 
Bacteria exploit fibronectin and use it for the adherence to host cells. It has been shown 
that a variety of both Gram negative and Gram positive bacteria have fibronectin binding 
proteins (Henderson et. al., 2011). Examples for fibronectin binding proteins are FnBPA 
and FnBPB in S. aureus (O'Neill et. al., 2008), surface protein F1 in S. pyogenes (Hyland 
et. al., 2007), curli in E. coli (Oh et. al., 2016) and the surface adhesin FlpA on 
Campylobacter jejuni (Konkel et.al, 2010). 
 
 
1.2.1.3 Laminins  
The laminins are abundant constituents of the extracellular matrix and play an important 
role in the architecture and stability of basement membranes (Li et. al., 2002; Durbeej, 
2010). Generally, laminins are high molecular weight glycoproteins (400–900 kDa), 
consisting of three different polypeptide chains; an alpha-chain, a beta-chain, and a 
gamma-chain, that are joined together through the coiled-coil region to make a cross-like 




gamma-chains are known in mammals (Miner and Yurchenco, 2004). Laminins bind to 
each other to form self-assembling networks of basement membranes; in addition they 
contain binding sites for ECM proteins such as entactin and they contain binding sites for 
cell surface receptors such as integrins and dystroglycan and other receptors (Yu and 
Talts, 2003). Through these interactions laminins influence cell adhesion, proliferation, 
migration and differentiation (Colognato  and Yurchenco, 2000; Durbeej, 2010). 
Laminins are targeted by a variety of pathogenic bacteria for the adherence and invasion 
of host cells (Lemichez et. al., 2010). It has been revealed that Streptococcus pyogenes, a 
causative agent of bacterial tonsillitis and skin infections, recognize laminin for adhesion 
to epithelial cells and dermal cells using Laminin-binding protein (Linke et. al., 2009). In 
addition, Moraxella catarrhalis bind to laminin through surface adhesins UspA1 and 
UspA2 (Tan et. al., 2006). Furthermore, leptospiral surface adhesin (Lsa27) mediates the 
binding of Leptospira interrogans to laminin (Longhi et. al., 2009). 
 
 
1.2.1.4 Type IV collagen 
Collagens are the main components of the extracellular matrix that play a significant role 
in the stability, organization and shape of tissue, in addition to their role in cell 
proliferation, differentiation and migration (Gelse et. al., 2003; Kadler et. al., 2007). To 
date, collagens consist of 28 different types (Ricard-Blum, 2011). They comprise of a 
triple-helix assembly which consists of three polypeptides with Gly-X-Y repeats, where X 




Type IV collagen is the major constituent of the basement membrane. Six α-chains (α1–α
6) have been characterized which form three different promoters: α1.α1.α2 (IV), α3.α4.α5 
(IV) and α5.α5.α6 (IV) (Hudson et. al., 2003). Each α-chain comprises of three domains: a 
7S domain, a triple-helical domain, and a non-collagenous NC1 domain. Three α- chains 
of collagen IV gather at the NC1 domain to form triple-helical molecule known as 
promotor. Further interactions between promotors form supramolecular networks which 
interact with the laminin network to form basement membrane scaffolds (Kalluri, 2003).  
Bacteria use collagens to bind to and enter host tissues. It has been found that M. 
catarrhalis  bind to collagen types I, II, and III, collagens IV and VI using ubiquitous 
surface protein A2 (UspA2 and UspA2H) (Singh et. al.,2016). The adhesin of collagen 
from E. faecalis (Ace) mediates bacterial binding to the Type IV collagen and the Type I 
collagen (Nallapareddy et. al., 2006). In addition, collagen IV is targeted by S. pyogenes 
M1 adhesin (Bober et. al., 2010). 
 
 
1.2.2 Sulfatide  
Sulfatide (3-O-sulfogalactosylceramide) is a type of glycosphingolipid that contains a 
sulfate group. It consists of the ceramide and one monosaccharide, galactose. The 
synthesis of sulfatide is started at the endoplasmic reticulum where a galactose from 
UDP-galactose is added to ceramides to make GalCer (galactocerebroside), a reaction 
catalysed by galactose transferase (Schaeren-Wiemers et.al., 1995). The product GalCer 
(galactocerebroside) is then transported into the Golgi apparatus to react with 3’-




out by cerebroside sulfotransferase (Honke et.al., 1997). The degradation of sulfatide 
occurrs in the lysosome, where Arylsulfatase A (ASA) hydrolyzes the sulfate group in the 
presence of saponin B (Kolter and Sandhoff, 2005). Sulfatide is abundantly expressed in 
the gastrointestinal tract, trachea, kidney, and particularly the central nervous system, 
accounting for for 4% of total membrane lipids (Ishizuka, 1997). Cellular sulfatide is mostly 
localized in the Golgi apparatus, cellular membrane, and lysosomes in cytosol (Takahashi 
and Suzuki, 2015; Takahashi and Suzuki, 2012; Hirahara et. al., 2000). Sulfatide 
contributes to a wide range of biological processes such as cell adhesion, aggregation 
and protein trafficking (Xiao et. al., 2013). Furthermore, sulfatide is involved in immune 
system function, cancer, insulin secretion and microbial infection (Takahashi and Suzuki, 
2012). Sulfatide has a role in the pathogenesis of Alzheimer’s disease. In a study on 
human brain tissues revealed that a significant decrease in sulfatides is associated with 
Alzheimer’s disease (Han et. al., 2002).  
For microbial infections, sulfatide is known to be a receptor for the adherence of many 
pathogenic bacteria (Piao et. al., 2011; Pantzar et. al., 2006; Hartmann et. al., 2001; Yagci 
et. al., 2007). It has been shown that H. pylori bind to the sulfatide via Hsp 70 on its 
surface (Kamisago et. al., 1996; Kobayashi et.al., 2009). In addition, P. aeruginosa binds 
to sulfatide on human pharyngeal epithelial cells (Xia et. al., 2007). Bordetella pertussis 
use Filamentous hemagglutinatinin adhesin (FHA) to bind to sulfatide on the host cells 
(Julie et. al., 2007). Enterotoxigenic Escherichia coli (ETEC) binds to sulfatide via coli 
surface antigen 6 (CS6) (Jansson et. al., 2009). Moreover, sulfatide is a receptor for Heat-





1.2.3 Mucus and Mucins 
Mucus is a highly hydrated viscous secretion that covers epithelial cell surfaces. It acts as 
a barrier to protect epithelial surfaces such as respiratory, gastrointestinal, reproductive, 
urinary tracts and the eye from environmental stresses (Derrien et. al., 2010). The key 
function of mucus is to protect against dehydration and damage that could be caused by 
drugs, toxins, acids and pathogens. Mucus thickness and composition varies depending 
on its location in the body. In the oral cavity, salivary glands produced saliva with a 
thickness of 70-100 µm. Saliva consists of water, mucin and other proteins to protect teeth 
and oral soft tissue (Collins and Dawes, 1987). The stomach is lined with a thick mucus 
layer of around 300 µm that protects the gastric epithelium from the damage resulting 
from either ingested compounds or the enzymes and the acidic pH in the stomach (Atuma 
et. al., 2001). In the intestinal tract, submucosal glands and goblet epithelial cells produce 
the intestinal mucus layer, a continuous layer that consists of a firm inner cell-attached 
layer and a loose outer non-attached layer (Atuma et. al., 2001). In the small intestine, the 
mucus layer is a discontinuous layer with a thickness around 150–400 μm (Atuma et. al., 
2001; Johansson et. al., 2011).  Colonic mucus layer thickness reaches to 800-900 µm in 
the distal colon. This thickness is essential for the protection of the underlying tissue from 
the interactions with pathogens (Derrien et. al., 2010). 95% of the mucus composition is 
water and the remainder is mucins and other components such as proteins, salts and 
lipids (Allen, 1981). In addition, mucus contains a variety of antimicrobial proteins and 
peptides involved in host defence, such as immunoglobulins, defensins and others 




The main constituents of the mucus are mucins that play a significant role in the 
interactions between host epithelial surfaces and microorganisms (Linden et. al., 2004; 
Johansson et. al., 2011). Even with the diversity among mucins, they are similar in their 
structures. Mucins are large glycoproteins with a high molecular weight of several million 
Daltons (Derrien et. al., 2010). They contain one or more glycosylated protein domains. 
The major constituents of these glycoproteins are carbohydrate (80% of the weight is 
carbohydrate) (Thornton and Sheehan, 2004). The domains have repeats of the amino 
acids serine and threonine, which work as the attachment point for N-
acetylgalactosamine. In addition, these domains may contain N-acetylglucosamine, sialic 
acids, fucose and galactose, and the sugars may be further modified by sulphate or 
phosphate. The attachment of oligossacharides to the polypeptides results in the 
enlargement of the molecule, which contributes to mucin functions such as filling the 
space and gel like properties (Jentoft, 1990; Thornton and Sheehan, 2004). In addition, 
the presence of oligosaccharides results in bacterial binding to the mucin which finally 
facilitates their removal by mucin shedding and inhibits the colonization of epithelial cells 
(Thornton and Sheehan, 2004). In addition to the high molecular weight and high 
carbohydrate contents, mucins have a low isoelectric point (are acidic under physiological 
conditions) because of their sialic acid and sulphate content (Rose, 1992). Currently, two 
types of mucins are known; secreted and cell surface attached mucins. Secreted mucins 
can be divided into secreted gel forming mucins such as MUC2, MUC5AC, MUC5B, 
MUC6, MUC19 and secreted non gel forming mucins such as MUC7. Whereas, cell 
surface mucins include MUC1, MUC3A/B, MUC4, MUC12, MUC13, MUC15, MUC16, 




components of mucus and they are responsible for the viscoelasticity of the mucus by 
forming disulphide bond via cysteine rich domains existing at the N- and C-termini (Perez-
Vilar et. al., 1998). 
 
1.2.3.1 Mucus- bacterial interactions 
Mucus provides a barrier to protect the underlying epithelium from colonization with 
pathogens and commensals. Intestinal mucus comprises of two layers; an outer layer and 
an inner layer. The outer layer provides nutrients for the commensals that aid in the 
protection against pathogens. It is well known that commensals do not enter the inner 
mucus layer and do not colonize the healthy mucosal surface. In the colon, commensal 
bacteria live in symbiotic relationship with the host. They contribute in processing 
indigestible glycoconjugates and provide the host with vitamins. Commensals also 
participate to limit pathogenic colonization and invasion of epithelial cells via the 
competition for nutrients, competition for binding sites and development of the mucosal 
immune response (Hudault et. al., 2001; Lu and Walker, 2001; Kamada et. al., 2013). In 
addition they release antimicrobial peptides known as bacteriocins that inhibit bacterial 
growth of other strains or species (Cunliffe and Mahida, 2001). Alteration of the microbiota 
composition results in an increase of pathogenic bacteria that cause ulcerative colitis such 
as Clostridium difficile (Leffler and Lamont, 2015) and enteroaggregative E. coli (EAEC) 
(Watanabe et. al., 2012). 
Mucin is an attractive niche for bacterial colonization (Tailford et. al., 2015). Bacteria use 




carbohydrates provide binding sites for bacteria. Those sites are similar to the binding 
sites present on the cell surface. Therefore, mucins inhibit pathogens adhesion to 
underlying cells (Derrien et. al., 2010). In addition, mucins carry a negative charge which 
provides protection against bacterial attack. This protection based on the repulsion forces 
between mucin and bacterial cell surface (Wiggins et. al., 2001) 
 
The importance of mucin has been reported in many studies. It has been shown that 
binding of Muc1 from human breast milk to pathogenic bacteria inhibits their adherence to 
the infant gastrointestinal tract (Ruiz-Palacios et. al., 2003). MUC2 is the main mucin 
found in the intestinal tract. Infection of mice with a deficiency in MUC2 with Citrobacter 
rodentium resulted in increased intestinal inflammation (Van der Sluis et. al., 2006), and 
more severe disease (Bergstrom et. al., 2010). 
A variety of strategies have been developed by pathogens in order to go through the 
mucus and infect the underlying epithelial cells. Pathogens trigger inflammation which 
results in altered microbiota composition and end the competition with commensals 
(Pedron and Sansonetti, 2008). In addition, commensals are affected by the increase in 
the amount of antimicrobial peptides (Raffatellu et. al., 2009; Stecher and Hardt, 2011). 
Furthermore, the production of specific compounds during the inflammation process can 
be used by pathogens for their growth such as glycosylated proteins or tetrathionate 
(Winter et. al., 2010; Stecher et. al., 2008). It has been revealed that tetrathionate is used 
by Salmonella typhimurium as a terminal electron acceptor during anaerobic respiration, 
thus this bacterium competes with other fermenting commensals in the infected region 




Pathogens use flagella to penetrate the mucus barrier. It has been shown that H. pylori 
decrease the mucus viscosity by changing the surrounding pH to increase their motility 
(Celli et. al., 2009). V. cholerae use its single polar flagellum to swim through the mucus 
and colonize the epithelial cells (Liu et. al., 2008). In addition, the curved shape of V. 
cholerae cells facilitates the movement through the mucus (Bartlett et. al., 2017). 
Mucin degradation is also used by pathogens to reduce the viscosity and dilute mucus 
compounds. Pathogenic bacteria produce a variety of enzymes such as glycosidases and 
proteases to degrade mucin (Roberton et. al., 2005). The enteric pathogenic bacteria use 
this strategy to reach the host epithelial cells. It has been shown that enterotoxigenic 
Escherichia coli (ETEC) secrete metalloprotease that degrade intestinal mucins, including 
MUC2 and MUC3 to aid bacterial access to enterocytes (Luo et. al., 2014). 
 
 
1.2.3.2 Mucin desulfation 
Mucin carbohydrates are heavily sulfated in the regions that are rich in microorganisms 
such as colon and mouth (Derrien et. al., 2010). This physically protects the 
carbohydrates and other substrates from enzymatic degradation (Tsai et.al., 1991). 
Sulfation of mucin oligosacharides occurs in the linkage to N-acetylglucoseamine, 
galactose and, rarely, N-acetylgalactosamine (Brockhausen et.al., 2009; Kawasaki, et. al., 
2001; Lo-Guidice et.al., 1994). However, to overcome this protection, microorganisms 
develop mechanisms to degrade mucin and infect epithelial cells. Some bacteria have 




as sulfomucins, sulfoglycoproteins and sulfoglycolipids. Therefore, sulfatases play a role 
in mucin desulfation and thus increase the degradation by glycosidases and proteinases 
(Rho et. al., 2005). Desulfation results in providing bacteria with sulphur and release 
carbohydrates and amino acids used as substrates for bacterial growth (Rho et. al., 2005). 
Several pathogenic bacteria secrete sulfatases, such as Proteus rettgeri (Fitzgerald and 
Milazzo, 1970), Salmonella enterica Serovar Typhimurium (Das et. al., 2013), Salmonella 
enterica Enteritidis (Ganguly and Joerger, 2017), Klebsiella aerogenes (Murooka et.al., 
1990), and Serratia marcescens (Murooka et.al., 1980). 
In addition, sulfatase is secreted by anaerobic commensals, such as Prevotella strain 
RS2, that has been shown to have a mucin-desulfating sulfatase (MdsA), and 
sulfoglycosidase (SGL) in the bacterial periplasm (Wright et. al., 2000). The 
sulfoglycosidase (SGL) from Prevotella strain RS2 desulfates mucin by removal of a 6-
SO3-β-GlcNAc residue from sulphated mucin to be a substrate for MdsA. The reasons 
behind removing the 6-SO3-β-GlcNAc residue could be to create or remove binding sites 
or to allow further mucin degradation (Rho et. al., 2005). The commensal Bacteroides 
thetaiotaomicron secretes sulfatase to remove sulphate groups and allow glycosidase 
enzymes to degrade mucins (Tsai et. al., 1991; Benjdia et. al., 2011).  







1.2.3.2.1   Bacteroides thetaiotaomicron 
 One of the commensal bacteria present in the human gut is Bacteroides thetaiotaomicron 
which makes up about 6% of the gut microbiota in healthy individuals (Murphy et.al, 
2011). B. thetaiotaomicron is an obligate anaerobic Gram-negative bacterium and belongs 
to the Bacteroidetes phylum. In the gut, B. thetaiotaomicron releases carbohydrate 
degrading enzymes that provide availability of nutrients for other commensals 
(Sonnenburg et. al., 2005; Xu et. al., 2003). In addition, it aids the human host in the 
metabolism of carbohydrates like sucrose, starch and lactose in the gastrointestinal tract 
because humans are able to metabolize only a limited range of dietary carbohydrates 
(Lammerts van Bueren et. al., 2015).  
 Although B. thetaiotaomicron is a commensal bacterium, it can be an opportunistic 
pathogen. B. thetaiotaomicron produce two virulence factors that have been involved in 
the pathogenicity of this bacterium; LPS and capsular polysaccharide (CPS) (Rokosz 
et.al., 1999). It can cause infections such as meningitis (Feuillet et. al., 2005), 
bacteraemia and intraabdominal sepsis (Aldridgeand O’Brien, 2002; Goldstein, 1996; 
Redondo et.al., 1995). In addition to the pathogenicity, the resistance of B. 
thetaiotaomicron to antibiotics such as cephalosporins and clindamycin has been reported 
(Aldridgeand O’Brien, 2002; Snydman, 1996; Tanaka-Bandoh et.al., 1995). 
B. thetaiotaomicron dedicates a large number of its genome to carbohydrate metabolism 
(Martens et.al, 2009). In addition to dietary sources, B. thetaiotaomicron is capable of 
using mucin and mucopolysaccharides as carbon sources (Sonnenburg et. al, 2005). B. 
thetaiotaomicron uses mucosal glycan for degradation when the dietary sources of 




polysaccharides and the mucosal glycans is a strategy by which B. thetaiotamicron is able 
to adapt and compete with other microorganisms in the gut.  
B. thetaiotamicron has carbohydrate active enzymes (CAZymes) that are implicated in the 
metabolism of carbohydrates (Hehemann et. al., 2012). In addition, B. thetaiotaomicron 
genome contains 28 putative sulfatase genes and an anaerobic sulfatase-maturating 
enzyme (anSME) (BT0238) which is necessary for the activity of all sulfatases (Benjdia et. 
al., 2011).  
B. thetaiotaomicron enzymes may have a role in gut infectious disease. B. 
thetaiotaomicron harvests sugars on mucins which become available for both 
commensals and pathogenic bacteria. It has been shown that B. thetaiotaomicron 
releases fucose which is used by S. typhimurium as a source of carbon (Ng et. al., 2013), 
and also it is used by EHEC to regulate the expression of virulence factors (Pacheco et. 
al., 2012). 
 In addition, mucin degradation by B. thetaiotaomicron sialidase results in release the 
sialic acid that supplying pathogenic bacteria such as Clostridium difficile and Salmonella 
enterica with sugars (Ng et. al., 2013). The contact between the outer membrane vesicles 
in B. thetaiotaomicron containing sulfatase and host macrophages results in gut 
inflammation, and deleting the anaerobic sulfatase maturating enzyme (anSME) from B. 






1.3 The commensal Escherichia coli  
Escherichia coli are Gram negative, non-sporulating rod shaped bacteria, facultative 
anaerobes, and belong to the family Enterobacteriaceae.  Commensal E. coli exist on the 
mucus layer of the human gastrointestinal tract in a symbiotic relationship with the host 
(Gill et. al., 2006). In addition to providing the host with vitamins, commensals E. coli 
enhance tight junctions between epithelial cells, stimulate the mucosal immune response 
and compete with pathogens and inhibit infections (Hudault et. al., 2001; Lu and Walker, 
2001). The inhibition of pathogenic bacteria by E. coli is the result of the competition for 
the binding sites, the competition for nutrients and the production of antibacterial agents 
(Cunliffe and Mahida, 2001). For example, it has been reported that the adhesion of 
pathogenic E. coli was inhibited when E. coli strain Nissle 1917 was co cultured with 
invasive E. coli using intestinal epithelial cell models (Boudeau et. al., 2003). In addition, 
using mouse models, it has been revealed that the establishment of the commensal E. 
coli JM105 strain and EM0 strain results in inhibition of S. typhimurium infection (Hudault 
et. al., 2001). Furthermore, the commensal E. coli strain HS competes with pathogenic E. 
coli O157:H7 for nutrients that are important for bacterial colonization and inhibit infections 
(Maltby et. al., 2013). In the current study, the human isolate E. coli strain HS was used to 
characterize its MAM7 homolog. E. coli HS was isolated from a healthy scientist at the 
Walter Reed Army Institute of Research, and it has the ability to inhabit the human 
gastrointestinal tract using pili or fimbria without causing illness (Rasko et. al., 2008).  




1.4 Aims  
The overall aim of the work performed for this thesis was to evaluate the potential role of 
adhesion inhibitors based on MAM7 adhesin from the human commensal E. coli strain HS 
to inhibit bacterial infection.  
Towards this aim: 
1- Characterize MAM7 protein from the human commensal E. coli strain HS. 
2- Design an adhesion inhibitors based on MAM7 protein from the commensal E. coli 
strain HS. 
A- An engineered bacterium expressing HSMAM7 protein on the surface (BL21-
HSMAM7). 
B- Polymer beads coupled to the purified recombinant GST- HSMAM7 protein. 
3- Evaluate the potential role of HSMAM7 based inhibitors against pathogenic bacteria. 
4- Dissect the biochemical interactions of HSMAM7 protein and its host cell receptors: 








Chapter 2.  Materials and Methods  
2.1 Bacterial strains and growth conditions 
The bacterial strains used were Escherichia coli strain HS (GenBank accession number 
ABV06236.1; GI 157066981) Pseudomonas aeruginosa PAO1, Enterococcus faecalis 
ATCC 49452, Staphylococcus aureus Newman and E. coli BL21. These strains were 
grown in LB medium at 37 °C. Bacteroides thetaiotaomicron (wild type strain VPI-5482) 
and a derivative strain lacking the anaerobic sulfatase-maturating enzyme (anSME), ∆
BT0238, was grown in Brain Heart infusion (BHI) medium under anaerobic conditions at 
37 °C . 
 
2.2 Cell lines and growth conditions  
Hela cells, Caco-2 cells and HT-29MTX cells were grown in a 75 cm2 flask and maintained 
in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% heat inactivated 
fetal bovine serum (HIFBS), 5 mM L-glutamine, 50 µg/ml streptomycin and penicillin in an 
atmosphere containing 5% CO2 at 37 °C. After confluent growth, cells were washed with 
sterile PBS (phosphate buffer saline) and treated with Trypsin EDTA to prepare the 







2.3 Molecular techniques 
2.3.1 Extraction of Genomic DNA 
Genomic DNA was extracted from E. coli strain HS using Gen Elute Bacterial Genomic 
DNA Kit (Sigma). The extraction process was done according to the manufacture’s 
instructions. Briefly, 1.5 ml of an overnight culture growth was centrifuged at 12000 xg for 
2 minutes and the pellet was re suspended in 180 µl lysis solution T.  20 µl of proteinase K 
solution were added to the sample, mixed well and incubated at 55 °C for 30 minutes. 
Followed by adding 200 µl of lysis solution C mixed gently and incubated at 55 °C for 10 
minutes. 200 µl of ethanol (95%) were added to the lysate and mixed. Then 500 µl of the 
column preparation solution were added to column, and centrifuged at 12000 xg for 1 
minute. The entire contents were transformed into binding column and centrifuged at 
12000 xg for 1 minute. The collection tube containing the flow through was discarded and 
the column was placed into new collection tube. Then 500 µl of wash solution 1 were 
added to the column and centrifuged at 12000 xg for 1 minute. 500 µl of wash solution 
were added to the column, centrifuged at 12000 xg for 3 minutes. 200 µl of the elution 
solution was pipetted into the centre of the column and incubated for 5 minutes at room 
temperature, then centrifuged at 12000 xg for 1 minute. The concentration of the purified 
DNA was measured. In addition, gel electrophoresis was run to test the quality of the 





2.3.2 Polymerase Chain Reaction (PCR) 
The E. coli HSMAM7 gene was amplified using the primers designed for the PCR reaction 
(table 2.1). 50 µl of PCR mixture  containing 10 µl of 5x phusion buffer, 1 µl of 10 mM 
dNTPs, 2.5 µl of 10 mM Forward primer, 2.5 µl of 10 mM Reverse primer, 0.5 µl of 
phusion polymerase, 0.5 µl of DNA template and the DNase free dH2O. The amplification 




 Table 2.1 Primers pairs used for the amplification of HSMAM7 gene 
 
Sequence Primer description 
 5’CAGTGGATCCGACAGTTATCAGGACCGGG 3'  E. coli HS(∆TM)MAM7 FOR      
5’CAGTCTCGAGTTATTTGGGAAGCGCAGTACC 3'  E. coli HS(∆TM)MAM7 RE          
 5’CAGTCCATGGGACACATGAGTCAGGAAACG 3'  E. coli HS (Full)MAM7 FOR      
5’CAGTAAGCTTTTATTTGGGAAGCGCAGTACC 3'  E. coli HS   (Full )MAM7 RE       









  Table 2.2 The PCR conditions used to amplify HSMAM7 gene 
No. of  cycles Time Temperature Condition 












1 5 min 72℃ Final extension 




2.3.3   Agarose gel electrophoresis 
The agarose gel was prepared as following: 
 A 0.8% agarose was made by mixing 0.8 g agarose with 100 ml of 1X TBE buffer and 
heated in microwave oven. Then, 2 µl Sybr safe stain was added, gently mixed and 
poured into a rack containing comb. After gel solidification, the comb was removed, and 
the gel was soaked into a chamber containing 1X TBE buffer. The loading dye was added 
to the DNA samples, they were loaded alongside to the DNA ladder. The gel was run at 




2.3.4 Agarose gel purification 
The DNA fragment was cut out the agarose gel and weighed in a 1.5 ml Eppendorf tube. 
Gene JET Gel Extraction Kit (Ferments) was used for DNA purification as following:  
1:1 volume of the binding buffer was added to the gel slice and left at 55 °C for 10 
minutes. 800 µl of the solution was moved into the column and centrifuged at 12000 xg for 
1 minute. Then, 700 µl of wash buffer was added to the column and centrifuged at 12000 
xg for 1 minute. The flow through was discarded and the empty column was centrifuged 
for 1 minute. The column was transferred into 1.5 ml micro centrifuge tube, and 50 µl of 
elution buffer were added to the column, incubated at room temperature for 2 minutes, 
and then centrifuged at 12000 xg for 1 minute.   
 
 
2.3.5 Digestion of DNA with restriction enzymes  
pGEX 4T-3 and pBAD/Myc-His plasmids were used in this study. The plasmids and the 
DNA amplicons were digested with the appropriate restriction enzymes as shown in tables 









Table 2.3 Digestion of the insert (∆TM MAM7) and pGEX 4T-3 vector 
 
Reagents insert (∆TM MAM7) pGEX4T-3 
DNA 30 µl 15 µl 
BamHI buffer 10 µl 10µl 
BamHI enzyme 1 µl 1µl 
XhoI enzyme 2 µl 2µl 
 d H2O 7 µl 22µl 
 
 
Table 2.4 Digestion of the insert (Full length HSMAM7) and pBAD /Myc-His vector 
 
Reagents Insert (Full length 
MAM7) 
pBAD /Myc-His 
DNA 30 µl 15 µl 
  Tungo buffer 10 µl 10 µl 
Hind III enzyme 1 µl 1 µl 
NCOI enzyme 2 µl 2 µl 








2.3.6 DNA ligation  
T4 DNA Ligase was used to ligate the digested inserts into the indigested vectors .The 
reaction mixture contained 2 μl of 10x Ligation Buffer, 1 μl of purified digested  vector ,16 
μl of purified digested DNA (insert) and 1μl of T4 DNA Ligase. The ligation mixture was 
incubated at room temperature overnight. 
 
2.3.7 Transformation  
Heat shock method was used to transform E. coli with the recombinant DNA as following: 
5 µl of ligation mixture was added to 50 µl of competent E. coli DH5α cells and incubated 
on ice for 30 minutes. The cells were heat-shocked at 42 °C for 30 seconds. Followed by 
incubation on ice for 5 minutes. 950 µl of SOC broth were added and incubated at 37 °C 
for an hour with shaking at 225 rpm. LB agar plate containing an appropriate antibiotic 
was inoculated with100 µl of the transformation mixture and incubated at 37 °C overnight. 
 
2.3.8   Purification of plasmid DNA 
 The recombinant plasmids were purified using Gen EluteTM plasmid mini prep kit (Sigma).  
1.5 ml of bacterial overnight growth was centrifuged at 12000 xg for 1 minute. The pellet 
was re suspended in 250 µl of re suspension solution. Then 250 µl of lysis solution was 
added and mixed gently. 350 µl of neutralizing solution was added; the tube was inverted 
4-6 times and centrifuged at 12000 xg for 5 minutes. The lysates were transferred to the 




solution was added and centrifuged at 12000 xg for 1 minute. The flow through was 
discarded, and these steps were repeated. The column was centrifuged to remove the 
ethanol. The column was transferred into a clean tube and 50 µl of elution buffer were 
added and incubated at room temperature for 2 minutes then centrifuged at 12000 xg for 
1 minute. The purified plasmids were stored at - 20 °C.  
 
2.3.9   DNA Sequencing  
The purified recombinant plasmids were sent to the Functional Genomic Service at the 
School of Bioscience at Birmingham University   
(http://www.brimingham.ac.uk/facilities/genomics/) for sequencing using the primers listed 
in table 2.5. In two separate micro centrifuge tubes, the reaction mixture contains 1 µl of 
the recombinant DNA (40-100 ng), 1 µl of fw or rev primer (3.2 pmol) and 8 µl of PCR 
water. 
 
Table 2.5 Primers pairs used for sequencing of the recombinant plasmids pGEX 
4T3-∆TMHSMAM7 and pBAD-Myc-His HSMAM7 
 
Primer description Sequence 
pGEX-4T3 Forward 5’GGGCTGGCAAGCCACGTTTGGTG3’ 
pGEX- 4T3 Reverse 5’CCGGGAGCTGCATGTGTCAGAGG3’ 
pBAD Forward 5’ ATGCCATAGCATTTTTATCC 3’ 





2.4 Protein expression and purification 
2.4.1 Protein expression 
IPTG induction method was used to produce the recombinant proteins GST-HSMAM7 and 
GST. 10 ml of LB containing 100 μg/ml ampicillin was inoculated with a colony of E. coli 
BL21 containing the recombinant plasmid (pGEX 4T-3 ∆TMMAM7) for production of GST-
HSMAM7 protein or E. coli BL21 containing pGEX 4T-3 plasmid for production of GST 
protein and incubated at 37◦C overnight with shaking at 225 rpm. 500 ml of LB broth 
containing 100 μg/ml of ampicillin was inoculated with 10 ml of the bacterial growth and 
incubated at 37 °C with shaking at 225 rpm until the optical density reached 0.6-0.7.  IPTG 
was added at a final concentration of 1 mM to the cultures and incubated at 37 °C for 4 
hours with shaking at 225 rpm. Cultures were centrifuged at 6,000 rpm for 10 minutes. 
The pellets were frozen at -20 °C until further purification. 
 
2.4.2 Protein purification using GST- affinity chromatography 
The frozen bacterial pellets were defrosted on ice and resuspended in 25 ml of GST lysis 
buffer (25 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, protease inhibitors, lysozyme, 
DNAse I) and 20 mM Na-cholate was added, and then incubated at 4 ℃ overnight. The 
suspension was sonicated on ice twice for 60 seconds each time (5 sec on, 5 sec off; 60% 
output) and centrifuged at 10000 rpm for 30 min at 4 ℃. The supernatants were filtered 
through a 0.45 µm filter. 1 ml of washed glutathione beads was added to the supernatant 
and rotated at 4 ℃ for 2 hours. 20 ml of binding buffer (25 mM Tris pH 7.5, 150 mM NaCl, 




twice. 1.5 ml of elution buffer (10 mM reduced glutathione/ 50 mM Tris-HCl pH 8.0) was 
added to beads and incubated for 15 minutes and drained. This step was repeated twice. 
1.5 ml of elution buffer (100 mM reduced glutathione) was added to beads and incubated 
for 15 minutes, then drained. This step was repeated three times. Glutathione was 
removed from the protein eluate by dialysis against PBS at 4 °C overnight.    
                                                                                                                         
2.4.3 Polyacrylamide gels 
12 % Polyacrylamide Gel was used in the experiments. The concentration of separating 
gel was12 %, stacking gel was 6 %. The recipe for 12 % Polyacrylamide Gel is shown 
below: 
32 ml of 12% Separating Gel        20 ml of 6% Stacking Gel 
10.5 ml   ddH2O       10.6 ml   ddHO 
12.8 ml   30% Acrylamide      4 ml   30% Acrylamide 
8 ml   1.5 M Tris pH 8.8       5 ml     0.5 M Tris pH 6.8 
320 µl     10% SDS         200 µl   10% SDS 
320 µl    10% APS          200 µl   10% APS 
32 µl      TEMED          20 µl   TEMED 
    
Separation gel was prepared and poured into the cast and isopropanol was added to layer 
the gel. Following the polymerization of gel, the isopropanol was removed and the gel was 
washed with water. The stacking gel was prepared and poured, and a comb was inserted 




2.4.4 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
20 µl of samples were boiled in 5 µl of 5x SDS buffer for 10 minutes at 100 ℃ and were 
loaded alongside protein markers. The samples were separated in 1x SDS buffer at 120 V 
for 15 minutes then180-200 V for 30-45 minutes. 
 
2.4.5 Coomassie blue staining  
Coomassie blue stain was used to stain the protein bands following SDS- PAGE. Staining 
steps involved adding Coomassie brilliant blue stain (0.1% Coomassie Brillant Blue R250, 
50% methanol and 10% glacial acetic acid) to the gel for 15 min with shaking. Followed by 
washing the gel with the destaining solution (10% methanol, 10% glacial acetic acid) for 
10 minutes with shaking. The destaining step was repeated several times to visualize the 
bands. 
 
2.5 Coupling of recombinant GST- HSMAM7 protein to the beads 
 Fluorescent beads of 2 µm diameter (Sigma) were used to be coupled to the recombinant 
GST-HSMAM7 protein or GST protein (control). 12 µl of beads were suspended into a 
tube containing 1 ml PBS and pelleted by spinning for 2 minutes at 16000 xg. The 
supernatant was dicarded and the pellet was re suspended in 1 ml of sterile PBS. The 
washing step was repeated three times followed by removing the supernatant. Beads 




rotating wheel at 25 ℃ for 1 hour. The activated beads were centrifuged for 2 minutes at 
16000 xg and the pellet was washed with 1 ml of sterile PBS. Then the pellet was re 
suspended in 1 ml of 6 µM of protein solution and incubated for 2 hours at 25 ℃ on a 
rotating wheel. Cysteine was added to give a final concentration of 50 mM and incubated 
for 30 minutes at 25 ℃ on rotating wheel. Beads were washed twice with PBS and re 
suspended in 1 ml of PBS to give the final product. In order to verify the coupling 
efficiency, the concentration of coupled protein was measured and calculated depending 
on the following the formula: [Coupled protein] = [Initial protein] – [Supernatant protein]. 
 
 
2.6 Attachment of protein-coupled beads to host cells 
Hela cells were seeded on cover slips at a concentration of 150000 cells/ml the day 
before the experiment. 10% v/v beads coupled to protein in colourless DMEM was added 
and incubated at 37 ℃ for 4 hours. The medium was removed and Hela cells were 
washed three times with sterile PBS.  4% paraformaldehyde in PBS was used to fix the 
cells for 15 minutes at room temperature. The cells were washed with PBS three times 
and 0.1% Triton X-100 in PBS was used for 5 minutes.  In a dark place, cells were 
incubated with Alexa Fluor 488-phalloidin for 10 minutes. The coverslips were washed 
three times with PBS. The coverslips were mounted using ProLong Gold anti fade 
medium and imaged using a Nikon Ti Eclipse microscope. Images were used to quantify 





2.7 Attachment of BL21-HSMAM7 to host cells 
E. coli BL21 was transformed with the recombinant plasmid (pBAD/Myc-His-HSMAM7) 
(BL21-HSMAM7) or transformed with empty pBAD (control) and grown in the LB broth 
containing kanamycin at a concentration of 50 µg /ml the day before experiment. For the 
attachment experiment, E. coli BL21-HSMAM7 was grown in LB broth and when the 
OD600 reached 0.6, protein expression was induced by adding arabinose to 0.05% and 
incubated at 37 ℃ for 4 hours. Hela cells were seeded into a 24-well plate at a 
concentration of 150000 cells/ml, the day before the experiment. Hela cells were washed 
three times using sterile PBS and BL21-HSMAM7 or BL21 (control) was added at an MOI 
of 100 and the plates were incubated at 37 ℃ for 1 hour. DMEM was removed and Hela 
cells were washed three times with PBS to remove non-attached bacterial cells, and 0.5% 
Triton X-100 was added to lyse Hela cells, then serial dilutions were prepared and 
cultured on LB agar and incubated at 37 ℃ for 24 hours followed by counting the number 
of colonies. To visualize the attachment, both BL21-HSMAM7 and BL21 (control) were co 
transformed with pDP151 plasmid for expressing mCherry. The infected cells were then 
stained with Alexa Fluor 488-phalloidin to stain actin and Hoechst to stain DNA. Samples 








2.8 Bacterial attachment  
Hela cells were seeded at a concentration of 150000 cells/ml into a 24-well plate, in 
triplicate. Hela cells were washed with PBS three times and infected with pathogenic 
bacteria at an MOI of 10 and incubated at 37 ℃ for 1 hour and 4 hours. After bacterial 
infection, DMEM medium was removed and Hela cells were washed three times with and 
0.5% Triton X-100  was added to lyse Hela cells, then serial dilutions were prepared and 
cultured on LB agar and incubated at 37 ℃ for 20 hours followed by counting the number 
of colonies.                                                                                                                             
 
2.9 Cytotoxicity measurement 
Lactate dehydrogenase release (LDH) assay was used to measure lactate 
dehydrogenase released into the medium using LDH cytotoxicity detection kit (Takara). 
Hela cells were seeded at a concentration of 150000 cells/ml into a 24 well –plate. In 
triplicate, Hela cells were infected with bacteria. In addition, a triplicate set of wells for 
untreated Hela cells (negative control) and a triplicate set of wells (1% Triton X-100) for 
complete cell lysis, were prepared. In triplicate, 200 µl of supernatant from each well were 
removed and transferred into a 96 well -plate and centrifuged at 22 ℃, 1000 xg for 5 
minutes, then 100 µl from each well were transferred into a fresh 96 well plate. 100 μl of 
the reagents Mix was added to each well and incubated at room temperature. The 




using the formula: % cytotoxicity=100 x ([OD490 for experimental release - OD490 for 
spontaneous release]/ [OD490 for maximum release– OD490 for spontaneous release]). 
 
2.10 Competition experiments 
The day before the experiment, Hela cells were seeded at a concentration of 150000 
cells/ml into a 24 well plate, in triplicate. A triplicate set of wells for untreated Hela cells 
(negative control) and a triplicate of wells for complete cell lysis (positive control) were 
also prepared. Bacteria were grown in LB broth. On the day of the experiment, E. coli 
BL21 -HSMAM7 was grown in LB broth and when the OD 600 was 0.6, protein expression 
was induced by adding arabinose to 0.05% and incubated at 37 ℃ for 4 hours. Hela cells 
were washed with PBS three times prior to the addition of E. coli BL21 HSMAM7 or E. coli 
BL21 (control) in colorless DMEM without antibiotics at an MOI of 100 and incubated for 1 
hour, followed by infection with either S. aureus, E. faecalis or P. aeruginosa at an MOI 10 
and the plates were incubated at 37 ℃ for 4 hours. For the attachment competition, 
DMEM medium was removed and Hela cells were washed three times with PBS and 0.5% 
Triton X-100 was added to lyse Hela cells, and then serial dilutions were prepared and 
cultured on the selective media, cetrimide agar for P. aeruginosa, mannitol salt agar for S. 
aureus and enterococcosel agar for E. faecalis. The plates were incubated at 37 ℃ for 20 
hours followed by counting the number of colonies. For measuring the cytotoxic effects 
caused by infection, Lactate dehydrogenase (LDH) release assay was used. When beads 
were used in competition experiments, Hela cells were infected with infection medium 




HSMAM7 coupled beads or GST coupled beads (control) and incubated for 4 hours. This 
was followed by attachment assays and cytotoxicity measurements. 
 
2.11 Immunostaining for Fluorescence Microscopy            
Following removal of the supernatants, cells were washed three times with sterile PBS. 
For fixation, 4% paraformaldehyde in PBS was used for 15 minutes at room temperature.  
Followed by washing the cells with PBS and 0.1% Triton X-100 in PBS was used for 5 
minutes to permeabilize the cells. In a dark place, cells were incubated with Hoechst and 
rhodamine-phalloidin or Alexa Fluor 488-phalloidin for 10 minutes. The coverslips were 
washed with PBS three times, then mounted and imaged using a Nikon Ti Eclipse 
microscope.  
 
2.12 The interactions between HSMAM7 and host receptors 
2.12 .1 Lipid overlay assays  
PIP-StripTM and Sphingo-Strips (Echelon biosciences) were used to test the lipid binding 
property of HS MAM7. The membrane was blocked with blocking buffer (1X PBS, 0.1% 
v/v Tween 20, 5 % milk) for 1 hour at room temperature with gentle shaking. 10 µM of 
protein were added and incubated for 1 hour with shaking at room temperature. Followed 
by washing with washing buffer (1X PBS, 0.1% v/v Tween 20) for 10 minutes, this step 
was repeated 3 times. Anti GST–mouse antibody (1:1000) was applied in blocking buffer 




with washing buffer for 10 minutes; this step was repeated three times. The secondary 
anti mouse IgG -HRP antibody (1:5000) in blocking buffer was added and incubated for 1 
hour at room temperature with shaking. Followed by washing with washing buffer for 10 
minutes; this step was repeated three times. The antibodies were detected using 
chemiluminescence reagents A (Clarity TM western ECL substrate) and B (peroxide 
solution). The positive control PIP-Grip TM was used. 
 
2.12.2   Protein-lipid interaction plate assays  
Protein binding to lipids was measured by a modified version of an indirect quantitative 
ELISA as follows: 1-C24 mono-sulfagalactosyl (B) ceramide(d 18:1/24:0), C24 ceramide 
(d 18:1/24:0) and phosphatidic acid (Avanti Polar Lipids) were dissolved in chloroform: 
methanol: water (C: M: W) at a ratio of 2:1:0.1. 50 µl of lipids at a concentration of 200 
µg/ml were immobilized in 96-well glass microtiter plates and left at room temperature for 
20 hours for solvent evaporation. Control wells contained only solvents but no lipid. 150 
µl/well of  blocking buffer (1% Bovine serum albumin in PBS) was added, sealed and 
incubated at room temperutre  for an hour. Following washing the wells, 100 µl/well of the 
recombinant GST-HSMAM7 or GST protein at a concentration of 500, 250, 125, 62.5, 31, 
15.5 and 7.75 µg/ml was added, plates were sealed and incubated for 2 hours at room 
temperature with gentle shaking. The wells were washed  with washing buffer (0.05% 
Tween 20 in PBS) three times. 100 µl/well of GST-antibody (1:1000 in blocking buffer) 
were added, plates were sealed and incubated for an hour at room temperature with 




secondary anti-mouse IgG-HRP antibody (1:5000 in blocking buffer) were added, plates 
sealed and incubated for 1 hour at room temperature with gentle shaking. The wells were 
washed three times and 100 µl/well of Clarity ECLTM Western substrate was added for 
detection. Bioluminescence was visualized on a BioRad Imaging system and quantified in 
a FLUOStar Omega plate reader.  
 
2.12.3   Protein-protein interactions using plate assays 
 Mucin from porcine stomach type II, mucin from porcine stomach type III and mucin from 
bovine submaxillary glands (Sigma) were used to study the binding between HSMAM7 
and mucin. Mucin was dissolved in PBS at 4 °C for 20 hours with gentle shacking. For 
mucin immobolization, 100 µl of mucin at a concentration of 50 µg/ml was added into 96-
well high-binding microtiter plates, plates were sealed and incubated at 4 °C for 20 hours. 
Plates were washed once with PBS, and 150 µl/well of  blocking buffer (1% BSA in PBS) 
was added, plates were sealed and incubated for an hour at room temperature with gentle 
shaking. Following washing the wells, 100 µl/well of the recombinant GST-HSMAM7 
protein or GST protein at a concentration of 500, 250, 125, 62.5, 31, 15.5 and 7.75  µg/ml 
was added, plates were sealed and incubated for 2 hours at room temperature with gentle 
shaking. The wells were washed  with washing buffer (0.05% Tween 20 in PBS) three 
times. 100 µl/well of GST-antibody (1:1000 in blocking buffer) were added, plates were 
sealed and incubated for an hour at room temperature with gentle shaking. Wells were 
washed three times with washing buffer, and 100 µl/well of secondary anti-mouse IgG-




hour at room temperature with gentle shaking. The wells were washed three times and 
100 µl/well of Clarity ECLTM Western substrate was added for detection. Bioluminescence 
was visualized on a BioRad Imaging system and quantified in a FLUOStar Omega plate 
reader.  
 
2.12 .4 Protein -desulfated  mucin  interaction using plate assay 
2.12.4.1  Desulfation of mucin using pure sulfatase 
Mucin from porcine stomach type II was dissolved in PBS at 4 °C for 20 hours with gentle 
shaking. 100 µl/well  of mucin at a concentration of 50 µg/ml was immobilized into 96 well 
high-binding microtiter plates, plates were sealed and incubated at 4 ℃ for 20 hours.100 
µl/well sulfatase from Helix promatia (Sigma) at concentrations of 0.1-3 U/ml in 20 mM 
sodium posphate buffer pH 5 was added and incubated at room temperature for 24 hrs 
with gentle shaking. The wells were washed three times with washing buffer. 150 µl /well 
of  blocking buffer was added, sealed and incubated at room temp for 1 hour. The wells 
were washed three times with washing buffer. 100 µl/well of GST-HSMAM7 protein at a 
concentration of 125 µg/ml was added, sealed and incubated for 2 hours at room 
temperature. The wells were washed three times with washing buffer. Protein binding was 





2.12.4.1.1 Measurement of sulfate released from mucin 
100 µl/well of mucin (mucin from porcine stomach type II) at a concentration of 50 µg/ml 
was immobilized into the 96-well microplate, the plate was sealed and incubated at 4 ℃ 
overnight. 100 µl/well sulfatase from Helix promatia (Sigma) at concentrations of 0.1- 3 
U/ml in 20 mM sodium posphate buffer pH 5 was added and incubated at room 
temperature for 24 hours with gentle shaking. In triplicates, 100 µl from each well was 
transferred into a new 96-well plate and 100 µl of 20% barium chloride solution was added 
to each well. Barium sulfate was measured at OD 600 nm, and converted into sulfate 
concentration using a standard curve of Na2SO4. The standard curve was prepared by 
dissolving Na2SO4 in distilled water to prepare different concentrations 200, 100, 75, 60, 
50, 25, 12.5, 6.3 and 3 µM. Then, in triplicate, 100 µl of 20% barium chloride  was added 
to 100 µl of each concentration of Na2SO4  in 96 well-plate, and the optical density (OD600) 
was measured. 
 
2.12.4.2  Desulfation of mucin using live B. theta 
Mucin from porcine stomach type II was dissolved in PBS at 4 °C for 20 hours with gentle 
shaking. 100 µl/well of mucin at a concentration of 50 µg/ml was immobilized into 96 well 
high-binding microtiter plates, plates were sealed and incubated at 4 ℃ for 20 hours. 50 
µl, 100 µl and 200 µl of B. theta wt or B. theta anSME mutant at OD 0.6 was added to the 
immobilized mucin and incubated at 37 ℃ for 24, 48 or 72 hours under anaerobic 
conditions. Bacteria were discarded and the wells were washed once with washing buffer. 




incubated at room temperature for an hour. The wells were washed with washing buffer 
three times. Then 100 µl/well of GST-HSMAM7 protein at a concentration of 125 µg/ml 
was added, the plate was sealed and incubated for 2 hours at room temperature. The 
wells were washed three times with washing buffer. Protein binding was done as 
described above for protein-protein interaction plate assays.  
 
2.12.5 Protein pull-down experiments and protein identification 
Hela cells in confluent growth were collected using a cell scraper and centrifuged at 1000 
xg, at 22 °C for 5 minutes. The pellet was washed in ice cold buffer (20 mM Hepes-KOH 
pH 7.3, 110 mM KAc, 2 mM MgAc, 1 mM EGTA ), and 1 ml of lysis buffer (10 mM Hepes-
KOH pH 7.3, 10 mM KAc, 2 mM MgAc, Roche protease inhibitor cocktail) was added and 
left on ice for 10 minutes. Cells lysate was centrifuged at 12000 xg for 12 minutes. 200 µg 
GST-HSMAM or GST (control) was added to the cell lysate and incubated for 5 minutes at 
room temperature. DSP cross-linker in DMSO was added to give a final concentration of 
100 µg/ml and incubated at room temperature for 30 minutes. Tris-HCl pH 8.0 was added 
to 10 mM to quench the reaction and the solution was added to 25 µl glutathione 
sepharose beads, incubated at room temperature for two hours and then 20 hours at 4 °C. 
The suspension was centrifuged and the pellet was washed 4 times with washing buffer 
(20 mM Hepes-KOH pH 7.3, 110 mM KAc, 2 mM MgAc, 1 mM EGTA, 2 mM DTT, 0.1% 
Tween-20,150-500 mM NaCl). Proteins were eluted into SDS sample loading buffer, 
boiled and resolved by SDS-PAGE. Gels were stained with Coomassie staine and bands 




on an Thermo Orbitrap Elite system coupled to a Dionex Nano LC (University of 
Birmingham Advanced Mass Spectrometry Core). 
 
2.13   Inhibition of bacterial attachment 
Caco2 cells at a concentration of 7.5 x 104 cell/well were seeded on coverslip two days 
before the experiments or Hela cells at a concentration of 15 x 104 cell/well were seeded 
the day before the experiment. In triplicate, cells were infected with colourless DMEM 
containing non -pathogenic E. coli BL21 expressing HSMAM7 at an MOI of 100 with 50 
µg/ml mucin, desulphated mucin and 200 µM lactose-3-sulfate, lactose, N-acetyl 
glucosamine 6-sulfate, N-acetyl glucosamine, galactose-6-sulfate or galactose and 
incubated for 1 hour. After bacterial infection, DMEM medium was removed and cells were 
washed three times with PBS to remove unattached bacterial cells, and 0.5% Triton X-100 
was added to lyse cells, then serial dilutions were prepared and cultured on LB agar and 
incubated at 37 ℃ for 24 hours to count bacterial colonies. To visualize bacterial 
attachment to cells, immunostaining was done as mentioned in section 2.8. 
 
2.14 Immunocytochemistry (ICC) 
HT-29MTX cells at a concentration of 2 x104  cells/ml were seeded on coverslips in a 24 
well plate and incubated for three weeks. Cells were fed with fresh media every two days. 
1 ml 4% paraformaldehyde was used to fix cells for 20 minutes. Then cells were washed 




washing with PBS, 1 ml of 1% BSA was added for an hour. Anti muc 2 antibody produced 
in mouse was added in blocking buffer (1:400) for an hour. Following washing cells with 
blocking buffer three times, the secondary antibody (anti mouse IgG FITC) (1:1000) was 
added for 1 hour in the dark. Cells were washed with PBS three times, followed by adding 
concanavalin A (25 µg/ml) for 20 minutes. Cells were washed three times with PBS and 
the coverslips were mounted using anti fade reagent. Slides were viewed using the 
microscope Zeiss Axio Observer.  
 
2.15 Alcian blue staining 
1 gram of Alcian blue was added to 100 ml of 3% glacial acetic acid mixed and filtered 
and the pH adjusted to 1 using glacial acetic acid. HT-29MTX cells at a concentration of 
2 x104 cell/ml were seeded on a coverslips in 24-well plate and incubated for three 
weeks. Cells were fed every two days. The medium was removed and 1 ml 4 % 
paraformaldehyde was added for 10 minutes. Cells were washed with PBS three times. 
Then 1ml Alcian blue solution was added for 30 minutes. Cells were washed and 






2.16 Attachment of bacteria to HT-29MTX cells 
To visualize bacterial attachment to HT-29MTX cells, HT-29MTX cells were infected with 
E. coli BL21 -HSMAM7 or E. coli BL21 (control) at an MOI 100 for 1 hour. After bacterial 
infection, DMEM medium was removed and HT-29MTX cells were washed three times. 
ICC staining was done as mentioned in section 2.14. 
 
2.17 Measurement of sulfatase activity produced by B. theta 
 B. theta sulfatase activity was measured using an enzymatic assay (sigma) as follows: B. 
theta wt and B. theta anSME mutant were cultured in BHI broth containing 2.5 mg/ml 
mucin from porcine stomach type II and incubated at 37 ℃ for 48 hours anaerobically. 
The supernatant was collected by centrifugation at 13000 xg for 5 minutes. Serial dilutions 
of the supernatant were prepared using 0.2% NaCl and incubated with 500 µl of 200 mM 
Sodium Acetate Buffer and 400 µl of 6.25 mM p-Nitrocatechol Sulfate Solution at 37 ℃ for 
30 minutes. Followed by adding 5 ml of 1 N NaOH. The absorbance at 515 nm was 
detected using a Jen Way 3600 UV-visible spectrophotometer. Sulfatase from Helix 
promatia (Sigma) at concentrations of 5, 4.5, 4, 3, 3.5, 3, 2.5, 2, 1.5, 1, 0.5, 0.25, 0.125, 






2.18 Mucin transmigration assays 
50 µl of 10 mg/ml mucin from porcine stomach type II were added to trans-well filters (24-
well thincert, 3.0 µm pore diameter, Greiner Bio-One) and incubated at 4 °C for 20 hours, 
and then placed onto 24-well plates containing 600 µl DMEM without phenol red. 100 µl of 
106 CFU/ml E. coli was added to the top compartment and incubated at 37 °C for 2 hours. 
Bacterial concentrations in the bottom well were enumerated by dilution plating on LB 
agar following incubation at 37 °C for 20 hours. To test the effect of B. theta sulfatase, B. 
theta was grown in BHI broth containing 2.5 mg/ml mucin and incubated anaerobically at 
37 °C for 48 hours. 100 µl of 10 mg/ml mucin was incubated with 100 µl of B. theta wt or 
B. theta mutant supernatant at room temperature for 24 hours with gentle shaking. In case 
of using sulfatase from Helix promatia, 100 µl of 1 U/ml sulfatase enzyme was incubated 
with 100 µl of 10 mg/ml mucin at room temperature for 24 hours with gentle shaking prior 
to coating the Trans-well filters. Then the treated filters were placed onto 24 well plate 
containing 600 µl colourless DMEM.  
 
2.19 Statistical analysis 
Statistical analysis of data was completed using GraphPad Prism version 5. Data were 
analysed for statistical significance with a two-tailed Student t test. All experiments were 
done at least three times in triplicate. Data are presented as mean ± SEM. *p≤0.05, **p≤







Chapter 3. Characterization of HSMAM7 protein 
Parts of this chapter have been published:  
Stones DH, Al-Saedi F, Vaz D, Perez-Soto N, Krachler AM. 2015. Biomimetic materials to 
characterize bacteria-host interactions. J Vis Exp. (105): 53400. 
Al-Saedi, F, Stones, D, Vaz, DP & Krachler, AM. 2016. Displacement of Pathogens by an 
Engineered Bacterium Is a Multifactorial Process That Depends on Attachment 
Competition and Interspecific Antagonism. Infection and Immunity. 84(6):1704-1711. 
 
3.1 Introduction  
Most Gram negative bacteria express Multivalent Adhesion Molecule7 (MAM7) adhesin 
(Krachler et. al., 2011). The well characterized Vibrio parahaemolyticus MAM7 is an outer 
membrane protein comprising of seven mammalian cell entry (mce) domains headed by 
an N-terminal region that is necessary for MAM anchoring on the bacterial outer 
membrane (Krachler and Orth, 2011). V. parahaemolyticus MAM7 aids bacterial binding 
to host cells via the recognition of two types of host receptors, phosphatidic acid and 
fibronectin (Krachler and Orth, 2011; Stones and Krachler, 2015a). Due to the role of 
MAM7 in bacterial attachment, it has been used as an inhibitor to compete with pathogens 
and inhibit infections (Krachler et. al., 2012). However, the interaction between MAM7 with 
phosphatidic acid induces host cellular signalling. Krachler and her group investigated 
host signalling induced due to the interaction between MAM7 and host receptors. They 
found that binding of MAM7 to fibronectin is not involved in host signalling, while the 




GTPase Rho A. Additionally, it causes disruption of the epithelial barrier due to breaching 
of the tight junctions between cells and thus aids bacterial transmigration and infection of 
the underlying tissue (Lim et.al., 2014). Therefore, the hypothesis of this work is that the 
MAM7 adhesin from a commensal bacterium may have as good an efficacy as an 
adhesion inhibitor as V. parahaemolyticus MAM7 to inhibit or prevent bacterial infections, 
but with no ill effects on host cells. The commensal Escherichia coli strain HS colonizes 
the human gut without causing disease and competes with pathogens to inhibit infections, 
and E. coli HS also encodes a putative MAM7 orthologue.  
E. coli is the predominant facultative anaerobic bacteria in the human gastrointestinal 
tract, involving a variety of biotypes; commensals and pathogens (Todar, 2004). The 
commensal E. coli include variety strains such as E. coli  strain HS, E. coli strain  Nissle 
1917, E. coli  strain MG1655, E. coli  strain EFC1 and E. coli  strain EFC2 (Maltby et.al., 
2013). The existence of the commensals in the gut confers a protective barrier to inhibit 
infections by pathogens (Leatham et. al., 2009; Conway and Cohen, 2015). The role of 
commensals in the protection of the host may occur via the competition for nutrients and 
binding sites.  It has been revealed that feeding mice with the pathogenic E. coli strain 
EDL933 previously colonized with commensal strains such as E.  coli strain Nissle 1917, 
E. coli strain MG1655 and E. coli strain HS, results in inhibition of E. coli EDL933 
colonization (Leatham et. al., 2009). This inhibition could be a result of the competition for 
nutrients. Using a mouse model, it has been reported that E. coli  strain HS  and E. coli  
strain Nissle 1917 consume nutrients that are essential for the attachment of pathogenic 
E. coli O157:H7, and thus prevent the first step towards infection (Maltby et. al., 2013). 




been found that E. coli Nissle 1917 outcompete enterohaemorrhagic, enteropathogenic 
and enterotoxigenic E. coli strains during biofilm formation, and this could explain why this 
commensal is protective against intestinal infections (Hancock et. al., 2010). Moreover, 
commensals may play a protective role via the production of antibacterial agents such as 
bacteriocins (Dezfulian et. al., 2008; Kamada, et. al., 2013). E. coli is the initial bacterium 
that colonizes neonatal guts (Nowrouzian et.al., 2003), and the colonization occurs via the 
expression of adhesins such as P fimbria (Nowrouzian et.al., 2001), type 1 fimbriae 
(Dhakal et.al., 2008; Rendon et.al., 2007), flagellum (Haiko and Westerlund-Wikstrom, 
2013) or the non fimbrial adhesion factor adherence E. coli (FdeC) (Nesta et. al., 2012) 
that facilitate the adherence to colonic epithelial cells. 
Dissecting the interactions between host receptors and bacterial adhesins is an important 
step towards developing antibacterial treatments.  Studying the role of particular adhesins 
in bacterial attachment is difficult due to the interactions of other components in the 
bacterial cell wall with host receptors (Colino et. al., 2013; Rubinsztein-Dunlop et. al., 
2005). Therefore, new methods have been developed to study these interactions, such 
as using recombinant purified adhesins, polymer beads coupled to adhesins or non -
adherent bacteria expressing heterologous adhesins. Recombinant peptides labelled with 
FITC were used to study the interaction between Streptococcus pyogenes surface 
adhesion (protein F1) with host fibronectin (Ensenberger et. al., 2001). The recombinant 
purified Fba protein was used to study the binding ability of Streptococcus pyogenes 
surface adhesin Fba to the complement regulatory proteins such as factor H-like protein 1 




fibronectin binding protein A (FbpA) was used to investigate the role of FbpA in the 
adherence of Streptococcus gordonii to fibronectin (Christie et. al., 2002). 
Polymer beads coupled to bacterial adhesins have been used to investigate the interaction 
between MAM7 from V. parahaemolyticus with host receptors and to treat bacterial 
infections (Krachler et. al., 2012). Non-pathogenic bacteria expressing a particular adhesin 
have also been used widely to investigate bacterial adhesin adhering to host cells. For 
example, it has been shown that expressing NadA adhesin from Neisseria meningitidis on 
the surface of non- adherent Escherichia coli BL21 leads to stimulation of bacterial 
adhesion to host cells (Capecchi et. al., 2005). Chitin binding protein CBP21 secreted by 
Serratia marcescens is a critical factor for bacterial adherence to the colonic epithelial 
cells. It has been shown that expressing chitin binding protein CBP21 from S. marcescens 
in E. coli BL21 increases the binding rate to the colonic epithelial cells (Kawada et. al., 
2008). 
This chapter describes the identification of a MAM7 ortholog from the commensal E. coli 
strain HS and investigates its role in bacterial adherence using two of the above 
approaches: an engineered bacterium expressing HSMAM7 (BL21-HSMAM7) as well as 








3.2 Identification of an E. coli HSMAM7 ortholog 
Multivalent Adhesion Molecules (MAMs) are implicated in early bacterial adherence to 
host cells and they are widely spread in Gram-negative bacteria, but show a large degree 
of sequence diversity. E. coli HSMAM7 has relatively low sequence similarity with the well 
characterized V. parahaemolyticus MAM7.  
MAM7 from V. parahaemolyticus has been used to compete with pathogens and inhibit 
their attachment, but its binding to host lipids results in host signalling that aids bacterial 
invasion. Choosing the commensal E. coli HS to identify MAM7 is based on its capability 
to mediate bacterial adherence and compete pathogenic bacteria to inhibit their infection. 
MAM7 from E. coli HS would be used as an adhesion inhibitor to inhibit bacterial 
infections.                   
The web site (http://www.ncbi.nlm.nih.gov/Genomes/index.html) was used for Basic Local 
Alignment Search TOOL (BLASTp) search of E. coli HSMAM7 protein. BLAST search has 
been done using V. parahaemolyticus MAM7 protein sequence as input. The sequence of 
E. coli HSMAM7 was identified and the results revealed that E. coli HS encodes for a 
MAM7 ortholog comprised of 879 amino acids. HSMAM7 protein consisting of an N-
terminal region and seven mammalian cell entry (mce) domains (Figure 3.1).  
Clustal Omega was used to assess the percentage homology between HSMAM7 protein 
and V. parahaemolyticus MAM7 protein. The result revealed that HSMAM7 protein has 










 Figure 3.1 Domain architecture of E. coli HSMAM7 protein. HSMAM7 protein consists of 

























VibMAM7       -MSDQNNSQTSYVPDVKRSKGISPLWLLPILTMVLAGWLVVKSIHDAGQRVQIYFSDAAG 59 
EchsMAM7      MHMSQETPASTTEAQIKNKRRISPFWLLPFIALMIAGWLIWDSYQDRGNTVTIDFMSADG 60 
                 .*:.  ::   ::*..: ***:****::::::****: .* :* *: * * * .* * 
VibMAM7       LVAGRTTIRYQGLEVGMVRDINLSEDLGSIYVDADIYPEATKLLNDKTRFWLVKPTASLT 119 
EchsMAM7      IVPGRTPVRYQGVEVGTVQDISLSDDLRKIEVKVSIKSDMKDALREETQFWLVTPKASLA 120 
              :* *** :****:*** *:**.**:** .* *...*  : .. *.::*:****.*.***: 
VibMAM7       GVSGLDALVSGNYISIQPGDGQEFETTFHALDSAPTDLRVSQGLNIKLKSRDLGGVSIGS 179 
EchsMAM7      GVSGLDALVGGNYIGMMPGKGKEQD-HFVALDTQPKYRLDNGDLMIHLQAPDLGSLNSGS 179 
              *********.****.: **.*:* :  * ***: *.    . .* *:*:: ***.:. ** 
VibMAM7       QIVYKKIPIGAVYSYQLDEDAKSITIQANIQEQYRHIINDRSRFWNVSGIGASIGFEGVD 239 
EchsMAM7      LVYFRKIPVGKVYDYAINPNKQGVVIDVLIERRFTDLVKKGSRFWNVSGVDANVSISGAK 239 
               : ::***:* **.* :: : :.:.*:. *:.:: .:::. ********:.*.:.:.*.. 
VibMAM7       VRLESMSALLGGAIAVDSPDDGEPVEENTEFRLYKDLKTAGRGIAIKIALPDDNKVSSEG 299 
EchsMAM7      VKLESLAALVNGAIAFDSPEESKPAEAEDTFGLYEDLAHSQRGVIIKLELPSGAGLTADS 299 
              *:***::**:.****.***::.:*.* :  * **:**  : **: **: **..  ::::. 
VibMAM7       APIMYRGIEIGQVTDLSLSEGREVILASAAIQPAFSDMLTTGTRFVLEEAKVSLSGVENI 359 
EchsMAM7      TPLMYQGLEVGQLTKLDLNPGGKVT-GEMTVDPSVVTLLRENTRIELRNPKLSLSDA-NL 357 
              :*:**:*:*:**:*.*.*. * :*  .. :::*:.  :*  .**: *.: *:***.. *: 
VibMAM7       ANLVRGNFLTIVPGDGERSRRFTAIRKNVFNQQQEKSIAIRLISDNSFGLDSGANVLYKG 419 
EchsMAM7      SALLTGKTFELVPGDGEPRKEFVVVPGEKALLHEPDVLTLTLTAPESYGIDAGQPLILHG 417 
              : *: *: : :******  :.*..:  :    :: . ::: * : :*:*:*:*  :: :* 
VibMAM7       IVVGSIINVGLVDEKKQTKHEVFMDVLIDHEYKHLIKSNNRFYVTGSASAELTESGLSVT 479 
EchsMAM7      VQVGQVIDRKLT------SKGVTFTVAIEPQHRELVKGDSKFVVNSRVDVKVGLDGVEFL 471 
              : **.:*:  *.      .: * : * *: :::.*:*.:.:* *.. ...::  .*:..  
VibMAM7       VPPAKQLLTGSISFVSEGSESIQKEYQLFQNESLAELAQYNKTGSKTLMLFASELPPISK 539 
EchsMAM7      GASASEWINGGIRILPGDKGEMKASYPLYANLEKALENSLSDLPTTTVSLSAETLPDVQA 531 
                 *.: :.*.* ::  .. .:: .* *: * . *   . ..  :.*: * *. ** :.  
VibMAM7       GSPLLYRNLPVGNVSDFHLVDGGVLIKATIENRFAYLVTPQTVFWNRSGIEIDASLSGVS 599 
EchsMAM7      GSVVLYRKFEVGEVITVRPRANAFDIDLHIKPEYRNLLTSNSVFWAEGGAKVQLNGSGLT 591 
              ** :***:: **:*  .:   ... *.  *: .:  *:* ::*** ..* ::: . **:: 
VibMAM7       VKAHPLKSLIEGGIAFDSVPGVE—NKVGERWKLYADQQKARKFGRVISLETDGTQEVLK  657 
EchsMAM7      VQASPLSRALKGAISFDNLSGASASQRKGDKRILYASETAARAVGGQITLHAFDAGKLAV 651 
              *:* **.  ::*.*:**.: *..  :: *::  ***.:  ** .*  *:*.: .: ::   
VibMAM7       GMPIEYQGVKVGEVTLVVPNFRRNLVEVTARILPEYVENIAVEGTHFWLTEPEIGLGGVK 717 
EchsMAM7      GMPIRYLGIDIGQIQTLDLITARNEVQAKAVLYPEYVQTFARGGTRFSVVTPQISAAGVE 711 
              ****.* *:.:*::  :     ** *:..* : ****:.:*  **:* :. *:*. .**: 
VibMAM7       NLGALVSKSISVEPGNGKAKFDFQLEKGF----DRVEGVMFTLQSEQRGSVQVGTPVLYR 773 
EchsMAM7      HLDTILQPYINVEPGRGNPRRDFELQEATITDSRYLDGLSIIVEAPEAGSLGIGTPVLFR 771 
              :*.:::.  *.****.*: : **:*::.       ::*: : ::: : **: :*****:* 
VibMAM7       QMEVGQVTDVRLGEFADRVVSTIKIKPEYAYLVRQNSVFWNVSGVDVSIGITGANIKAGT 833 
EchsMAM7      GLEVGTVTGMTLGTLSDRVMIAMRISKRYQHLVRNNSVFWLASGYSLDFGLTGGVVKTGT 831 
               :*** **.: ** ::***: :::*. .* :***:***** .** .:.:*:**. :*:** 
VibMAM7       IDSLVRGGIAFSTPEQSQIPPAAKRGHSFYLYPRADESWVQWRTPIPKP 882 
EchsMAM7      FNQFIRGGIAFATPPGTPLAPKAQEGKHFLLQESEPKEWREWGTALPK- 879 
              ::.::******:**  : : * *:.*: * *     :.* :* * :**  
                                  
 
Figure 3.2 Comparison between V. parahaemolyticus and E. coli HSMAM7 protein. 
Alignment of the amino acid sequences of V. parahaemolyticus MAM7 and E. coli HS 
MAM7 using the Clustal Omega program. (*) indicates the identical residues. (:) indicates  




3.3 Cloning of E.coli HSMAM7 for expression analysis 
3.3.1  Extraction of E. coli HS genomic DNA 
The genomic DNA was extracted from the overnight growth culture of the commensal E. 
coli HS using Gen Elute Bacterial Genomic DNA Kit (Sigma). The purified DNA was 
analysed by agarose gel electrophoresis to confirm the quality and purity of the DNA. Gel 
electrophoresis results revealed the presence of a pure band of the E. coli HS genomic 
















                      
 Figure 3.3 E.coli HS genomic DNA. Lane M: DNA Marker. Lane 1: the extracted E. coli 













 3.3.2 Amplification of HSMAM7 gene 
The extracted genomic DNA from E. coli HS was used as a template to amplify the 
MAM7 gene. The sequence (∆TM MAM7) encoding the soluble portion of the protein was 
amplified using primers (table 2.1) comprising 5' BamHI and 3' XhoI restriction sites for 
subsequent cloning into pGEX4T-3 plasmid for recombinant expression. For expression 
of the full-length HSMAM protein on the surface of non- adherent E. coli  BL21, the 
complete gene was amplified using the primers (table 2.1) comprising 5' NcoI and 
3'HindIII restriction sites for subsequent cloning into pBADMyc-His plasmid. The PCR 
products were tested by agarose gel electrophoresis to confirm the presence and the 
purity of the bands. The results of gel electrophoresis revealed the presence of the 
expected bands (Figure 3.4), a band size of 2517 bp for ∆TM MAM7 and of 2640 bp for 
























Figure 3.4: Escherichia coli HSMAM7 gene. Images show the PCR products.A): Lane 
M: DNA Marker.Lane 1: ∆TM MAM7 gene (2517 bp). B): Lane M: DNA Marker. Lane1: full 














3.3.3   Construction of HSMAM7 expression plasmids  
 In order to construct HSMAM7 expression plasmids, pGEX 4T-3-∆TM MAM7 and p 
BAD/Myc-His-HSMAM7, both inserts and plasmids were digested with the restriction 
enzymes.  The insert (∆TM MAM7) and pGEX 4T-3 plasmid were digested with XhoI 
and BamHI enzymes. However, the full-length MAM7 insert and pBAD/Myc-His plasmid 
were digested with NcoI and HindIII restriction enzymes using the conditions mentioned 
in tables 2.3 and 2.4. The purified digested DNA was ligated using T4 ligase enzyme. 
The ligation products were transformed into the competent E. coli DH5α cells and grown 
on LB medium containing appropriate antibiotics. The plasmids were extracted from the 
growth of the picked colonies using the mini prep extraction kit. To prove the success of 
ligation, the purified recombinant plasmids were digested with the appropriate restriction 
enzymes and analysed using agarose gel electrophoresis to check the presence of the 
exact bands. The results revealed the presence of the expected bands of both vectors 
and inserts. The digested pGEX 4T-3 plasmid showed a band size of 4900 bp and the 
digested insert a band size of 2517 bp. The digested pBAD/Myc-His had a band size of 















Figure 3.5 Gel electrophoresis of the digested recombinant plasmids. A: Lane M: DNA 
Marker. Lane1: digested recombinant plasmid into pGEX4T-3 (4900 bp) and ∆TM MAM7 
(2517 bp). B: Lane M: DNA Marker. Lane 1: digested cloned plasmid into p BAD/Myc-His 
(4100 bp) and MAM7 (2640 bp). 










In addition to the detection of the bands of both inserts and vectors using agarose gel 
electrophoresis, sequencing analysis was done to confirm the cloning success and to 
verify the sequence of the recombinant plasmids. The plasmids were sent to the 
Functional Genomics Service at the School of Bioscience at Birmingham University for the 
sequencing. The sequence analysis results revealed that the cloning was successful.  
 
3.4 Expression and purification of recombinant HSMAM7 protein 
For the expression of GST-HSMAM7protein, 10 ml of LB medium containing ampicillin 
was inoculated with a colony of E. coli BL21 transformed with pGEX4T-3 containing the 
HSMAM construct and incubated with shaking at 37°C overnight.  5 ml of the LB broth 
culture was added per 500 ml LB broth containing ampicillin and incubated at 37 ℃ until 
the optical density (OD) reached 0.6-0.7 at 600 nm, then IPTG was added at a final 
concentration of 1 mM. The cultures were centrifuged and the pellet was collected for the 
purification using GST affinity chromatography. After the purification process, the eluted 
proteins were collected and dialyzed in PBS buffer. The samples from the elution were 
analysed using SDS- PAGE analysis. The SDS- PAGE results showed the presence of 
the expected size of the recombinant protein (121 kDa). This mass included the GST tag 
of 26 kDa and the MAM protein of 95 kDa (Figure 3.6). GST protein was expressed using 
the same method. The E. coli BL21 strain was transformed with empty pGEX 4T-3 
plasmid. The SDS-PAGE results showed the presence of the GST protein (26 kDa) 








            
 
Figure 3.6 SDS -PAGE analysis of recombinant GST- HSMAM7 protein. Lane M:  marker; 
Lane P: the pellet; Lane SF: supernatant fraction; Lane FT: Flow through; Lanes W1, W2, 























Figure 3.7 SDS -PAGE analysis of GST protein purification.  Lane M: marker; Lane P:  
pellet; Lane SF: supernatant fraction; Lane FT: Flow through; Lanes W1, W2, W3: 














3.5 Coupling of purified proteins to polymer beads  
Polymer beads coupled to the purified recombinant protein GST-HSMAM7 were designed 
to investigate the role of HSMAM7 in bacterial attachment and to be used as a tool to 
inhibit bacterial infection. Coupling the recombinant GST-HSMAM7 to beads provides a 
mimic for its display on bacterial surface. Herein, the recombinant purified GST-HSMAM7 
protein and polystyrene fluorescent beads of 2 µm diameter were used. The principle of 
this coupling is that cysteine containing proteins couple to the amine-functionalized 
polymer beads by using the cross linker Sulfosuccinimidyl4-p-maleimidophenyl butyrate 
(Sulfo-SMPB) (Figure 3.8). Fluorescent beads were incubated with 10 mM Sulfo-SMPB for 
an hour. Then the activated beads were incubated with the recombinant GST- HSMAM7 
protein at a concentration of 6 µM for 2 hours at 25 ℃. Followed by adding cysteine at a 
final concentration of 50 mM. The beads were pelleted, and then the supernatant was 
used to evaluate the concentration of the coupled protein. Following washing the beads 
with strerile PBS twice, they were resuspended in sterile PBS to provide the final product. 
The same steps were followed to prepare beads coupled to GST protein. This would be 
used as a control for the subsequent experiments. 
The concentration of the coupled protein was calculated based on the following: 
 [Coupled protein = (Initial protein) – (Supernatant protein)]. The concentration of the 
coupled protein was 5 µM. The optimized version of this protocol was published (Stones 













       
 
 
Figure 3.8 Scheme of bead coupling to purified GST-HSMAM7 protein. Sulfo-SMPB linker 
was used to activate the polymer beads which were then coupled to GST- HSMAM7 
protein due to the reaction between maleimide group and free cysteine in the GST protein. 













3.6 Role of HSMAM7 in bacterial adhesion 
3.6.1 Beads coupled to HSMAM7 attach to host cells 
Since the E. coli HSMAM7 ortholog has low sequence similarity with V. parahaemolyticus 
MAM7, the ability of E. coli HSMAM7 protein to mediate the attachment to host cells was 
investigated. The attachment activity of HSMAM7 to host cells was characterized using 
beads coupled to recombinant protein GST-HSMAM7.  Herein, Hela cells were seeded on 
cover slips at a concentration of 150000 cells/ml the day before the experiment. 10 % v/v 
beads coupled to GST-HSMAM7 or GST protein (control) in colourless DMEM (2 X 1010 
beads/ml containing protein at a final concentration of 500 nM) were added to Hela cells 
and incubated at 37 °C for 4 hours.  Immunostaining was used to visualize and count the 
beads attached to Hela cells. The results revealed that GST-HSMAM7 coupled beads 
adhere to Hela cells (average 767 beads per 100 cells), whereas, no adherence was 
observed for GST coupled control beads (average of 20 beads per 100 cells, Figure 3.9). 
 























                                  
                   
Figure 3.9 The attachment of HSMAM7- beads to the Hela cells. Attachment of beads 
(blue) coupled to GST (A) or GST-HSMAM7 (B) to Hela cells (green), scale bar 10 µm. 
(C) The numbers of attached beads/100 cells. Values represent the means ± SEM. 





3.6.2 HSMAM7 enhances bacterial binding to host cells 
To study the role of HSMAM7 in bacterial adhesion, an engineered bacterium expressing 
HSMAM7 was generated by transforming E. coli BL21 with the expression plasmid pBAD-
Myc-His containing the full-length HSMAM7.  HSMAM7 was expressed on the surface of 
E. coli BL21 following arabinose induction. The capability of BL21-HSMAM7 to bind to 
host cells was investigated using Hela cells.  Herein, Hela cells were infected with BL21 
expressing HSMAM7 or BL21 containing empty vector (control) at an MOI of 100 and 
incubated for 1 hour. Both BL21-HSMAM7 and BL21 control were co-transformed with a 
pDP151 plasmid expressing mCherry to visualize the attachment. Immunostaining was 
used to visualize bacterial attachment and to count the number of attached bacteria. In 
addition, the number of colony forming units (cfu) was calculated via plating of the bacteria 
following infection of Hela cells. The results revealed that BL21 expressing HSMAM7 on 
the surface adhere to Hela cells with an average of 1,070 ± 250 bacteria per 100 host 
cells, whereas BL21 (control) adhere with an average of 170 ± 20 bacteria per 100 host 
cells. The number of attached bacteria using dilution plating revealed similar results: 73% 
of the BL21 bacteria expressing HSMAM7 were attached compared to 19% of the BL21 
control (Figure 3.10). These results indicate that HSMAM7 enhances bacterial attachment 













          
 
  
Figure 3.10 HSMAM7 enhances bacterial attachment to host cells. Hela cells were 
infected with BL21 control (A) or BL21 HSMAM7 (B) at an MOI of 100 for 1 hour.  Cells 
were fixed and stained with Hoechst for DNA (blue) and phalloidin for actin (green). Bar 
10 µm, and the number of attached BL21 HSMAM7 or BL21 per Hela cells were counted 
(C). For the bacterial attachment assay, DMEM medium was removed and Hela cells 
were washed three times with PBS. 0.5% Triton X-100 was added to lyse Hela cells, and 
then serial dilutions of attached bacteria were cultured on LB agar. The number of 
colonies was counted after incubation at 37 °C for 24 hrs (D). The values shown are 




3.7 Discussion   
Previously, it has been reported that using inhibitors based on the V. parahaemolyticus 
MAM7 can impede the attachment of a broad range of pathogenic bacteria. However, the 
binding of MAM7 from V. parahaemolyticus to host cells induces host signalling that aids 
bacterial invasion (Lim et. al., 2014). Therefore, a MAM7 ortholog from the commensal E. 
coli strain HS was characterized for its adhesion properties, to have an alternative protein 
for the design of future MAM7 based adhesion inhibitors. The commensal E. coli strain HS 
colonizes the human gut without causing disease and has the ability to compete 
pathogenic bacteria (Maltby et. al., 2013). 
This study involves identification and characterization of the MAM7 ortholog from the 
commensal E. coli strain HS. The results revealed that E. coli strain HS harbours a MAM7 
orthologue consisting of 879 amino acids with an identity of 35.78% to MAM7 from V. 
parahaemolyticus. HSMAM7 is expected to be similar to V. parahaemolyticus MAM7, an 
outer membrane protein comprising an N-terminal region followed by seven MCE domains 
(Krachler and Orth, 2011). Another study confirmed MAM7 localization and function within 
the bacterial cell. It has been reported that MAM7 from Shigella sonnei is an outer 
membrane protein comprising seven MCE domains that exposed extracellularly, and this 
protein contributes in Shigella sonnei attachment and invasion of epithelial cells and 
macrophages (Mahmoud et. al., 2016). MAM7 is not limited just to these pathogens, but 
other pathogens express it such as enteropathogenic E. coli, Yersinia pseudotubercolusis 




To study the role of HSMAM7 in bacterial attachment, two modes were designed in this 
study; firstly, an engineered bacterium expressing HSMAM7 on the surface (BL21-
HSMAM7). The ability of BL21-HSMAM7 to attach to host cells was investigated. The 
results revealed that the expression of HSMAM7 protein on BL21 cell surface enhances 
bacterial attachment to host cells.  
For the second method, polymer beads were coupled to the purified recombinant GST- 
HSMAM7 protein. The polymer beads have a size similar to bacteria (2 µm), and coupling 
the recombinant protein to beads provide a mimic for its display on bacterial surface. 
Thus, studying the role of MAM7 in bacterial attachment to host cell would be independent 
of other bacterial adhesins. The binding ability of beads coupled to GST-HSMAM7 
towards host cells has been investigated. The results showed that HSMAM7 mediates the 
binding to host cells. 
Previous studies with V. parahamolyticus MAM7 have shown similar results. It has been 
revealed that BL21 express MAM7 from the pathogenic bacteria V. parahamolyticus and 
beads coupled to MAM7 have the ability to bind to the host and induce host signalling 
(Lim et. al., 2014).  
The ability of HSMAM7 to bind to host cells has led to the investigation into the role of 
HSMAM7 as an adhesion inhibitor. In addition to characterize its interaction with host cells 







Chapter 4. Displacement of pathogens using HSMAM7 based 
inhibitors   
 
This chapter has been published:  
Al-Saedi, F, Stones, D, Vaz, DP & Krachler, AM. 2016. Displacement of Pathogens by an 
Engineered Bacterium Is a Multifactorial Process That Depends on Attachment 
Competition and Interspecific Antagonism. Infection and Immunity. 84(6): 1704-1711. 
 
4.1 Introduction 
The increased prevalence of pathogenic bacteria that are resistant to conventional 
antibiotics has become the most serious problem in treating bacterial infections. 
Therefore, researchers are trying to find alternative ways to overcome this problem. The 
early steps of bacterial interaction with host cells involve a variety of virulence factors that 
are necessary for successful interaction and infection. Therefore, targeting virulence 
factors could be a successful solution for preventing or treating infectious disease (Allen 
et. al., 2014). Since bacterial adherence to host cells is an important step towards 
bacterial colonization and infections (Schluter et. al., 2015), the focus on bacterial 
adhesion may be a potential way for treating bacterial infections. Anti-adhesion therapy is 
an alternative way to inhibit bacterial infections due to the interference with bacterial 
adherence to the host cells as well as to avoid further selection for antibiotic resistant 
strains. In anti-adhesion treatment, bacteria are not killed by the adhesion inhibitors, but 




development of antibiotic resistance will occur. Additionally, if mutants evolve with 
increased resistance to anti- adhesion treatments, this would deteriorate bacterial ability to 
attach to the host cells (Krachler and Orth, 2013). Anti-adhesion therapy involves different 
strategies that result in the inhibition of bacterial adherence to the host such as the 
interference with adhesin biosynthesis, adhesin or receptor analogs that are structurally 
similar to adhesins or receptors, or the use of  microbes (probiotics and an engineered 
bacterium) and antibodies (Krachler and Orth, 2013). Studies have revealed the potential 
of synthetic adhesion inhibitors in preventing bacterial attachment such as using 
carbohydrate based inhibitors as receptor analogs to block Streptococcus suis adherence 
to host cells (Kouki et. al., 2013). In addition synthetic glycosides were used to inhibit 
bacterial adhesion to HT29 cells mediated by type 1 fimbriae (Hartmann et. al., 2012). 
Polymer beads coupled to particular proteins were used as antimicrobial agents to 
compete with bacterial adhesins for attachment to host cells (Krachler et. al., 2012).  
Probiotic bacteria and recombinant probiotics have been used to compete with pathogens 
and inhibit infections (Dhanani et. al., 2011; Beltran et. al., 2016). It has been revealed 
that the adhesion of the pathogenic strains Escherichia coli  and Salmonella spp to the 
host glycoproteins and Caco2 cells was inhibited using the commensal lactobacilli sp (Lee 
et.al., 2003). Furthermore, a particular adhesin from lactobacillus was used as adhesion 
inhibitor such as the purified elongation factor Tu (EF-Tu) from Lactobacillus plantarum  
that used to impede the binding of E. coli and S. typhi to the gut epithelium (Dhanani et. 
al., 2011). In addition, the commensal E. coli Nissle 1917 was used to out compete 




The commensal E. coli HS compete with pathogenic E. coli O157:H7 for the nutrients that 
are important for bacterial colonization (Maltby et. al., 2013), in addition to the production 
of bacteriocins (Dezfulian et.al., 2008; Kamada, et. al., 2013), and the expression of the 
adhesion factors such as type 1 fimbria and flagella that enable them to displace 
pathogenic bacteria (Dhakal et. al., 2008; Rendon et.al., 2007). 
In the current chapter, the work is based on the anti-adhesion principles to inhibit bacterial 
infection via the interference with bacterial attachment to host cells without affecting their 
viability. Herein, adhesion inhibitors based on the MAM7 protein from the commensal E. 
coli strain HS (HSMAM7); semisynthetic adhesion inhibitor (beads coupled to purified 
GST- HSMAM7) and an engineered bacterium expressing HSMAM7 on the surface 
(BL21-HSMAM7) will be tested for their potential to outcompete with both Gram positive 
and Gram negative pathogenic bacteria causing wound infections. The aim of this study 
was to identify antibacterial agents to be used as wide spectrum inhibitors for the 
treatment of wound infections. 
Wound infections are a major problem contributing to mortality and morbidity. This is due 
to the rise in the infections that are caused by multidrug resistant bacteria which makes 
the treatment more difficult and takes more time and increases the cost of medical care 
(Anderson et. al., 2007; Alebachew et. al., 2012). Factors which contribute to wound 
infections include obesity, diabetes, age, anaemia, malnutrition and unhygienic conditions 
(Bandaru et. al., 2012).  
 A broad range of aerobic and anaerobic pathogenic bacteria can cause wound infections. 
Common bacteria isolated from wound infections comprise P. aeruginosa, S. aureus, 




al., 2006). Among the isolated pathogens from infected wounds, S. aureus is the most 
frequent pathogen (25.8%), followed by enterococci species (7.9%), and P. aeruginosa 
(6.7%), (Cantlon et. al., 2006).  
In the current study, S. aureus, E. faecalis and P. aeruginosa were used due to their 
clinical importance and their role in wound and tissue infections. Gram positive cocci such 
as S. aureus and Enterococcus spp constitute the main burden of wound infections 
(Weiss et.al., 1999; Cantlon et. al., 2006). Strains that are broadly resistant to antibiotics, 
such as vancomycin resistant enterococci and methicillin resistant S. aureus (MRSA) 
make the treatment of infected patients more difficult and are associated with longer stays 
in hospitals and higher healthcare costs (Rajkumari et.al.,2014; Cantlon et. al.,2006). In 
addition to wound infections, S. aureus can result in a wide range of infections such as 
skin infections including atopic dermatitis (AD), boils and impetigo, and systemic infections 
such as osteomyelitis, urinary tract infections, endocarditis, meningitis, food poisoning and 
pneumonia (Ogston and Witte, 1984; Tong et.al., 2015).  
E. faecalis can cause several diseases in addition to wound infections such as deep 
tissue infections, bacteraemia and urinary tract infections (Huycke et.al., 1998; Agudelo 
Higuita and Huycke, 2014). 
P. aeruginosa is the most common Gram negative bacillus isolated from wound and burn 
infections. P. aeroginosa is able to cause chronic wound infections as a result of its 
capability to form biofilms that make the treatment with antibiotics less effective 
(Rasamiravaka et. al., 2015). Several studies have revealed that multi-drug resistant 




Godebo et. al., 2013). In addition, P. aeruginosa can cause cystic fibrosis and septicaemia 
(Sousa, and Pereira, 2014; Vitkauskiene, et. al., 2010). 
Due to the increasing resistance of these bacteria to available antibiotics, there is an 
urgent need to find potential compounds that prevent bacterial infections without affecting 
bacterial viability.  
Targeting bacterial virulence factors is a promising strategy to treat bacterial infections. 
Bacterial adhesins are important factors for virulence, that enable tight binding with host 
cells towards infection. Therefore, using inhibitors based on bacterial adhesins is a 
potential way to compete with the attachment of pathogens and inhibit bacterial infection 
(Huebinger et. al., 2016).  
The well characterized MAM7 from the pathogenic bacteria V. parahaemolyticus has been 
used as an adhesion inhibitor to inhibit bacterial infections both in vivo and in vitro.  
Recently, using a rat model, polymer beads coupled to MAM7 from V. parahaemolyticus 
were used to treat burn wounds infected with P. aeruginosa (Huebinger et. al., 2016). In 
addition, MAM7 has been used to displace a variety of pathogenic bacteria from host cells 
and inhibit their attachment and cytotoxic effects.  MAM7 has been used against variety of 
pathogenic bacteria such as Y. pseudotuberculosis, V. cholerae, V. parahaemolyticus or 
enteropathogenic E. coli (EPEC) (Krachler et. al., 2011) and P. aeruginosa (Krachler et. 
al., 2012). Furthermore, it has been used to compete with the Gram positive bacterium S. 
aureus (Hawley et. al., 2013). However, V. parahaemolyticus MAM7 was recently shown 
to interfere with cellular signaling in intestinal epithelial cells and to increase the 
permeability of intestinal cell junctions in vitro, on the basis of its ability to bind to and 




commensal E. coli strain HS colonizes the human gut and has the ability to compete 
pathogenic bacteria (Maltby et. al., 2013), MAM7 ortholog from the commensal E. coli HS 
is chosen in this study to investigate its functionality as an adhesion inhibitor. 
This chapter shows the potential role of adhesion inhibitors based on the  MAM7 protein 
from the commensal E. coli  strain HS; a semisynthetic adhesion inhibitor (beads coupled 
to GST-HSMAM7) and an engineered bacterium expressing HSMAM7 (BL21-HSMAM7), 















4.2 Anti- adhesion activity of HSMAM7 based inhibitors 
 In the previous chapter, the capability of HSMAM7 to adhere to host cells has been 
shown, using both beads coupled to GST-HSMAM7 and an engineered bacterium 
expressing HSMAM7 on the surface (BL21-HSMAM7). Herein, the ability of beads 
coupled to GST-HSMAM7 and BL21-HSMAM7 to out compete pathogenic bacteria was 
investigated, aiming to identify anti–adhesion agents involved in wound infection 
treatment. The anti–adhesion activity of HSMAM7 based inhibitors was done in vitro 
against S. aureus, E. faecalis and P. aeruginosa.  
 
4.2.1 The attachment of pathogenic bacteria to host cells 
The ability of the pathogenic bacteria S. aureus, E. faecalis and P. aeruginosa to adhere 
to host cells and their effect on host cell morphology was investigated prior to testing the 
effect of HSMAM7 based inhibitors on bacterial attachment and cytotoxic effects. Hela 
cells were infected with S. aureus, P. aeruginosa and E. faecalis followed by an 
attachment assay and immunostaining assay. The results revealed the ability of those 
bacteria to bind to Hela cells. In addition the incubation of Hela cells with those pathogens 
for 4 hours resulted in changes in cell morphology. Most Hela cells were rounded and 










     
 
Figure 4.1The attachment of pathogenic bacteria to Hela cells. The figure shows the 
attachment of S. aureus (A, B, C), P. aeruginosa (D, E, F) and E. faecalis (G, H, I) to Hela 
cells. Hela cells were seeded on coverslips and incubated with pathogenic bacteria at an 
MOI of 10 for 1 hour (A, D, G) and 4 hours (B, E, H) or uninfected cells (control)(J,K). 
Cells were fixed and stained with Hoechst for DNA (blue) and rhodamine-phalloidin for 
actin (red). Scale bar 20 µm.  The attachment of bacteria to Hela cells was also quantified 




4.2.2 Beads coupled to HSMAM7 compete with pathogens for 
attachment sites 
Due to the ability of beads coupled to the recombinant protein GST-HSMAM7 to adhere to 
host cells (chapter 3, figure 3.9), they were used as adhesion inhibitors to inhibit bacterial 
attachment and cytotoxic effects. Herein, Hela cells were infected with the infection 
medium containing S. aureus, P. aeruginosa or E. faecalis at an MOI of 10 with10% v/v 
GST-HSMAM7 coupled beads and incubated for 4 hours, followed by immunostaining, an 
attachment assay and LDH release assay. The results revealed a significant decrease in 
bacterial adherence and cytotoxicity towards Hela cells in the presence of beads coupled 
to GST-HSMAM7 compared to the control GST-beads. The infection in the presence of 
beads coupled to GST-HSMAM7 resulted in decreased attachment of S. aureus (8-fold 
reduction), E. faecalis (2-fold reduction) and P. aeruginosa (2-fold reduction) to host cells. 
In addition, the inhibitor also resulted in the inhibition of the cytotoxic effects of S. aureus, 
E. faecalis and P. aeruginosa (7-fold reduction, 2-fold reduction and 4-fold reduction, 
respectively). In contrast, no marked effect on bacterial binding and cytotoxic effects was 
detected in the presence of the control beads (Figure 4.2, Figure 4.3 and Figure 4.4). 
These results were confirmed using an immunostaining assay to visualize the treatment. 
Microscopic analysis of multiple images suggests that the infection of Hela cells in the 
presence of beads coupled to GST-HSMAM7 result in the protection of Hela cells from the 
cytotoxic effects of S. aureus, E. faecalis and P. aeruginosa. In contrast, the morphology 
of Hela cells was affected in the presence of these pathogens or the pathogens with 




In combination, these results indicate the ability of beads coupled to HSMAM7 to protect 
host cells from bacterial infections due to their ability to bind to host cells and compete 





















       
 
 
Figure 4.2 Beads coupled to GST- HSMAM7 compete with S. aureus. Hela cells were 
infected with S. aureus at an MOI of 10 (A). Attachment was visualized after the addition 
of 10% v/v GST coupled beads (control), (B) or beads coupled to GST-HSMAM7 (C). 
After incubation for 4 hours, cells were stained with phalloidin (green). Scale bar 20 µm. 
For the bacterial attachment assay, DMEM medium was removed and Hela cells were 
washed three times with PBS. 0.5% Triton X-100 was added to lyse Hela cells, and then 
serial dilutions of attached bacteria were cultured on LB agar. The number of colonies was 
counted after incubation at 37 °C for 24 hours (D). Cytotoxicity was determined using LDH 
release assays (E). The values shown are means ±SEM. Significance was determined 








     
          
Figure 4.3 Beads coupled to GST-HSMAM7 compete with E. faecalis. Hela cells were 
infected with E. faecalis at an MOI of 10 (A). Attachment was imaged following the 
addition of 10% v/v GST coupled beads (control), (B) or beads coupled to GST- HSMAM7 
(C). After incubation for 4 hours, cells were stained with phalloidin (green). Scale bar 20 
µm. For the bacterial attachment assay, DMEM medium was removed and Hela cells 
were washed three times with PBS. 0.5% Triton X-100 was added to lyse Hela cells, and 
then serial dilutions of attached bacteria were cultured on LB agar. The number of 
colonies was counted after incubation at 37 °C for 24 hours (D). Cytotoxicity was 
determined using LDH release assays (E). The values shown are means ± SEM. 







   
 
 
Figure 4.4 Beads coupled to GST-HSMAM7 compete with P. aeruginosa. Hela cells were 
infected with P. aeruginosa at an MOI of10 (A). Attachment was imaged after the addition 
of 10% v/v GST coupled beads (control), (B) or beads coupled to GST-HSMAM7 (C). 
After incubation for 4 hours, cells were stained with phalloidin (green). Scale bar 20 µm. 
For the bacterial attachment assay, DMEM medium was removed and Hela cells were 
washed three times with PBS. 0.5% Triton X-100 was added to lyse Hela cells, and then 
serial dilutions of attached bacteria were cultured on LB agar. The number of colonies was 
counted after incubation at 37 °C for 24 hours (D). Cytotoxicity was determined using LDH 
release assays (E). The values shown are means ±SEM (n=3). Significance was 





4.2.3 Anti adhesion activity of E. coli BL21-HSMAM7     
4.2.3.1 E. coli BL21-HSMAM7 is not cytotoxic to host cells 
Prior to investigation of the ability of the engineered bacterium expressing HSMAM7 
(BL21-HSMAM7) to displace pathogens and inhibit their infections, it was necessary to 
determine whether BL21-HSMAM7 can cause cytotoxic effects to host cells. Hela cells 
were infected with BL21-HSMAM7 at an MOI of 100 and incubated at 37 ℃ for 1 hour, 
followed by an LDH release assay. The results show there was no cytotoxic effects due to 
incubation of Hela cells with E. coli BL21-HSMAM7 or BL21 (control) for 1 hour compared 






















Figure 4.5 E. coli BL21 HSMAM7 was not cytotoxic on Hela cells. Hela cells were infected 
with BL21-HSMAM7 or BL21 (control) at an MOI of 100 for 1 hour. Cytotoxicity was 
determined using LDH release assays. The values shown are means ± SEM (n=3). 











4.2.3.2 Displacement of pathogens by BL21-HSMAM7 depends on 
attachment competition and interspecies interactions 
 
4.2.3.2.1 The competition between BL21-HSMAM7 and S. aureus is 
based on competition for attachment sites and interspecies 
antagonism 
The ability of BL21-HSMAM7 to inhibit S. aureus infection was investigated. Herein, Hela 
cells were incubated with E. coli BL21-HSMAM7 or BL21 (control) at an MOI of 100 for 1 
hour prior to infection with S. aureus at an MOI of 10 for 4 hours, followed by 
immunostaining assay, attachment assays and LDH release assays. 
Microscopic analysis of multiple images suggest that the pre- incubation of Hela cells with 
BL21-HSMAM7 prior to infection with S. aureus result in the protection of Hela cells 
compared to the BL21(control) (Figure 4.6 A, B, C). The results of the competition 
experiments revealed that both attachment and cytotoxic effects of S. aureus were 
reduced 6-fold in the presence of BL21-HSMAM7 compared to a 2-fold reduction using 
the BL21 control (Figure 4.6 D, E). Further investigation was done to study the 
interactions between BL21 and S. aureus. In LB broth, BL21 at an MOI of 100 was mixed 
with S. aureus at an MOI of 10 and incubated for 4 hours. Serial dilutions from the mixed 
culture were then plated on selective media to count the number of bacterial colonies of 
each species. The results revealed that BL21 does not affect S. aureus growth when S. 
aureus and E. coli BL21 were grown together in LB broth (Figure 4.6 F).  However, BL21 
growth was significantly decreased in the presence of S. aureus (Figure 4.10). The 




The results indicate that the inhibitory effect of BL21-HSMAM7 on S. aureus is as a result 



















Figure 4.6 Inhibitory effect of BL21- HSMAM7 on S. aureus. Hela cells were infected with 
S. aureus only (A), S. aureus with BL21 control (B) or S.aureus with BL21-HSMAM7(C) 
for 4 hours. Cells were fixed and stained with Hoechst for DNA (blue) and phalloidin for 
actin (red). Scale bar 20 µm. For the bacterial attachment competition, 0.5% Triton X-100 
was added and then serial dilutions were cultured on mannitol salt agar medium, and the 
number of colonies was counted (D). The cytotoxicity was determined using LDH release 
assays (E). S. aureus and BL21 were mixed and grown in liquid medium for 4 hours, 
followed by plating S. aureus on mannitol salt agar medium for counting bacterial colonies 
(F).The values shown are means ± SEM, (n=3). Significance was determined using two 




4.2.3.2.2 The competition between BL21-HSMAM7 and E. faecalis is a 
combination of competition for attachment sites and nutrients. 
The inhibitory role of BL21-HSMAM7 on E. faecalis was investigated. Hela cells were 
incubated with E. coli BL21- HSMAM7 or BL21 (control) at an MOI of 100 for 1 hour prior 
to infection with E. faecalis at an MOI of 10 for 4 hours. Immunostaining assays, 
attachment assays and LDH release assays were then performed. 
Microscopic analysis of multiple images suggests the protective role of BL21-HSMAM7 
compared to the BL21 (control) (Figure 4.8 A, B, C). The results of the competition 
experiments revealed that E. faecalis attachment was reduced 2-fold in the presence of 
BL21–HSMAM7 or BL21 (control). In addition, inhibition of cytotoxicity to host cells 10-fold 
reduction in the presence of BL21-HSMAM7 and 3-fold reduction in the presence of BL21 
was observed (Figure 4.8 D, E). The interaction between E. coli and E. faecalis was 
further investigated via co incubation in LB broth. The results revealed that the co- 
incubation of both E. coli BL21 and E. faecalis in LB broth showed that the growth of both 
species was significantly decreased and this decrease might be due to a competition for 
nutrients (Figure 4.8 F and Figure 4.10). These results indicated that the competition 








Figure 4.8 Inhibitory effect of BL21- HSMAM7 on E. faecalis. Hela cells were infected with 
E. faecalis alone (A), E. faecalis with BL21 control (B) or E. faecalis with BL21-
HSMAM7(C) for 4 hours. Cells were fixed and stained with Hoechst for DNA (blue) and 
phalloidin for actin (red). Scale bar 20 µm. For bacterial attachment competition, 0.5% 
Triton X-100 was added and then serial dilutions were cultured on enterococcosel   agar 
medium, and the number of colonies was counted (D). The cytotoxicity was determined 
using LDH release assay (E). E. faecalis and BL21 were mixed and grown in liquid 
medium for 4 hours, followed by plating E. faecalis on enterococcosel   agar medium for 
counting bacterial colonies (F). The values shown are means ± SEM, (n=3). Significance 




4.2.3.2.3 The competition between BL21-HSMAM7 and P. aeruginosa 
is only for attachment sites 
Hela cells were incubated with E. coli BL21- HSMAM7 or BL21 (control) at an MOI of 100 
for 1 hour prior to infection with P. aeruginosa at an MOI of 10 for 4 hours.         
Immunostaining assays, attachment assays and LDH release assays were then 
performed.  
Microscopic analysis of multiple images suggest that the pre- incubation of Hela cells with 
BL21-HSMAM7 prior to infection with P. aeruginosa result in the protection of Hela cells 
compared to the BL21(control) (Figure 4.9 A, B, C). The results of the competition 
experiments revealed a significant decrease in both attachment (3-fold reduction) and 
cytotoxic effects (18-fold reduction) of P. aeruginosa to the host cells in the presence of 
BL21-HSMAM. No significant changes in bacterial attachment and the cytotoxic effects 
were observed in the presence of the BL21 control (Figure 4.9 D, E). The interactions 
between P. aeruginosa and BL21 in liquid medium was investigated to test if another 
factor was involved in this competition in addition to the competition for the binding sites. 
Co incubation of E. coli BL21 with P. aeruginosa in LB broth revealed no changes in the 
growth of both species (Figure 4.9 F and Figure 4.10). These results indicate the inhibitory 
effect of BL21-HSMAM7 on P. aeruginosa is via the competition for the binding sites 
alone. 
Considering all competition results, this study demonstrates that the competition between 
BL21 and pathogens does not solely depend on binding sites, but other factors can also 





      
 
Figure 4.9 Inhibitory effect of BL21- HSMAM7 on P. aeruginosa. Hela cells were infected 
with P. aeruginosa alone (A), P. aeruginosa with BL21 control (B) or P. aeruginosa with 
BL21-HSMAM7(C) for 4 hours. Cells were fixed and stained with Hoechst for DNA (blue) 
and phalloidin for actin (red). Scale bar 20 µm. For the bacterial attachment competition, 
0.5% Triton X-100 was added and then serial dilutions were cultured on cetrimide agar 
medium, and the number of colonies was counted (D). The cytotoxicity was determined 
using LDH release assays (E). P. aeruginosa and BL21 were mixed and grown in liquid 
medium for 4 hours, followed by plating P. aeruginosa on cetrimide agar for counting 
bacterial colonies (F). The values shown are means ± SEM, (n=3). Significance was 









Figure 4.10 The interactions between E. coli BL21 and the pathogens. BL21 at an MOI of 
100 was mixed with P. aeruginosa, S. aureus or E. faecalis at an MOI of 10 in LB broth, 
and incubated at 37 ℃ for 4 hours. Serial dilutions from the mixed cultures were prepared 
and cultured. BL21 colonies were counted after incubation at 37 ℃ for 24 hours. The 
values shown are means ± SEM, (n=3). Significance was determined using two tailed 









The current chapter describes targeting bacterial adherence to host cells as a potential 
method of treating bacterial infections. It is well known that commensal E. coli strains have 
the ability to bind to epithelial cells via the expression of a range of adhesins, such as 
fimbriae and flagella (Nowrouzian et. al., 2001; Dhakal et. al., 2008; Haiko and 
Westerlund-Wikstrom, 2013). The adherence ability of the commensals leads to the 
protection of host cells due to the competition with pathogenic bacteria. It has been 
revealed that commensal strains of E. coli have the capability to displace pathogenic E. 
coli strains during intestinal infections (Hancock et. al., 2010). In this study, adhesion 
inhibitors based on the MAM7 adhesin homolog from the commensal E. coli strain HS 
were designed, using beads coupled to GST-HSMAM7 and an engineered BL21-
HSMAM7 to adhere to host cells. Herein, the inhibitory effects of beads coupled to GST-
HSMAM7 and BL21-HSMAM7 on S. aureus, P. aeruginosa and E. faecalis was 
investigated. The findings revealed that both HSMAM7 based inhibitors have the ability to 
decrease bacterial attachment and cytotoxic effects. 
Beads coupled to GST-HSMAM and BL21-HSMAM7 inhibited P. aeruginosa infection. 
However, no effects were observed using the controls. The inhibition was due to the 
competition for the attachment sites. Similar results were obtained when V. 
parahaemlyticus MAM7 based inhibitors were used against P. aeruginosa (Krachler et. al., 
2012). 
Beads coupled to HSMAM7 inhibited S. aureus attachment and cytotoxic effects. These 
results agree with the previous results obtained using beads coupled to V. 




BL21 expressing MAM7 from V. parahaemolyticus was used to inhibit the infections 
caused by Gram negative bacteria such as V. cholerae, V. parahaemolyticus, Y. 
pseudotuberculosis, enteropathogenic E. coli (Krachler et.al., 2011), Pseudomonas 
aeruginosa, Klebsiella pneumoniae, and Acinetobacter spp (Krachler et.al., 2012). 
However, no studies were done using BL21 expressing MAM against Gram positive 
bacteria. Herein, BL21 expressing HSMAM was used against Gram positive bacteria; S. 
aureus and E. faecalis. Using BL21 -HSMAM7 as an adhesion inhibitor against S. aureus 
showed significant effects on both bacterial attachment and cytotoxicity (6-fold reduction). 
However, the incubation with the BL21 control results in a slight inhibition (2 fold) in both 
adherence and cytotoxicity. Co-incubation of BL21 with S. aureus in liquid medium 
resulted in the decrease of BL21 growth but no effects on S. aureus growth (Figures 4.6 
and Figure 4.10). This inhibition could be because of the production of secreted inhibitory 
agents by S. aureus. It has been shown that S. aureus produces antimicrobial agents 
such as bacteriocin (staphylococcins) (Al-Gosha’ah et. al., 2014). Bacteriocins from Gram 
positive bacteria have inhibitory effects against Gram positive in addition to some of Gram 
negative bacteria (Hsu and Wiseman, 1971; Ahmad et.al., 2003). Nevertheless, the 
secretion of antibacterial factors by S. aureus does not affect BL21-HSMAM7 inhibitory 
activity. However, its production of antibacterial factors does impact its potential to attach 
and cause cytotoxicity. The inhibitory role of BL21-HSMAM7 was also confirmed via 
visualization of the treatment. 
Beads coupled to GST-HSMAM7 reduced E. faecalis cytotoxicity (2 fold reduction), while 
BL21–HSMAM7 reduced the cytotoxicity (10-fold reduction) and the BL21 control cause a 




was inhibited when both bacteria were co incubated in liquid medium. This inhibition could 
be because of the competition for nutrients. The limitation of E. coli growth does not affect 
its ability to outcompete E. faecalis. This could be because of the initial excess of E. coli 
over E. faecalis in the experiment.  
This study demonstrates that HSMAM7 based inhibitors have the ability to displace the 
tested pathogenic bacteria from host cells. In addition, using an engineered live bacterium 
(BL21-HSMAM7) may increase this displacement effect over that of semi-synthetic 
materials, depending on the competing pathogen. Besides the competition for the 
attachment sites, the competition between live bacteria with pathogens may involve other 
factors such as competition for nutrients or the production of antimicrobial agents that 
impact the production of virulence factors. Therefore, these factors need to be considered 
when designing adhesion inhibitors.  
It seems that the anti-adhesion property is a conserved feature among MAMs. In the case 
of Vibrio MAM7-based inhibitors, it has been shown that MAM7 has the ability to displace 
pathogens from the host surface and it utilizes phosphatidic acids as a receptor to bind to 
host cells. In this study, the next steps would involve identification of host surface 







Chapter 5. The E. coli HSMAM7 adhesin binds to host 




An important step in bacterial colonization is the adherence to the host cells. Most 
bacteria that interact with host cells express adhesins on their surface that aids their 
attachment. Bacterial attachment occurs via recognizing and adhering to specific 
structures on the host cells such as the extracellular matrix (ECM) proteins and/or host 
lipids. The successful interaction depends on the affinity and the concentration of 
adhesins and receptors, in addition to the presence of inhibitory and nutritional materials 
(Khan et.al., 1996). Multivalent Adhesion Molecule7 (MAM7) is expressed on the cell 
surface of Gram negative bacteria and mediates the interactions with the host receptors. It 
has been shown that MAM7 from the pathogenic bacteriumV. parahaemolyticus adhere to 
a wide range of host cells such as macrophages, epithelial cells and fibroblasts. V. 
parahaemolyticus MAM7 recognizes phosphatidic acid and fibronectin to achieve a tight 
binding to the host (Krachler et. al, 2011; Krachler and Orth, 2011). These interactions 
stimulate host signalling that aid pathogenic invasions (Lim et. al., 2014).  
Based on the fact that intestinal commensals colonize the human gastrointestinal tract 
and confer a protective barrier to inhibit infections by pathogens, the MAM7 ortholog of the 




In this chapter, the results revealed that sulfates are important for the binding of MAM7 
from the commensal Escherichia coli HS to the host ligands. The interactions between 
HSMAM7 with sulfated receptors and mucin have not been reported previously.  
Mucosal surfaces have carbohydrate moieties as binding sites for pathogens and 
carbohydrate moieties exist either in the form of glycolipids or glycoproteins. Sulfatide (3-
O-sulfogalactosylceramide) is present in the membranes of many cell types (Takahashi 
and Suzuki, 2012) and is mainly found in myelin and accounts for 4% of total membrane 
lipids (Ishizuka, 1997). Sulfatide is known to mediate the binding of variety of bacteria to 
the host cell surface and is recognized by a variety of bacteria such as the respiratory 
pathogen, Bordetella pertussis. It has been shown that filamentous hemagglutinin (FHA) 
adhesin in B. pertussis binds to sulfated glycolipids to initiate infection (Julie et. al., 2007).  
In addition, the binding of Mycoplasma pneumoniae to sulfated glycolipids was 
investigated. It has been found that M. pneumoniae bound to sulfatide and the binding to 
purified sulfatides and human colon adenocarcinoma cells WiDr was inhibited using 
Dextran sulfate (Krivan et. al., 1989). H. pylori bind to sulfatide via the heat-shock protein 
Hsp 70 (Huesca et.al., 1998; Kobayashi et.al., 2009). 
Mucus covers epithelial surfaces and acts as lubricant and a protective barrier to protect 
the underlying epithelial cells from damage that could be caused by drugs, toxins, acids 
and microbial infections. Goblet cells secret the mucus layer that cover both of the small 
and large intestine. In the small intestine, the mucus layer is a discontinuous loosely-
adherent layer (Johansson et. al., 2011; Atuma et. al., 2001). Whereas, the colon is 




layer and an inner firmly-attached layer. The outer layer provides nutrients for the 
commensals that contribute to the protection against pathogens. 
Most of the commensal bacteria that inhabit the colon are obligate anaerobic bacteria. 
The majority of bacteria from the phyla Firmicutes and Bacteroidetes (Mariat et al. 2009), 
in addition to Actinobacteria, Verrucomicrobia, Fusobacteria, Proteobacteria and 
Spirochaetes (Rajilic-Stojanovi et. al., 2007; Zoetendal et. al., 2008). Facultative 
anaerobes such as Lactobacillus spp, Escherichia coli and Enterobacter  spp are present 
as well. It is well known that commensals do not cause infection in the healthy host and 
the interactions between commensal bacteria and the host is useful. Therefore, 
commensals contribute in limiting pathogenic colonization and the invasion of epithelial 
cells due to the competition for nutrients and binding sites. Moreover, commensals 
release antimicrobial peptides known as bacteriocins that inhibit bacterial growth (Cunliffe 
and Mahida, 2001). The mucus inner layer does not contain bacteria due to the high 
content of digestive enzymes, immunoglobulins and antimicrobial peptides (Phillipson et. 
al., 2008). The major constituents of the mucus are mucins that contribute in the 
interactions between epithelial cells surfaces and microorganisms (Linden et. al., 2008; 
Johansson et. al., 2011). Bacterial binding to the mucin oligosaccharides facilitates 
removal of bacteria and inhibits their colonization of epithelial cells (Thornton and 
Sheehan, 2004). Although many pathogens can be trapped when they bind to the 
secreted mucin within the mucus, some pathogens go through this barrier to infect the cell 
surface. Therefore, cell surface mucins act as hindrance to release these pathogens from 




Depending on the composition of sugars on the mucins, they can be classified into two 
groups; acidic and neutral mucins. Acidic mucins comprise sialic acid and thus they are 
known as sialo mucins and/or sulfate groups, thus they are known as sulfo mucins 
(Derrien et. al., 2010; Brockhausen, 2003). In the sulfo mucins, the sulphate group is 
linked to specific sites on the sugar chain. Sulphate is linked to the C-6 of N-
acetylglucosamine (GlcNAc), C-6 N-acetylgalactoseamine or the C-3 of terminal galactose 
groups (Robbe et. al., 2004). Mucin is a main factor for bacterial attachment and 
colonization because of its carbohydrate content (Shuter et. al., 1996; Trivier et.al., 1997).  
 Although mucin carbohydrates being considered as the binding sites for bacterial 
attachment (Roos and Jonsson, 2002), bacterial adhesins bind to a specific residue on 
carbohydrates. Some bacterial adhesins recognize and bind to sialic acid groups while 
others recognize sulfate residues in mucin as well as in cells receptors. For example, 
sialic acid recognition has been reported for Streptococcus pyogenes. It has been found 
that the M protein in Streptococcus pyogenes binds to pharyngeal epithelial cells and 
mucins through recognizing sialic acid residues (Ryan et. al., 2001). However, 
Lactobacillus reuteri JCM1081 binds to sulfated carbohydrate moieties of mucins and 
glycolipids (Nishiyama et. al., 2013). H. pylori recognize and bind to sulphated 
oligosaccharides on salivary mucins but a very weak binding was also observed to sialic 
acids (Veerman et.al., 1997). 
In a healthy colon, mucus contains heavily sulphated mucins that protect the mucus from 
bacterial degradation (Nieuw Amerongen et.al., 1998). The sulfation process is important 
to protect mucins from degradation by bacterial enzymes. Under some conditions the 




opportunistic bacterial infection. B. thetaiotaomicron is a prominent bacterium in the 
gastrointestinal tract (Qin et. al., 2010). The interactions between B. thetaiotaomicron and 
the host are beneficial for both. Although B. thetaiotaomicron is a commensal bacteria, it 
can cause opportunistic infections such as meningitis (Feuillet et. al., 2005), bacteraemia 
and intraabdominal sepsis (Aldridge and O’Brien, 2002; Goldstein, 1996; Redondo et.al., 
1995).  
 The ability to forage both dietary polysaccharides and the mucosal glycans is a strategy 
by which B. thetaiotamicron is able to adapt and compete with other microorganisms in 
the gut. B. thetaiotaomicron has carbohydrate active enzymes (CAZymes) that contributes 
to the metabolism of carbohydrates (Hehemann et.al., 2012). In addition, the B. 
thetaiotaomicron genome contains 28 putative sulfatase genes and an anaerobic 
sulfatase-maturating enzyme (anSME) (BT0238) which is essential for the activity of all 
sulfatases (Benjdia et. al., 2011). It was reported that the deletion of the gene that 
encodes an SME resulted in the loss of the ability to desulphate the sulfated 
polysaccharides as a result of loss of sulfatase activity (Benjdia et. al., 2011). B. 
thetaiotaomicron uses mucosal glycan for degradation when the dietary sources of 
glycans are unavailable (Benjdia et. al., 2011). It has been shown that a diet high in fiber 
and thus complex glycans promotes both the growth of the gut microbiota and the 
protection from disease (Sonnenburg and Sonnenburg, 2014). The protection may occur 
via the degradation of the dietary carbohydrates instead of mucus glycans. A recent study 
has shown that feeding mice colonized with synthetic microbiota with fibre rich dietary 
sources resulted in a thicker mucus layer compared with those that were fed with fibre 




Degradation of mucus by the microbiota may affect human health and cause disease. 
Inflammatory bowel disease (IBD), a chronic inflammation in the gut, could result from 
both genetic problems and alteration in the microbiota composition (Khor et. al., 2011; 
Andrew et. al., 2015). The major categories of inflammatory bowel disease are Crohn's 
disease and ulcerative colitis. B. thetaiotaomicron may have a role in causing 
inflammatory bowel disease. It has been shown that B. thetaiotaomicron produces 
sialidase to release the sialic acid from the host glycans and this process results in 
supplying sugars to pathogens such as Salmonella enterica and Clostridium difficile 
(Katharine et. al., 2013). In another study, it has been reported that the inflammation 
results from the contact between the outer membrane vesicles secreted from B. 
thetaiotaomicron containing sulfatase, and host immune cells (Hickey et. al., 2015). 
This chapter describes the interactions between MAM7 from the commensal E.coli HS 
with sulfated ligands such as sulfatide, several components of extra cellular matrix and 
mucin and how the desulfation affects this binding. In addition to describe the interactions 
between the gut microbiota and the host via investigating the ability of B. thetaiotaomicron 
to desulfate and degrade mucosal glycans that might provide a new aspect of how this 








5.2 HSMAM7 binds to phosphatidylinositol -3- phosphate and sulfatide  
The purpose of the current study is to investigate the interactions between HSMAM7 
protein and host lipids. The binding of V. parahaemolyticus MAM7 to host lipids has been 
investigated and it has been revealed that MAM7 binds to phosphatidic acids (Krachler 
and Orth, 2011). 
To test the binding of MAM7 from the commensal E. coli HS to host lipids, recombinant 
purified GST- HSMAM7 protein was used in this study. Lipid overlay and indirect ELISA 
assays have been done for this purpose. For lipid overlay assay, PIP-Strips TM and 
Sphingo-Strips were used. These membranes contain different immobilized lipids on the 
surface. The assay involves incubation of the purified recombinant protein GST-HSMAM7 
or GST protein (control) with these lipids. Then anti GST–mouse antibody and anti- mouse 
IgG-HRP antibodies were used to probe for bound GST- HSMAM7, followed by ECL 
detection. The results revealed that GST-HSMAM7 protein binds to phosphatidylinositol -
3- phosphate (PI (3) P) on the PIP- Strip and sulfatide on the Sphingo-Strip. Whereas, no 













                                                                                                             
Figure  5.1  Lipid  overlay assay of  GST- HSMAM7 protein. (A) Layout and lipid contents 
of Sphingo-Strip. (B) Layout and lipid contents of PIP –Strip. GST-HSMAM7 protein and 
GST(control) at concentration of 10 µM was incubated with membranes which contain 100 
pmol of spotted lipids, and bound proteins detected by probing membranes with anti GST–
mouse and anti-mouse IgG-HRP antibodies, and developing with enhanced 








Because phosphatidylinositol -3- phosphate is intracellular and does not have a role in 
bacterial adhesion, the interaction between E. coli HSMAM7 and phosphatidylinositol -3- 
phosphate has not been investigated further. However, a large variety of bacteria 
recognizes and binds to sulfatide, so this interaction was investigated in more detail. An 
ELISA assay was used to quantitate the binding of HSMAM7 to the host lipids sulfatide, 
ceramide, which is the same scaffold as sulfatide but lacks the sulfate group, and 
phosphatidic acid, which binds V. parahaemolyticus MAM7. Wells of a high-bind microtiter 
plate were coated with 50 µl of 200 µg/ml sulfatide, ceramide, phosphatidic acid or were 
left uncoated. GST-HSMAM7 was added at indicated concentrations and binding 
quantified by incubation of plates with anti GST–mouse followed by incubation with anti-
mouse IgG-HRP antibodies and ECL detection. The results demonstrate that GST-
HSMAM7 bound to sulfatide with high affinity, but displayed much lower binding to 
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Figure 5.2 ELISA to quantitate binding of GST-HSMAM7 to host lipids. (A) Diagram of the 
structures of sulfatide, ceramide and phosphatidic acid (PA). (B) The luminescence output 
is plotted against GST- HSMAM7 protein concentration. Results shown are means ± SEM 






5.3 HSMAM7 binds to host sulfated proteins  
This study was aiming to investigate the interactions between HSMAM7 with the proteins 
of the host cells using a pull down assay. The principle of this assay is that GST fusion 
protein binds to the glutathione beads and pulls down specific proteins in the cell lysate. 
These proteins are collected by centrifugation of the beads and boiling them in the SDS 
buffer. Then they are subjected to SDS–PAGE and Coomassie staining to separate and 
visualize protein bands. In this study, Hela cells lysate was prepared as mentioned in 
section 2.12.5. The purified recombinant proteins (GST-HSMAM7) or GST protein 
(control) were incubated with Hela cells lysate. Then the mixture was added to the 
glutathione agarose beads. The reaction mixture was centrifuged and the pellet was 
washed with washing buffer to remove unbound proteins, followed by separating bound 
proteins using SDS- PAGE. Commassie stain was used to visualize the bands. The result 
of the SDS–PAGE revealed the presence of seven individual protein bands that were 
pulled down by the recombinant protein GST- HSMAM7, and only one band for GST 
control. To analyze and identify the bands, they were cut and sent for mass spectrometry. 
The results revealed identification of the following proteins specifically bound to GST-












Figure 5.3 E. coli HSMAM7 binds to host sulfated proteins. (A) SDS-PAGE of the 
recombinant HSMAM7 protein using a pull down assay. The purified recombinant protein 
HSMAM7 at a concentration of 200 µg/ml was incubated with Hela lysate. Followed by 
adding DSP at a final concentration of 100 µg/ml and incubated at room temperature for 
30 minutes. GSH beads were added and incubated overnight at 4 °C. The reaction 
mixture was centrifuged and the pellet was washed 4 times with washing buffer. Proteins 
were eluted into SDS sample buffer.  SDS -PAGE was run followed by Commassie stain 
to detect the protein bands. Lysate (Lys), Flow through (Flt), pellet washes (W1-W4), 
eluate fractions (Eluate) and the control (Eluate cont).  Bands 1-7 were cut out and 
subjected to tryptic digest and protein ID by LC-MS/MS. (B) Top hits for protein bands 1-7 









5.4 HSMAM7 binds to gastric mucin but does not bind to bovine 
submaxillary mucin 
Based on the mass spectrometry analysis, mucin was one of the glycoproteins that were 
pulled down by HSMAM7. Since mucin is one of the first host receptors intestinal bacteria 
will encounter, this interaction was investigated further. An indirect ELISA assay was 
performed to quantify the interaction of the GST- HSMAM7 protein with mucin. Different 
types of gastric mucins and salivary mucin were used in this study to test if MAM7 binding 
was limited to a specific type of mucin. Mucin from porcine stomach type II, mucin from 
porcine stomach type III and mucin type I-S from bovine submaxillary glands (Sigma) were 
used. Different concentrations of GST-HSMAM7 protein were added to the immobilized 
mucin in 96 well microtiter plates for 2 hours. Anti GST–mouse antibody (1:1000), then 
secondary anti mouse IgG–HRP antibody (1:5000) in blocking buffer was added, followed 
by ECL detection.  The results revealed that GST-HSMAM7 strongly bound both mucin 
type II and III from porcine stomach (Figure 5.4 and Figure 5.5), while no binding was 
detected to mucin type I-S from bovine submaxillary glands (Figure 5.6). All three mucins 
contain the same Muc2 core structure, but differ in their level and quality of glycosylation, 
with mucin type I-S carrying shorter O-linked glycans and being most heavily sialylated. It 
has been shown that the amount of sialic acid in porcine gastric mucin (0.5-1.5%) is less 
than mucin type I-S bovine submaxillary glands (9-17%) of the total mass (Madsen et. al., 
2016).  These data suggest that HSMAM7 specifically recognizes glycosylation patterns 
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Figure 5.4 ELISA to detect the binding of HSMAM7 protein to mucin from the porcine 
stomach type II. (A) The luminescence output is plotted against protein concentrations. (B) 
Imaging the 96 well microtiter plate. Wells coated with either 50 μg/ml mucin from the 
porcine type II or were left uncoated. GST-HSMAM7 or GST protein (control) were added 
at concentrations between 0-500 µg/ml. Binding of GST-HSMAM7 or GST to mucin was 
quantified using anti GST-mouse and anti-mouse HRP antibodies coupled with 
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Figure 5.5 ELISA to detect the binding of HSMAM7 protein to mucin from the porcine 
stomach type III. (A) The luminescence output is plotted against proteins concentrations. 
(B) Imaging the 96 well microtiter plate. Wells coated with either 50 μg/ml mucin from the 
porcine type III or were left uncoated. GST-HSMAM7 or GST protein (control) were added 
at concentrations between 0-500 µg/ml. Binding of GST-HSMAM7 or GST to mucin was 









Figure 5.6 ELISA to detect the binding of HSMAM7 protein to mucin type I-S from bovine 
submaxillary glands. Wells contained either 50 μg/ml mucin type I-S from bovine 
submaxillary glands or were left uncoated. GST-HSMAM7 or GST protein (control) were 
added at concentrations between 0-500 µg/ml. Binding of purified GST-HSMAM7 or GST 
protein (control) to mucin was quantified using anti GST-mouse and anti-mouse HRP 
antibodies coupled with chemiluminescence detection. The luminescence output is plotted 









5.5 Mucin inhibits bacterial binding to epithelial cells 
Since mucus, in the form of the mucus layer is usually the first surface encountered by 
bacteria entering the intestinal lumen, and contributes in keeping the microbiota at a 
distance from the epithelial cells. Herein, the ability of mucin to compete with E.coli 
expressing HSMAM7 on their surfaces was investigated. In vitro, mucin from porcine 
stomach type II was used to compete with E.coli expressing HSMAM7 and inhibit their 
binding to Hela cells. In triplicate, Hela cells were infected by adding E. coli expressing 
HSMAM7 (BL21-HSMAM7) or E. coli (BL21 control) at an MOI of 100 with mucin at a final 
concentration of 50 µg/ml and incubated for 1 hour. The attachment was assessed via 
counting the colony forming units that adhered to Hela cells. In addition, the infected cells 
were fixed and stained with Hoechst and green phalloidin for imaging the bacterial 
attachment of mCherry expressing bacteria and counting bacterial cells that adhered to 
the Hela cells. The results revealed that pre-incubation of HSMAM7-expressing BL21 with 
mucin type II decreased bacterial attachment to Hela cells to background levels (BL21 
control without HSMAM7), while the non-specific adherence of BL21 without HSMAM7 
was not affected by incubation of bacteria with mucin (Figure 5.7 and Figure 5.8). These 
results demonstrate that interaction of HSMAM7 with mucin inhibits bacterial attachment 
to the epithelial surface. 
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Figure 5.7 Mucin inhibits the attachment of E. coli HSMAM7 to Hela cells. Hela cells were 
incubated with E. coli BL21-HSMAM or E. coli BL21 at an MOI of 100 and mucin from 
porcine stomach type II at a final concentration of 50 μg/ml for 1 hour. (A) The adhered 
bacterial cells were counted using image analysis. (B) CFU counts of the attached 
bacterial cells to Hela. Values show means ± SEM. Significance was determined using 
two tailed student’s t test (* p ≤0.05).  
 






                             
 
Figure 5.8 Mucin inhibits the attachment of E. coli HSMAM7 to Hela cells. (A) Adherence 
of E. coli (BL21-HSMAM7) expressing mCherry (red) to Hela cells. (B) Mucin from porcine 
stomach type II inhibits attachment of E. coli (BL21-HSMAM) to Hela cells. Cells were 














5.6 Sulfation is necessary for the binding of HSMAM7 to mucin 
E. coli strain HS inhabits the human colon, which is covered by mucus containing heavily - 
sulphated mucins (Nieuw Amerongen et.al., 1998). Based on the results above showing 
that HSMAM7 binds to the gastric mucins, but does not bind to mucins type I-S from 
bovine submaxillary glands. The aim of this work was to investigate if mucin sulfation was 
required for the interaction between HSMAM7 and mucin. An indirct ELISA assay was 
used to study the interaction of HSMAM7 protein with desulfated mucin. To desulfate the 
mucin, a pure sulfatase from Helix promatia was used. Different concentrations of 
sulfatase were added to the immobolized mucin (mucin from porcine stomach type II) and 
incubated at room temperature for 24 hours, followed by blocking with the  blocking buffer. 
To detect HSMAM7 binding, 125 µg/ml of the recombinant GST-HSMAM7 was added for 
2 hours. For quantitation of binding, anti GST–mouse antibody, secondary anti mouse IgG 
–HRP antibody were used followed by the ECL detection. The results revealed that the 
binding of the recombinant GST-HSMAM7 protein to mucin was decreased when the 
protein was incubated with desulfated mucin. Desulfation decreased the binding of GST-













       
      
Figure 5.9 ELISA to detect binding of HSMAM7 to the desulfated mucin. 50 µg/ml mucin 
was treated with different concentrations of sulfatase and 125 µg/ml of the recombinant 
GST-HSMAM7 protein was added. Anti GST–mouse and anti- mouse IgG -HRP 
antibodies were used. Followed by ECL detection. The luminescence output is plotted 











5.7 Barium chloride to quantify sulphate released from mucin 
Barium chloride was used to quantify sulphate that was released from mucin upon 
sulfatase treatment. It is well known that adding barium chloride to sulphate ions result in 
forming a white precipitate of barium sulphate: Ba2 + SO4-2 =BaSO4 (Atkinson and Hibbert, 
2000).  This method was adapted to measure the released sulfate, so it could be used to 
measure the efficiency of desulfation. Herein, Na2SO4 at concentrations (3-200 µM) was 
prepared for calculating the calibration curve. In triplicates, 100 µl of 20% barium chloride 
was added to 96 -well plate containing 100 µl/well of each concentration of Na2SO4. The 
absorbance was read at OD 600 nm (Figure 5.10).  
To quantify sulphate released from mucin upon sulfatase treatment, 50 µg/ml of mucin 
was immobilized in a 96 well plate at 4 °C overnight. To desulphate mucin, 100 µl of 
sulfatase at concentrations of 0.1- 3 U/ml was added and incubated at 37 ℃ overnight.  
To quantify the released sulphate, 100 µl of the mixture was removed into a new 96- well 
plate and 100 µl barium chloride 20% were added to each well. The absorbance was read 
at OD 600 nm. The results revealed the presence of sulphate (SO4-2) and the 
concentration of the released sulphate increased with increasing concentration of 
sulfatase enzyme. The concentration of the released sulphate (SO4-2) from the used 
mucin was ranging from 250 -350 µM and showed complete desulfation was achieved by 












Figure 5.11 Sulfate quantification using 20% barium chloride.  
 
y = 0.0022x + 0.0136 























5.8 The ability of mucin to block bacterial adhesion to epithelial cells is 
dependent on mucin sulfation 
The aim of this work was to study the binding of E. coli expressing HSMAM7 to mucin and 
desulphated mucin to confirm the effect of sulphation in the interaction of HSMAM7 
protein to sulphated receptors and mucin. Competition assays and immunostaining were 
used. Caco-2 cells were seeded on coverslips for two days before the experiments. For 
HSMAM7 protein expression, E. coli HSMAM7 was grown in LB broth containing 
arabinose to 0.05%.  In triplicate, Caco-2 cells were infected with colourless DMEM 
containing E. coli expressing HSMAM7 at MOI of 100 with 50 µg/ml mucin, or de- 
sulphated mucin. The results indicate there was a significant difference in the number of 
colony forming units (CFU) of E. coli BL21HSMAM7 that attached to Caco-2 cells in the 
presence of mucin and the number of CFUs of E. coli BL21HSMAM7 that attached to 
Caco-2 cells (control).  In contrast, no differences between the number of CFUs of E. coli 
BL21 HSMAM7 that attached to Caco-2 cells in the presence of desulphated mucin and 
the control were detected (Figure 5.12 E). Immunostaining results revealed that the 
attachment of E. coli BL21 HSMAM7 to Hela cells and Caco2 cells was inhibited in the 
presence of mucin (Figure 5.12 A,B,C,D). These data demonstrate that desulfated mucin 
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Figure 5.12 E. coli BL21 expressing HSMAM7 attaches to sulfated mucin. Caco-2 cells (A 
and B) or Hela cells (C and D) were infected with infection medium containing BL21HS 
MAM7 at an MOI of 100 with 50 µg/ml mucin (A, C), or de sulphated mucin (B, D) for 1 
hour. Cells were fixed and stained with Hoechst for DNA (blue) and phalloidin for actin 
(green). Bar 10 µm. For attachment, 0.5% Triton X-100 was added to lyse cells, and serial 
dilutions were cultured on LB agar and incubated at 37 °C for 24 hours (E). Data 
represent the means ± SEM (n=3). Significance was determined using two tailed student’s 




5.9 HSMAM7 recognizes 3-o-sulfo-galactosyl moieties found in host 
receptors 
In the sulfomucins, the sulphate group is linked to specific sites on the sugar chain. 
Sulphate is linked either to the C-6 of N-acetylglucosamine (GlcNAc), C-6 of N-
acetylgalactoseamine or the C-3 of terminal galactose (Gal) residues (Robbe et. al., 
2004). Herein, the role of sulfated sugars in inhibiting the binding of E. coli BL21HSMAM7 
to host cells was investigated. Competitive attachment assays and immunostaining 
assays were used. Caco-2 cells were seeded on coverslips for two days before the 
experiments. Caco-2 cells were infected with colourless DMEM containing E. coli 
expressing HSMAM7 at MOI of 100 with 200 µM of lactose 3 –sulphate or lactose 
(control), D- galactose-6-sulphate or D-galactose (control), N-acetyl glucosamine-6-sulfate 
or N-acetyl glucosamine (control) and incubated for 1 hour. The results revealed that 
HSMAM7 -mediated adhesion was specifically inhibited by lactose-3-sulfate. However, the 
adhesion was unaffected by the presence of of lactose, galactose, galactose-6-sulfate, N-
acetyl-glucosamine, or N-acetyl-glucosamine-6-sulfate (Figure 5.13, Figure 5.14 and 
Figure 5.15). Lactose-3-sulfate shares the 3-O-sulfo-galactosyl group found in sulfatide 
and mucin.  Taken together, these data show that recognition is glyco-specific, but also 
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Figure 5.13 E. coli BL21 expressing HSMAM7 binds to lactose 3- sulphate. Caco-2 cells 
(A and B) or Hela cells (C and D) were infected with infection medium containing BL21 
HSMAM7 at an MOI of 100 with 200 µM lactose 3 sulfate (A, C), or lactose (B, D) for 1 
hour. Cells were fixed and stained with Hoechst for DNA (blue) and phalloidin for actin 
(green). Bar 10 µm. For attachment, 0.5% Triton X-100 was added to lyse cells, and serial 
dilutions were cultured on LB agar and incubated at 37 °C for 24 hours (E). Data 
represents the means ± SEM (n=3). Significance was determined using Student’s two-
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Figure 5.14 E. coli BL21 expressing HSMAM7 does not bind to Gal-6-sulfate. Caco-2 cells 
(A and B) or Hela cells (C and D) were infected with infection medium containing BL21 
HSMAM7 at an MOI of with 200 µM D-Gal-6- sulfate (A, C), or D –Galactose (B, D) for 1 
hour. Cells were fixed and stained with Hoechst for DNA (blue) and phalloidin for actin 
(green). Scale bar 10 µm. For attachment, 0.5% Triton X-100 was added to lyse cells, and 
serial dilutions were cultured on LB agar and incubated at 37 °C for 24 hours (E). Data 
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Figure 5.15 E. coli BL21 expressing HSMAM7 does not bind to N-acetyl glucose amine 6 
sulfate. Caco-2 cells (A and B) and Hela cells (C and D) were infected with infection 
medium containing BL21HSMAM7 at an MOI of 100 with 200 µM NAGA6S (A, C), or 
NAGA (B, D). Cells were fixed and stained with Hoechst for DNA (blue) and phalloidin for 
actin (green). Scale bar 10 µm. For attachment, 0.5% Triton X-100 was added to lyse 
cells, and serial dilutions were cultured on LB agar and incubated at 37 °C for 24 hours 




5.10 The effect of B. theta on E. coli HS MAM7 binding to mucin 
5.10.1 Quantification of B. theta sulfatase activity 
Because of the highly sulphated mucins in the colon, mucins are resistant to bacterial 
degradation and thus protect the host from bacterial invasion. However, some bacteria 
use desulfation of mucins to increase their degradation by bacterial enzymes and infect 
host cells. The commensal B. thetaiotaomicron produces sulfatase and carbohydrate 
active enzymes which are involved in the carbohydrates metabolism. Bacterial sulfatase 
was quantified using enzymatic assay of sulfatase protocol from Sigma. The principle of 
this assay is that sulfatase enzymes catalyse the hydrolysis of sulfate ester of p - 
Nitrocatechol sulphate into 4-nitrocatechol which can be detected at OD 515 nm: 
p - Nitrocatechol Sulphate +  sulfatase  ------------> p - Nitrocatechol + sulphate 
Brain heart infusion (BHI) broth containing 2.5 mg/ml mucin from porcine stomach type II 
was inoculated with B. theta wt and B. theta anSME mutant and incubated 48 hours at   
37 ℃ under anaerobic conditions. Bacterial growth was centrifuged and serial dilutions 
from the supernatant were prepared using 0.2% NaCl. Then follow the protocol steps as 
mentioned in section (2.17). Sulfatase from Helix promatia (Sigma) at different 
concentrations was used to prepare the standard curve (Figure 5.16). The results 
revealed that the supernatant from B. theta wt contain sulfatase enzyme. Sulfatase 
concentration was reduced when the supernatant was diluted. No sulfatase was detected 











Figure 5.17 B. theta wt sulfatase activity. Sulfatase activity was quantified via hydrolysis of 
p - nitrocatechol sulphate into 4-nitrocatechol that was detected at OD 515 nm. Values are 
means ± SEM (n=3). 
 
y = 0.147x + 0.0062 























5.10.2 Bacterial attachment to HT-29MTX cells 
5.10.2.1 Immunocytochemistry (ICC) staining to visualize HT-29MTX 
mucin 
Prior to investigating bacterial binding to mucin on HT-29MTX cells and investigating the 
effect of B. theta on this binding, immunocytochemistry (ICC) staining was used to 
visualize mucin on HT-29MTX cells. The results show the presence of mucus spots 
covering HT-29MTX cells and not continuous mucus layer. This indicates that the mucus 




















Figure  5.18 Immunocytochemistry staining of HT-29MTX mucin. The fixed cells were 
treated with 0.1% Triton X-100 and blocked with blocking buffer. Followed by adding Anti 
muc 2 antibody produced in mouse (1:400) and the the secondary antibody (anti mouse 
IgG FITC) (1:1000). ConA was added to stain cell membrane. The image shows cell 











5.10.2.2 Alcian Blue stain to visualize HT-29MTX sulfomucin 
Alcian Blue stain was used in this study to stain mucins on HT-29MTX cells. Herein, 
Alcian Blue stain pH 1 was used to stain sulfomucins. Sulfomucins can be detected using 
Alcian blue at pH 1 or less because they are ionized at pH 1. The results show the 























         
Figure 5.19 Alcian Blue stain to visualize HT-29MTX sulfomucins. The fixed cells were 
incubated with Alcian blue stain pH 1 for 30 minutes. Cells were washed and mounted 











5.10.2.3 Bacterial binding to mucin on HT-29MTX cells 
In order to visualize bacterial adherence to HT-29MTX mucin, immunocytochemistry 
staining was used. HT-29MTX cells were seeded on coverslips in 24-well plate and 
incubated for three weeks. HT-29MTX cells were infected with BL21-HSMAM7 expressing 
mCherry and BL21 expressing mCherry at an MOI of 100 for 1 hour. After the infection, 
ICC staining was done. The images show that the tested bacteria adhere to the mucin 
spots on HT-29MTX cells (Figure 5.20 and Figure 5.21). The results indicate that the 
mucin is important for bacterial colonization due to mucin carbohydrates that might be 
















Figure 5.20 Adherence of E. coli BL21 HSMAM7 to HT-29MTX mucin. Cells were infected 
with E. coli HS (BL21-HSMAM7) expressing mCherry for 1 hour. Cells were fixed and 
stained for ICC. The image shows cell membrane (blue) (A), mucin (green) (B), E. coli 












Figure 5.21 Adherence of E. coli BL21 to HT-29MTX mucin. Cells were infected with E. 
coli BL21 expressing mCherry for 1 hour. Cells were fixed and stained for ICC. The image 
shows cell membrane (blue) (A), mucin (green) (B), E. coli BL21 expressing m Cherry 








To study the effect of B. theta on the binding of E. coli HSMAM7 to mucin, indirect ELISA 
and transmigration assays were set up using a purified mucin instead of using HT-
29MTX cells. The reason is because the mucus layer does not cover the cells completely 
under the experimental conditions. Attempts to optimize the protocol to obtain HT-29MTX 
cells with a more even mucin layer formation by mixing HT-29MTX cells in different ratios 
with Caco-2 cells, introducing movement, or by adding endogenous mucin for the last 
day of the cell growth all failed.   
 
5.10.3 B. theta inhibits HSMAM7 binding to mucin 
According to my previous results, sulfate is important for the binding of HSMAM7 to 
mucins. The aim of these next experiments was to investigate the role of sulfatase 
produced from B. theta in the inhibition of HSMAM7 binding to the mucin. An indirect 
ELISA assay was used and involved testing the interaction between GST-HSMAM7 and 
mucin in the presence of live B. theta. Different volumes of B. theta wt or B. theta anSEM 
mutant growth at OD 0.6 was added to the immobilized mucin in 96-well microtiter plate 
and incubated for different time points. Bacterial growth was discarded and the wells were 
washed once using washing buffer followed by blocking step. 125 µg/ml of HSMAM7 
protein was added and incubated for 2 hours with gentle shaking. GST–mouse antibody, 
then secondary anti mouse IgG–HRP antibody were added, followed by ECL detection. 
The results revealed that incubation of immobilized mucin with the wild type B. theta 
resulted in inhibition of HSMAM7 binding to mucin and this inhibition was increased with 




mucin with the sulfatase-deficient B. theta anSME mutant resulted in loss the binding of 
HSMAM7 to mucin after extended incubation time (Figure 5.22). These results indicate 
that binding of HSMAM7 to mucin depends on the presence of sulfoglycan on mucin. 
Thus, desulfation of mucin by sulfatase-secreting B. theta resulted in inhibition of the 
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Figure 5.22 ELISA to detect the effect of B. theta on the binding of HSMAM7 to mucin. 
Different volumes of B. theta wt or B. theta anSME mutant growth was incubated an 
aerobically with the immobilized mucin for 48 hours (A) and 72 hours (B). GST-HSMAM7 
was added at concentration of 125 µg/ml. Anti GST–mouse and anti- mouse IgG -HRP 
antibodies were used. Followed by ECL detection. The luminescence output is plotted 





5.10.4 Desulfation of the mucin layer increases bacterial 
transmigration  
In a healthy colon, mucus contains heavily sulphated mucins that protect them from 
bacterial degradation that result in the infection of the epithelial cells. Bacterial attachment 
to mucin facilitates their removal and inhibits their colonizing on epithelial cells. Herein, the 
effect of mucin sulfation on E. coli transmigration through an artificial mucus barrier was 
investigated. 100 µl of 10 mg/ml mucin was treated with 100 µl of 1U/ml Helix promatia 
sulfatase enzyme and incubated at room temperature for 24 hours with gentle shaking. 
Trans-well filters were either coated with 50 µl of 10 mg/ml mucin, desulfated mucin or  un 
coated and incubated at 4 °C for overnight, then placed onto 24 well plate containing 600 
µl colourless DMEM. Followed by adding 100 µl of 10 6 E. coli BL21 expressing HSMAM7 
or BL21 (control) growth to the trans-well filter and incubated for 2 hours. Serial dilutions 
were prepared from the filtrate and cultured on LB agar medium and incubated at 37 °C 
for 24 hours. Followed by counting bacterial colonies. The results revealed that E. coli 
rapidly migrated through uncoated transwells and motility was unaffected by the presence 
or absence of HSMAM7. Coating of transwells with a mucin gel inhibited the 
transmigration of E. coli, but retained E. coli expressing HSMAM7 more efficiently, 
suggesting the mucin layer constitutes a physical barrier but its effect is enhanced through 
specific interactions between mucin and the HSMAM7 adhesin. Treatment of mucin with 
Helix pomatia sulfatase increased the transmigration of E. coli expressing HSMAM7 to 
levels seen with BL21 control bacteria, while mucin desulfation had no significant effect on 




bacteria were trapped by mucin that acts as a physical barrier to inhibit bacterial invasion 























Figure 5.23 Recovery of E. coli transmigrated through the mucin and desulfated mucin 
coated transwells. E. coli BL21HSMAM7 or BL21 were added to the top compartment of a 
transwell either coated with type II mucin (mucin +) or left uncoated (mucin -). Mucin used 
for coating was either desulfated with sulfatase from Helix pomatia (sulfatase +) or left 
untreated (sulfatase -) prior to coating transwells. Bacterial transmigration (recovery from 
bottom well following 2 hours of incubation at 37 °C) was measured by serial dilution and 
plating. Values represent means ± SEM (n=3). Significance was determined using two 







5.10.5 B. theta desulfates and degrades mucin and aids bacterial 
transmigration 
In order to survive and compete with other microorganisms, B. theta has mucin 
degradation enzymes that are involved in the metabolic breakdown of carbohydrates 
either from dietary sources or glycoproteins in the mucus. B. theta uses mucus 
glycoproteins when dietary glycan sources are unavailable. Because mucins are highly 
sulphated in the colon, B. theta releases sulfatase enzymes to desulfate them prior to 
degradation.  Herein, the effect of B. theta on bacterial transmigration using transmigration 
assay was investigated. 100 µl from B. theta wt or B. theta anSME mutant supernatant 
was incubated with mucin at room temperature for 24 hours. 50 µl of the treated mucin 
was added into trans-well filter and incubated at 4 ℃ overnight.  Followed by adding 100 
µl of 10 6 E. coli BL21HSMAM7 growth to the coated trans-well filters and incubated at 37 
℃ for 2 hours. Serial dilutions were prepared from the filtrate and cultured on LB agar 
medium. The results indicate that the number of CFUs of E. coli BL21HSMAM7 that 
migrated through the treated mucin coated filters with B. theta wt or B. theta anSME 
mutant was significantly higher than the number of CFUs that passed through the mucin 
coated filters (Figure 5.24). The results indicate that desulfation and mucin degradation by 
B. theta can accelerate transmigration of E. coli expressing MAM7, which otherwise get 









Figure 5.24 Recovery of E. coli BL21-HSMAM7 transmigrated through the desulfated and 
degraded mucin coated transwells. E. coli BL21HSMAM7 was added to the top 
compartment of a transwell either coated with type II mucin (mucin +) or left uncoated 
(mucin -). Mucin used for coating was either treated with supernatant from wild type B. 
theta (Bt+) or from the sulfatase-deficient B. theta (anSME) mutant (Bt-) prior to coating 
transwells. Bacterial transmigration (recovery from bottom well following 2 hours of 
incubation at 37 °C) was measured by serial dilution and plating. Values represent means 









The aim of this work was to study the interactions between HSMAM7 protein and host 
ligands in detail, and identify the biochemical basis for adhesin-ligand interactions.     
Previously, it has been reported that the well characterized MAM7 from Vibrio 
parahaemolyticus recognizes the host lipid phosphatidic acid and the extracellular matrix 
protein fibronectin as receptors (Krachler et. al., 2011; Krachler and Orth, 2011). Herein, 
the results revealed that MAM7 from the commensal bacteria E. coli strain HS (HSMAM7) 
uses the host lipid sulfatide for adherence. Sulfatide is an abundant host cell lipid, 
accounting for 4 % of total membrane lipid content (Ishizuka, 1997). Sulfatides participate 
in a wide range of cellular functions; including protein trafficking, cell adhesion and 
aggregation, as well as immune responses ((Xiao et. al., 2013; Takahashi and Suzuki, 
2012; Takahashi and Suzuki, 2015). Additionally, both viruses and bacteria have been 
found to utilize sulfatides as host receptors for adherence. It has been revealed that 
sulfatides serve as a receptor for P. aeruginosa (Xia et. al., 2007), Bordetella pertussis 
(Julie et. al., 2007), H. pylori (Kamisago et. al., 1996; Kobayashi et.al., 2009), 
enterotoxigenic Escherichia coli (ETEC) (Janson et. al., 2009) and Influenza A virus 
(Takahashi and Suzuki, 2015).                                              .                                                                                                
Pull-down experiments with purified recombinant GST-HSMAM7 protein as a bait 
identified five host epithelial proteins specifically interacting with the adhesin; perlecan, 
mucin, fibronectin, collagen IV and laminin. All identified binding partners are extracellular 
proteins, and have been reported to be heavily glycosylated and sulfoglycosylated 
(Hummel et. al., 2007; Colburn et.al., 1987), or to bind to sulfated ligands, such as in the 




been found that a variety of bacteria utilize these proteins as host receptors for adherence 
(Bucior, et.al., 2012; Oh et. al., 2016; Longhi et. al., 2009; Bober et. al., 2010; Tailford et. 
al., 2015). 
The identified receptors are either localized at the epithelial surface or at the basement 
membrane. Therefore, further work was done on the interaction between HSMAM7 and 
mucin. Mucin is a major component of the mucosal layer of the gastrointestinal tract and is 
one of the earliest targets faced by bacteria entering the gastrointestinal tract. The 
interactions between microbes and mucin oligosaccharides have been shown to facilitate 
bacterial clearance and to inhibit colonization of epithelial cells (Martin Sosa et. al., 2002; 
Ruiz Palacios et. al., 2003). The deficiency in mucin results in a severe disease and 
intestinal inflammation (Bergstrom et. al., 2010; Van der Sluis et. al., 2006). 
A variety of bacteria use mucin specifically as a binding site such as P. aeruginosa 
(Lillehoj et. al., 2002), S. aureus (Shuter et. al., 1996) and H. pylori (Linden et. al., 2004). 
The specificity in the binding could be because of the similarity in structure between 
secreted mucins and the glycoproteins on the cell surfaces (Ryan et. al., 2001).                                                       
The current study involves characterization of the binding of HSMAM7 protein to mucin. 
Herein, the results revealed that HSMAM7 protein interacts with mucin in a sulfation- 
dependent manner. The interaction of HSMAM7 protein with sulfated mucin competitively 
inhibits attachment of E. coli expressing HSMAM7 to epithelial cells, and desulfation of 
mucin using purified sulfatase decreased the binding of HSMAM7 protein to mucin. In 
addition, desulfated mucin also lost the ability to inhibit E. coli expressing HSMAM7 from 




Further analysis of competitive inhibition with sugars or sulfosaccharides showed that 
HSMAM7 protein recognize 3-O-sulfo-galactosyl moiety, found in both mucin and 
sulfatide. The identification of 3-O-sulfo-galactosyl as a common binding moiety for MAM7 
binding to both host lipids and proteins has not been reported previously. Similar results 
have been shown when the 47-kDa adhesin from Lactobacillus reuteri JCM1081 binds to 
mucin and sulfatide via the 3-O-sulfo-galactosyl moiety (Nishiyama et. al., 2013). Sulfation 
of colonic mucins has been shown to play a protective role in animal models of colitis 
(Tobisawa et. al., 2010), and reduced sulfation has been associated with impaired barrier 
function and with infectious disease (Dawson et. al., 2009; Xia et. al., 2005).  
It is known that gut microbiota contribute in the protection of the host epithelial cells by 
inhibition of pathogens colonization and activates the immune response. However, 
abnormalities in microbiota composition have been contributed in human diseases (Chow 
and Mazmanian, 2010). The competition for polysaccharides is considered to be an 
important factor that shape microbiota composition. Thus some bacterial species develop 
strategies to compete with others for the host glycans when the dietary sources are an 
available such as producing sulfatase that increases glycans susceptibility to be degraded 
by bacterial glycosidases (Tsai et.al., 1995). However, degradation of the mucus layer by 
the endogenous leads to damage of the mucus layer and helps pathogens to cause 
infections (Gazzaniga and Kasper, 2016; Sonnenburg and Sonnenburg, 2014; Katharine 
et. al., 2013). The commensal an aerobic bacterium B. thetatiomicron compete with others 
for the sulphated glycans by producing sulfatase enzyme. Sulfatases are essential for 
mucosal foraging, and have a direct impact on the chemical composition and architecture 




Enhanced sulfatase activity by the intestinal microbiota has been detected in fecal 
samples from patients suffering ulcerative colitis (Corfield et.al., 1993). Herein, the 
findings suggest that the sulfation of mucin effects specific bacterial adherence to, and 
thus retention of bacteria by the mucin gel. However, desulfation and degradation of 
mucin by B. thetatiomicron can act to modulate the adherence of commensals to mucin, 
and may directly affect their retention by the mucus barrier. A limitation in predicting in 
vivo modulation of the mucus barrier effect from our in vitro assays is that the 
physiological mucus layer has components in addition to mucin, which contribute to the 
barrier’s structure and function. Additionally, mucus viscosity is not uniform, since the 
barrier consists of two layers; a loose outer layer and a denser, cell-adherent layer that is 
largely free of microbes in the healthy intestine. This complexity cannot be fully 
reproduced by the assays mentioned this study. Because the work showed in this chapter 
focused on the biochemical determinants of HSMAM7-receptor interactions, further work 
is suggested to study the effect of B. thetatiomicron sulfatase on commensals binding to 
mucin in a physiologically relevant model. Such experiment will determine if the observed 
changes in adherence in response to desulfation described herein may have an impact on 







Chapter 6.  General discussion and recommended future 
work 
Antibiotic resistance is a serious problem in the treatment of infectious diseases. 
Antibiotics are highly effective against bacteria, as they kill or prevent bacterial growth by 
targeting processes which are critical for bacterial proliferation or physiology. However, 
bacteria have developed strategies to resist the threat of antibiotics. Therefore, looking for 
alternatives to antibiotics to treat bacterial infections is indispensable.  
Since bacterial attachment to host cells is a critical step of bacterial infections, targeting 
bacterial binding to host cells is a potential strategy to treat bacterial infections without 
killing them.  
Because the commensal E. coli strains have the ability to bind to host without harming the 
host, and they can provide a barrier against infections by pathogenic bacteria via the 
competition for nutrients, binding sites and secretion of antibacterial agents known as 
bacteriocins that kill pathogens, they have been used to compete with pathogens and 
inhibit their infections. Examples include using the commensal E. coli strain Nissle 1917 to 
out compete pathogenic bacteria causing intestinal infections (Hancock et.al, 2010), and 
using the commensal E. coli strain HS to compete with pathogenic E. coli O157:H7 for  
nutrients that are important for bacterial colonization and inhibit infections (Maltby et.al., 
2013). 
In this thesis, there were several investigations based on the interactions between the 




the host cells. MAM7 is an outer membrane protein found in most Gram negative bacteria 
and contributes in bacterial attachment in the early stages of infections. 
The first chapter of the results involves the identification and characterization of a MAM7 
ortholog (accession number YP_001458619) from the commensal E. coli strain HS. I 
demonstrated that E. coli HS contain a MAM7 ortholog consisting of 879 amino acids with 
an identity of 35.78% to the well characterized MAM7 from V. parahaemolyticus. 
Previously, it had been shown that several Gram negative pathogens such as Y. 
pseudotubercolusis, V. cholera, enteropathogenic E. coli, and Shigella sp harbour MAM7 
(Krachler et. al., 2011; Mahmoud et. al., 2016), but orthologs from commensal bacteria 
had not been studied. 
The potential role of MAM7 from the commensal E. coli HS in bacterial attachment to host 
cells was investigated. An engineered bacterium expressing HSMAM (BL21-HSMAM7) 
and polymer beads coupled to the purified recombinant HSMAM were designed and their 
attachment ability was investigated. I demonstrated that both BL21-HSMAM7 and beads 
coupled to HSMAM7 were able to bind to host cells. HSMAM7 confers adhesive 
properties to these agents to bind to host cells. Previously, it had been shown that BL21 
expressing MAM7 from the pathogenic bacteria V. parahamolyticus and beads coupled to 
MAM7 are able to bind to host cells (Krachler et. al., 2012; Lim et. al., 2014). MAM7 
contributes to bacterial attachment and deleting MAM7 from bacteria affects bacterial 
binding. It has been shown that the attachment of a variety of pathogenic bacteria such as 
V. parahaemolyticus, Y. pseudotuberculosis, V. cholera, or enteropathogenic E. coli to 




The second results chapter involves investigating the ability of the MAM7 from E. coli HS 
to compete with pathogenic bacteria and inhibit infection. Herein, I used BL21-HSMAM7 
and beads coupled to HSMAM7 depend on their ability to attach to host cells. In this 
study, S. aureus, E. faecalis and P. aeruginosa were used due to their clinical importance 
and their role in wound and tissue infections. I demonstrated that beads coupled to 
HSMAM were able to protect host cells from bacterial infections due to their ability to bind 
to host cells and compete with pathogens for the attachment sites. However, the 
protection of host cells using BL21-HSMAM7 does not solely depend on binding sites, but 
other factors also affected the competition between BL21-HSMAM7 and pathogens, and 
these factors depended on the bacteria involved. I found that the competition between S. 
aureus and BL21-HSMAM7 is caused by both attachment competition and interspecies 
antagonism. It is well known that S. aureus produces antimicrobial agents such as 
bacteriocin (Al-Gosha’ah et. al., 2014). It has been shown that bacteriocins from Gram 
positive bacteria have activity against Gram positive as well as some of Gram negative 
bacteria (Hsu and Wiseman, 1971; Ahmad et.al., 2003). I found that the co incubation of 
S. aureus with the BL21 in liquid medium resulted in inhibition of BL21 growth. This 
inhibition could be resulted by the production of bacteriolytic enzymes or bacteriocins by 
S. aureus, as the supernatant of an S. aureus growth caused inhibition zone on E. coli 
BL21 growth. The results showed that the secretion of inhibitory agents by S. aureus 
affects it’s potential to adhere and cause cytotoxic effects, but does not affect BL21- 





The competition between BL21-HSMAM7 and E. faecalis is both for attachment sites and 
for nutrients. The competition between BL21-HSMAM7 and P. aeruginosa is due to the 
competition for the binding sites alone. Previously, beads-coupled MAM7 and live bacteria 
expressing MAM7 inhibited the adherence and infections of P. aeruginosa (Krachler et. 
al., 2012). Beads-coupled MAM7 was used to inhibit S. aureus (MRSA)  that cause wound 
infections without affect the host cellular functions (Hawley et. al., 2013). S. aureus bind 
with high affinity to host fibronectin via the surface adhesin fibronectin binding protein A 
(FnBPA) (O'Neill et. al., 2008). MAM7 interact with the host cell lipid, phosphatidic acid in 
high affinity and use fibronectin as a co-receptor to facilitate this binding (Krachler and 
Orth, 2011). This means that the stable interaction of beads-coupled MAM7 with host cells 
can impede the attachment of S. aureus that use fibronectin as a binding site without 
affecting fibronectin related cellular functions (Hawley et. al., 2013). BL21 expressing 
MAM7 from V. parahaemolyticus inhibited the infections of a broad range of pathogenic 
bacteria (Krachler et. al., 2011). 
Targeting MAM7 and using MAM7 based inhibitors seems to be a potential way to inhibit 
bacterial infections. In case of using an engineered live bacterium E. coli (BL21-
HSMAM7) to displace pathogenic bacteria in vitro, the competition depends on the 
bacteria involved, and includes different factors such as competition for nutrients, the 
competition for the binding sites or the production of antimicrobial agents. However, the 
competition between beads coupled to HSMAM7 with pathogens depends on the 
binding sites only. Thus, using BL21-HSMAM may increase the displacement effect over 
that of beads coupled to HSMA7. In contrast, BL21-HSMAM7 could be used in vivo to 




using them for treating wounds might result in inflammatory responses and thus, delay 
the treatment. Therefore, using beads coupled to MAM7 to deliver MAM7 to the site of 
infection could be a potential approach to treat burn wound infections (Krachler et. al., 
2012; Huebinger et. al., 2016).  
Herein, the recommended future work is using MAM7 from the commensal E. coli HS in 
vivo. For example it would be interesting to treat skin infections with beads coupled to 
HSMAM7, in addition to inhibit the infections caused by food- borne pathogens using 
BL21 expressing HSMAM7. Previously, MAM7 from V. parahaemolyticus has been used 
to treat bacterial infections in vivo. It has been reported that beads coupled MAM7 has the 
potential to treat burn wounds infected with multi drug resistant P. aeruginosa due to the 
competition with the pathogen for receptors on the host. The success of this treatment 
based on that MAM7 does not affect wound healing and does not enhance inflammatory 
response (Huebinger et. al., 2016). However, using V. parahaemolyticus MAM7 to 
compete pathogens in vitro has revealed to induce cellular signaling in intestinal epithelial 
cells and break of intestinal cell junctions due to the interactions with host cells 
phospatidic acid (Lim et. al., 2014). Since commensal E. coli are capable of binding to 
epithelial cells without any illness and HSMAM7 binds to sulfatid on cell membrane with 
no affinity to phosphatidic acids, this means that the host cell signalling will be different 
from those induced by V. parahaemolyticus MAM7. Furthermore, HSMAM7 has the ability 
to adhere to host, compete with pathogens and inhibit their infections in vitro. Thus, using 
MAM7 protein from a commensal bacterium may have a good efficacy as antibacterial 




The third results chapter involves investigating of interactions between MAM7 from the 
commensal E. coli HS with host receptors. I demonstrated that HSMAM7 was able to bind 
to the host lipid sulfatide. Sulfatide is a glycolipid that has been used by a variety of 
bacteria to bind to host cells such as Helicobacter pylori (Kamisago et. al., 1996 
Kobayashi et. al., 2009), P. aeruginosa (Xia et. al., 2007) and enterotoxigenic Escherichia 
coli (ETEC) (Jansson et. al., 2009). In addition to the binding to sulfatide, HSMAM7 was 
able to bind to the extracellular matrix constituents such as, collagen IV, fibronectin, 
perlecan and laminin. It is well known that extracellular matrix components are attractive 
receptors exploited by bacteria for the binding to host cells (Vazques et. al., 2011; Singh 
et. al., 2012). Previous work on MAM7 from V. parahaemolyticus revealed that MAM7 
binds to the host cell lipid phosphatidic acid and fibronectin (Krachler and Orth, 2011).  
The binding of V. parahaemolyticus MAM7 with phosphatidic acids on the host membrane 
results in the induction of host cellular signalling that involve actin rearrangements, the 
activation of the GTPase RhoA and disruption of the epithelial barrier which aid bacterial 
invasion of the underlying tissue (Lim et. al., 2014). Because HSMAM7 does not bind to 
the host cell phosphatidic acids, thus host cell signalling will be different from those 
induced by V. parahaemolyticus MAM7. Therefore, more work is recommended to study 
how host signalling is affected by the binding of HSMAM7 to the host cell membrane lipid, 
sulfatide.    
In the same chapter, the binding ability of HSMAM7 to mucins was investigated in more 
depth. I demonstrated that HSMAM7 binds to mucins via a 3-O-sulfo-galactosyl moiety.  It 
is well known that the sulfation of mucin occurs on the 3-position of Gal and the 6-position 




sulfogalactosylceramide) also occurs at the 3-position of galactose. Thus, I demonstrated 
that HSMAM7 binds to mucin and the host lipid sulfatides via a common 3-O-sulfo-
galactosyl moiety. Furthermore, the investigation was expanded to test whether mucin 
sulfation was required for the interaction between HSMAM and mucin. I demonstrated that 
mucin desulfation using sulfatase enzyme decreased the binding of HSMAM to mucin. 
In a healthy colon, mucus contains heavily sulphated mucins that protect the mucus from 
bacterial degradation. Under some conditions, such as when B. thetaiotaomicron 
desulfate and degrade mucosal glycans when the dietary sources of glycans are 
unavailable (Benjdia et. al., 2011), mucus becomes more susceptible to degradation and 
the host more susceptible to infection. In the current study, I demonstrated that desulfation 
of mucin by the sulfatase producer B. thetaiotaomicron that inhabit the same niche as the 
commensal E. coli,  resulted in inhibition of  the binding of HSMAM7 to mucin. This means 
that mucin’s role is to trap but also bind to the commensal E. coli HS, and inhibition of this 
binding by desulfation increases bacterial attachment to the epithelial surface which has 
been linked to increase inflammation and disease (Bergstrom and Xia, 2013). Further 
work is recommended to evaluate the effect of sulfatase-produced by B. thetaiotaomicron 
on commensal adherence in a physiologically relevant in vivo model.  
In conclusion, since the inhibitors based on MAM7 from the commensal E. coli HS have 
the ability to bind to host cells, compete pathogenic bacteria and inhibit infections, 
HSMAM7 based inhibitors  could be considered as a possible opportunity to treat bacterial 
infections; especially, in case of antibiotics resistant bacteria.  In addition, the binding of 
HSMAM7 to sulfated mucin and the importance of sulfation for this binding may provide 




sulfatase producing bacteria, i.e. B. thetaiotaomicron may provide a possible approach for 
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